5-fluoro pyrimidine derivatives

ABSTRACT

This present disclosure is related to the field of 5-fluoro pyrimidines and their derivatives and to the use of these compounds as fungicides.

CROSS REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional PatentApplication Ser. No. 61/011,799 filed Jan. 22, 2008, and U.S.Provisional Patent Application Ser. No. 61/115,297 filed Nov. 17, 2008.

FIELD OF THE INVENTION

This present disclosure is related to the field of 5-fluoro pyrimidinesand their derivatives and to the use of these compounds as fungicides.

BACKGROUND AND SUMMARY OF THE INVENTION

Fungicides are compounds, of natural or synthetic origin, which act toprotect and cure plants against damage caused by agricultural relevantfungi. Generally, no single fungicide is useful in all situations.Consequently, research is ongoing to produce fungicides that may havebetter performance, are easier to use, and cost less.

The present disclosure relates to 5-fluoro pyrimidine compounds andtheir use as fungicides. The compounds of the present disclosure mayoffer protection against ascomycetes, basidiomycetes, deuteromycetes andoomycetes.

One embodiment of the present disclosure may include compounds ofFormula I:

wherein R¹ is —N(R³)R⁴;

R² is —OR²¹; R³ is:

-   -   H;    -   C₁-C₆ alkyl optionally substituted with 1- to 3 R⁵;    -   C₂-C₆ alkenyl optionally substituted with 1-3 R⁵;    -   a 5- or 6-membered heteroaromatic ring selected from the group        consisting of furanyl, pyridinyl, pyridinyl-N-oxide,        pyrimidinyl, pyridazinyl, pyrazinyl, thiazolyl, triazinyl,        thiadiazolyl, oxazolyl, isoxazolyl, triazolyl, each        heteroaromatic ring being optionally substituted with 1-3 R³⁰;    -   imidazole fused with an aromatic or heteroaromatic ring selected        from the group consisting of benzene, oxazole, isoxazole, furan,        thiazole, pyrimidine, pyridine, pyrrole, pyrazine, thiophene,        each aromatic or heteroaromatic ring being optionally        substituted with 1 to 3 R³⁰;    -   benzo[1,3]dioxolyl;    -   3H-isobenzofuran-1-onyl;    -   cyano;    -   C₃-C₆ alkynyl optionally substituted with 1-3 R⁵;    -   —C(═O)R⁶;    -   —C(═O)OCH₂C(═O)R⁸;    -   —C(═S)R⁶;    -   —C(═S)NHR⁸;    -   —C(═O)N(R⁸)R¹⁰;    -   —OR⁷;    -   —P(O)(OR¹⁵)₂;    -   —S(O)₂R⁸;    -   —SR⁸;    -   —Si(R⁸)₃;    -   —N(R⁹)R¹⁰;    -   —N═C(R¹⁵)R¹⁶;    -   —(CHR²²)_(m)R³⁷;    -   —(CHR²⁴)OR²⁹; or    -   —C(═NR¹⁶)SR¹⁶;        wherein m is an integer from 1-3;

R⁴ is:

-   -   H;    -   C₁-C₆ alkyl, optionally substituted with 1-3 R⁵;    -   —C(═O)R⁶; or    -   —C(═O)N(R)R¹⁰;        alternatively R³ and R⁴ may be taken together to form:    -   a 5- or 6-membered saturated or unsaturated ring containing 1-3        heteroatoms wherein each ring may be optionally substituted with        1-3 R¹¹;    -   ═C(R¹²)N(R¹³)R¹⁴;    -   ═C(R¹³)(R¹⁴);    -   ═C(R¹⁵)OR¹⁵;    -   ═S(R³⁴)₂; or    -   ═NR³⁵;        R⁵ is independently halogen, C₁-C₆ alkyl, C₁-C₄ haloalkyl, C₁-C₄        alkoxy, C₁-C₄ haloalkoxy, C₁-C₄ alkylthio, C₁-C₄ haloalkylthio,        amino, C₁-C₃ alkylamino, C₂-C₆ alkoxycarbonyl, C₂-C₆        alkylcarbonyl, C₂-C₆ alkylaminocarbonyl, —OH, N-methyl        piperazine or C₃-C₆ trialkylsilyl;        R⁶ is independently H, C₁-C₆ alkyl, C₁-C₅ haloalkyl, C₁-C₅        alkoxy, C₁-C₅ haloalkoxy C₂-C₆ alkoxycarbonyl, C₁-C₄        alkoxyalkoxy, C₂-C₆ alkylaminocarbonyl;        1-benzo[1,2,3]thiadiazol-7-yl, thiazolyl, benzyl, phenyl,        phenoxy, or benzyloxy wherein the thiazolyl, benzyl, phenyl,        phenoxy, or benzyloxy may be optionally substituted with 1-3        R²⁰, a 5- or 6-membered saturated or unsaturated ring containing        1-3 heteroatoms wherein each ring may be optionally substituted        with 1-3 R¹¹;        R⁷ is H, C₁-C₆ alkyl, C₂-C₆ alkenyl, C₁-C₅ haloalkyl, benzyl        which may be optionally substituted with 1-5 R²⁰, CHR¹⁸C(O)OR¹⁹,        or a 5- or 6-membered saturated or unsaturated ring containing        1-3 heteroatoms wherein each ring may be optionally substituted        with 1-3 R¹¹;        R⁸ is independently C₁-C₆ alkyl, C₁-C₆ haloalkyl, amino, C₁-C₆        alkylamino, C₂-C₆ dialkylamino, phenyl optionally substituted        with 1-3 R³⁰, or a 5- or 6-membered saturated or unsaturated        ring containing 1-3 heteroatoms wherein each ring may be        optionally substituted with 1-3 R¹¹;        R⁹ is H, C₁-C₆ alkyl C₁-C₆ haloalkyl, —C(═O)R¹⁷, or phenyl        optionally substituted with 1-3 R²⁰,        R¹⁰ is H or C₁-C₆ alkyl, C₁-C₆ haloalkyl, or phenyl optionally        substituted with 1-3 R²⁰;        R¹¹ is independently halogen, C₁-C₆ alkyl, C₁-C₆ haloalkyl,        C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, C₁-C₆ alkylthio, C₁-C₆        haloalkylthio, amino, C₁-C₆ alkylamino, C₂-C₆ dialkylamino,        C₂-C₆ alkoxycarbonyl, or C₂-C₆ alkylcarbonyl;        R¹² is H or C₁-C₄ alkyl;        R¹³ and R¹⁴ are independently H, cyano, —OH, C₁-C₄ alkyl, C₁-C₆        alkoxy, C₂-C₆, alkylcarbonyl, phenyl, or benzyl wherein the        phenyl or benzyl may be optionally substituted with 1-3 R²⁰;        alternatively R¹³ and R¹⁴ may be taken together to form:    -   a 5- or 6-membered saturated or unsaturated ring containing 1-3        heteroatoms wherein each ring may be optionally substituted with        1-3 R¹¹, or 3,4-dihydro-1H-isoquinolin-2-yl;        alternatively R¹² and R¹³ may be taken together to form:    -   a 5- or 6-membered saturated or unsaturated ring containing 1-3        heteroatoms wherein each ring may be optionally substituted with        1-3 R¹¹;        R¹⁵ is H or C₁-C₆ alkyl;        R¹⁶ is H, C₁-C₆ alkyl, or phenyl optionally substituted with 1-3        R²⁰;        alternatively R¹⁵ and R¹⁶ may be taken together as —(CH₂)₄— or        —(CH₂)₅—;        R¹⁷ is H, C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆ alkoxy, phenyl,        phenoxy, or benzyloxy wherein each ring may be optionally        substituted with 1-3 R²⁰;        R¹⁸ is H, C₁-C₆ alkyl, or C₁-C₆ haloalkyl;        R¹⁹ is H, C₁-C₆ alkyl, C₁-C₆ haloalkyl, or benzyl;        R²⁰ is independently halogen, cyano, nitro, amino, C₁-C₆        alkoxyalkoxy, C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆ hydroxyalkyl,        C₂-C₆ alkoxyalkyl, C₂-C₆ haloalkoxyalkyl, C₂-C₆ alkenyl, C₂-C₆        haloalkenyl, C₃-C₆ alkynyl, C₃-C₆ haloalkynyl, hydroxyl, C₁-C₆        alkoxy, C₁-C₆ haloalkoxy, C₂-C₆ alkenyloxy, C₂-C₆        haloalkenyloxy, C₃-C₆ alkynyloxy, C₃-C₆ haloalkynyloxy, C₁-C₆        alkylthio, C₁-C₆ haloalkylthio, C₁-C₆ alkylsulfonyl, C₁-C₆        haloalkylsulfonyl, C₂-C₆ alkenylthio, C₂-C₆ haloalkenylthio,        C₂-C₆ haloalkenylsulfonyl, C₃-C₆ alkynylthio, C₃-C₆        alkynylsulfonyl, C₃-C₆ haloalkynylsulfonyl, C₁-C₆ alkylamino,        C₂-C₈ dialkylamino, C₃-C₈ dialkylaminocarbonyl, C₂-C₆        alkoxycarbonyl, C₂-C₆ alkylcarbonyl, C₃-C₆ trialkylsilyl,        2-[(E)-methoxyimino]-N-methyl-acetamidyl, phenyl, benzyl,        benzyloxy, phenoxy, or a 5- or 6-membered heteroaromatic ring        wherein each phenyl, benzyl, benzyloxy, phenoxy, or 5- or        6-membered heteroaromatic ring may be optionally substituted        with 1-3 substitutents independently selected from R³¹;

R²¹ is:

-   -   H;    -   C₁-C₁₄ alkyl;    -   C₁-C₆ haloalkyl;    -   C₂-C₄ alkenyl;    -   C₂-C₄ haloalkenyl;    -   C₃-C₄ alkynyl;    -   C₃-C₄ haloalkynyl;    -   phenyl, naphthyl, or tetrahydroquinolinyl each optionally        substituted with 1-3 R²⁰    -   —(CHR²²)_(m)R²³;    -   —(CHR²⁴)_(m)C(O)OR²⁵;    -   —(CHR²⁴)_(m)C(O)R²⁶;    -   —(CHR²⁴)_(m)C(O)N(R²⁷)R²⁸;    -   —(CHR²⁴)_(m)OR²⁹;    -   —(CHR²⁴)_(m)SR²⁹    -   —(CHR²⁴)_(m)N(R²⁷)R²⁸;    -   —C(═O)R³²;    -   —N═C(R³²)(R³⁶);    -   —NR²⁵C(═O)OR²⁵    -   —Si(R⁸)₃;    -   —SO₂R³³;    -   C₂-C₆ alkoxy carbonyl;    -   C₂-C₆ alkylaminocarbonyl;    -   C₂-C₆ alkylcarbonyl;    -   sugars selected from the group consisting of        beta-D-glucose-tetraacetate, rhamnose, fructose, and pentose; or    -   a 5- or 6-membered heteroaromatic ring selected from the group        consisting of furanyl, pyridinyl, pyridinyl-N-oxide,        pyrimidinyl, pyridazinyl, pyrazinyl, pyrazolyl, thiazolyl,        triazinyl, thiadiazolyl, oxazolyl, triazolyl or isoxazolyl        wherein each 5- or 6-member heteroaromatic ring may be        optionally substituted with 1-5 R²⁰;        R²² is independently:    -   H;    -   halogen;    -   cyano;    -   nitro;    -   C₁-C₆ alkyl;    -   C₁-C₆ haloalkyl;    -   phenyl or benzyl optionally substituted with 1-3 R²⁰    -   C₁-C₆ hydroxyalkyl;    -   C₂-C₆ alkoxylalkyl;    -   C₃-C₆ haloalkynyl;    -   C₂-C₆ alkenyl;    -   C₂-C₆ haloalkenyl;    -   C₃-C₆ alkynyl;    -   C₁-C₆ alkoxy;    -   C₁-C₆ haloalkoxy;    -   C₁-C₆ alkylthio;    -   C₁-C₆ alkylamino;    -   C₂-C₈ dialkylamino;    -   C₃-C₆ cycloalkylamino;    -   C₄-C₆ (alkyl)cycloalkylamino;    -   C₂-C₆ alkylcarbonyl;    -   C₂-C₆ alkoxycarbonyl;    -   C₂-C₆ alkylaminocarbonyl;    -   C₃-C₈ dialkylaminocarbonyl;    -   C₃-C₆ trialkylsilyl;    -   ring-fused heteroaromatic rings selected from the group        consisting of benzothiophenyl, quinolinyl, isoquinolinyl,        thieno[2,3-b]pyridyl, 1-methyl-1H-thieno[2,3-c]pyrazolyl, and        benzoimidazolyl, wherein each of the rings may be further        substituted with 1-3 R²⁰; or    -   a 5- or 6-membered heteroaromatic ring selected from the group        consisting of furanyl, pyridinyl, pyridinyl-N-oxide,        pyrimidinyl, pyridazinyl, pyrazinyl, thiazolyl, triazinyl,        thiadiazolyl, oxazolyl, isoxazolyl, triazolyl and thienyl;

R²³ is:

-   -   H;    -   halogen;    -   C₁-C₆ alkyl;    -   C₁-C₆ haloalkyl;    -   C₂-C₆ dialkylamino;    -   phenyl optionally substituted with 1-5 R²⁰;    -   ring-fused heteroaromatic rings selected from the group        consisting of benzothiophenyl, quinolinyl, isoquinolinyl,        thieno[2,3-b]pyridyl, 1-methyl-1H-thieno[2,3-c]pyrazolyl,        benzofuranyl and benzoimidazolyl, 2,3-dihydro-benzofuran-2-yl,        4-methyl-4H-thieno[3,2-b]pyrrol-5-yl, 1-methyl-1H-indol-5-yl,        imidazo[1,2-a]pyridin-2-yl, imidazo[2,1-b]thiazol-6-yl,        benzothiazol-2-yl, benzo[b]thiophen-7-yl, and        1-methyl-1H-indazol-3-yl, wherein each of the rings may be        further substituted with 1-3 R²⁰;    -   naphthyl;    -   benzo[1,3]dioxolyl;    -   pyrrolidinonyl;    -   oxetanyl;    -   C₁-C₆ alkylthio optionally substituted with 1-5 R²⁰;    -   a 5- or 6-membered saturated or unsaturated ring containing 1-3        heteroatoms wherein each ring may be optionally substituted with        1-3 R¹¹; or    -   a 5- or 6-membered heteroaromatic ring selected from the group        consisting of furanyl, pyridinyl, pyridinyl-N-oxide,        pyrimidinyl, pyridazinyl, pyrazinyl, pyrazolyl, thiazolyl,        triazinyl, thiadiazolyl, oxazolyl, isoxazolyl, triazolyl,        imidazolyl, thiophene-2-yl and thiophen-3-yl wherein each        heteroaromatic ring may be optionally substituted with 1-3 R²⁰;        R²⁴ is H, C₁-C₆ alkyl, C₁-C₆ alkoxy, benzyl, or phenyl wherein        each of the benzyl or phenyl may be optionally substituted with        1-3 R²⁰;        R²⁵ is H, C₁-C₆ alkyl, phenyl or benzyl optionally substituted        with 1-3 R²⁰;

R²⁶ is:

-   -   H;    -   C₁-C₆ alkyl;    -   C₁-C₆ alkoxy;    -   phenyl optionally substituted with 1-3 R²⁰; or    -   a 5- or 6 membered heteroaromatic ring selected from the group        consisting of furanyl, pyridinyl, pyridinyl-N-oxide,        pyrimidinyl, pyridazinyl, pyrazinyl, thiazolyl, triazinyl,        thiadiazolyl, oxazolyl, triazolyl and isoxazolyl;        R²⁷ and R²⁸ are independently:    -   H;    -   C₁-C₆ alkyl;    -   benzyl or phenyl wherein each of the benzyl or phenyl may be        optionally substituted with 1-3 R²⁰; or    -   a 5- or 6-membered saturated or unsaturated ring containing 1-3        heteroatoms wherein each ring may be optionally substituted with        1-3 R¹¹;

R²⁹ is:

-   -   H;    -   C₁-C₆ alkyl;    -   C₁-C₆ haloalkyl;    -   C₁-C₆ alkoxyalkyl;    -   C₂-C₆ alkylcarbonyl;    -   benzyl or phenyl wherein each of the benzyl or phenyl may be        optionally substituted with 1-3 R²⁰; or    -   a 5- or 6-membered saturated or unsaturated ring containing 1-3        heteroatoms wherein each ring may be optionally substituted with        1-3 R¹¹;        R³⁰ is independently halogen, cyano, nitro, C₁-C₆ alkyl, C₁-C₆        haloalkyl, C₁-C₆ hydroxyalkyl, C₂-C₆ alkoxyalkyl, C₂-C₆        haloalkoxyalkyl, C₂-C₆ alkenyl, C₂-C₆ haloalkenyl, C₃-C₆        alkynyl, C₃-C₆ haloalkynyl, hydroxyl, C₁-C₆ alkoxy, C₁-C₆        haloalkoxy, C₂-C₆ alkenyloxy, C₂-C₆ haloalkenyloxy, C₃-C₆        alkynyloxy, C₃-C₆ haloalkynyloxy, C₁-C₆ alkylthio, C₁-C₆        alkylsulfonyl, C₁-C₆ haloalkylsulfonyl, C₂-C₆ alkenylthio, C₂-C₆        haloalkenylthio, C₂-C₆ haloalkenylsulfonyl, C₃-C₆ alkynylthio,        C₃-C₆ alkynylsulfonyl, C₃-C₆ haloalkynylsulfonyl, C₁-C₆        alkylamino, C₂-C₈ dialkylamino, C₃-C₈ dialkylaminocarbonyl,        C₃-C₆ trialkylsilyl, thiazolyl, phenyl, pyrimidinyl, or pyridyl,        wherein the thiazolyl, phenyl, pyridyl, or pyrimidinyl may be        optionally substituted with 1-3 R²⁰;        R³¹ is independently halogen, cyano, nitro, C₁-C₆ alkyl, C₁-C₆        haloalkyl, C₁-C₆ hydroxyalkyl, C₂-C₆ alkoxyalkyl, C₂-C₆        haloalkoxyalkyl, C₂-C₆ alkenyl, C₂-C₆ haloalkenyl, C₃-C₆        alkynyl, C₃-C₆ haloalkynyl, hydroxyl, C₁-C₆ alkoxy, C₁-C₆        haloalkoxy, C₂-C₆ alkenyloxy, C₂-C₆ haloalkenyloxy, C₃-C₆        alkynyloxy, C₃-C₆ haloalkynyloxy, C₁-C₆ alkylthio, C₁-C₆        alkylsulfonyl, C₁-C₆ haloalkylsulfonyl, C₂-C₆ alkenylthio, C₂-C₆        haloalkenylthio, C₂-C₆ haloalkenylsulfonyl, C₃-C₆ alkynylthio,        C₃-C₆ alkynylsulfonyl, C₃-C₆ haloalkynylsulfonyl, C₁-C₆        alkylamino, C₂-C₈ dialkylamino, C₃-C₈ dialkylaminocarbonyl, or        C₃-C₆ trialkylsilyl;        R³² is independently:    -   C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆ hydroxyalkyl, C₂-C₆        alkoxyalkyl, C₂-C₆ haloalkoxyalkyl, C₂-C₆ alkenyl, C₂-C₆        haloalkenyl, C₃-C₆ alkynyl, C₃-C₆ haloalkynyl, hydroxyl, C₁-C₆        alkoxy, C₁-C₆ haloalkoxy, C₂-C₆ alkenyloxy, C₂-C₆        haloalkenyloxy, C₃-C₆ alkynyloxy, C₃-C₆ haloalkynyloxy, C₁-C₆        alkylthio, C₁-C₆ alkylsulfonyl, C₁-C₆ haloalkylsulfonyl, C₂-C₆        alkenylthio, C₂-C₆ haloalkenylthio, C₂-C₆ haloalkenylsulfonyl,        C₃-C₆ alkynylthio, C₃-C₆ alkynylsulfonyl, C₃-C₆        haloalkynylsulfonyl, C₁-C₆ alkylamino, C₂-C₈ dialkylamino, C₃-C₈        dialkylaminocarbonyl, C₃-C₆ trialkylsilyl;    -   phenyl wherein the phenyl ring may be optionally substituted        with 1-3 R²⁰; or    -   a 5- or 6-membered saturated or unsaturated ring containing 1-3        heteroatoms wherein each ring may be optionally substituted with        1-3 R¹¹;        R³³ is independently:    -   C₁-C₆ alkyl, C₁-C₆ haloalkyl, phenyl or thienyl optionally        substituted with 1-3 R²⁰; or    -   a 5- or 6-membered saturated or unsaturated ring containing 1-3        heteroatoms wherein each ring may be optionally substituted with        1-3 R¹¹;

R¹⁴ is:

-   -   C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₂-C₆ alkoxyalkyl, C₁-C₆        alkylamino; or    -   a 5- or 6-membered saturated or unsaturated ring containing 1-3        heteroatoms wherein each ring may be optionally substituted with        1-3 R¹¹;

R³⁵ is:

-   -   C₁-C₆ alkyl, C₂-C₆ alkylcarbonyl; or    -   a 5- or 6-membered saturated or unsaturated ring containing 1-3        heteroatoms wherein each ring may be optionally substituted with        1-3 R¹¹;        R³⁶ is H, cyano, C₁-C₆ alkyl, C₁-C₆ alkoxy, benzyl, or phenyl        wherein each of the benzyl or phenyl may be optionally        substituted with 1-3 R²⁰;        alternatively R³² and R³⁶ may be taken together to form:    -   a 5- or 6-membered saturated or unsaturated ring containing 1-3        heteroatoms wherein each ring may be optionally substituted with        1-3 R¹¹; and        R³⁷ is independently:    -   H, halogen, or phenyl optionally substituted with 1-5 R²⁰;    -   C₁-C₆ alkyl, C₁-C₆ haloalkyl, hydroxyl, C₁-C₆ alkoxy, or C₁-C₆        haloalkoxy; or    -   a 5- or 6-membered saturated or unsaturated ring containing 1-3        heteroatoms wherein each ring may be optionally substituted with        1-3 R¹¹.

Another embodiment of the present disclosure may include a fungicidalcomposition for the control or prevention of fungal attack comprisingthe compounds described below and a phytologically acceptable carriermaterial.

Yet another embodiment of the present disclosure may include a methodfor the control or prevention of fungal attack on a plant, the methodincluding the steps of applying a fungicidally effective amount of oneor more of the compounds described below to at least one of the fungus,the plant, an area adjacent to the plant, and the seed adapted toproduce the plant.

The term “alkyl” refers to a unbranched, branched, or cyclic carbonchain, including methyl, ethyl, propyl, butyl, isopropyl, isobutyl,tertiary butyl, pentyl, hexyl, cyclopropyl, cyclobutyl, cyclopentyl,cyclohexyl and the like.

The term “alkenyl” refers to a branched, unbranched or cyclic carbonchain containing one or more double bonds including ethenyl, propenyl,butenyl, isopropenyl, isobutenyl, cyclohexenyl, and the like.

The term “alkynyl” refers to refers to a branched or unbranched carbonchain containing one or more triple bonds including propynyl, butynyland the like.

As used throughout this specification, the term ‘R’ refers to the groupconsisting of C₂₋₈ alkyl, C₃₋₈ alkenyl or C₃₋₈ alkynyl, unless statedotherwise.

The term “alkoxy” refers to an —OR substituent.

The term “alkoxycarbonyl” refers to a —C(O)—OR substituent.

The term “alkylcarbonyl” refers to a —C(O)—R substituent.

The term “alkylsulfonyl” refers to an —SO₂—R substituent.

The term “haloalkylsulfonyl” refers to a sulfonyl substitution on analkyl which is partially substituted with halogen atoms.

The term “alkylthio” refers to an —S—R substituent.

The term “alkylaminocarbonyl” refers to a —C(O)—N(H)—R substituent.

The term “dialkylaminocarbonyl” refers to a —C(O)—NR₂ substituent.

The term “alkylcycloalkylamino” refers to a cycloalkylamino substituentthat is substituted with an alkyl group.

The term “trialkylsilyl” refers to —SiR₃.

The term “cyano” refers to a —C≡N substituent.

The term “hydroxyl” refers to a —OH substituent

The term “amino” refers to a —NH₂ substituent

The term “alkylamino” refers to a —N(H)—R substituent

The term “dialkylamino” refers to a —NR₂ substituent

The term “alkoxyalkoxy” refers to —O(CH2)_(n)—O—(CH2)_(n) where n is aninterger from 1-3

The term “alkoxyalkyl” refers to an alkoxy substitution on an alkyl.

The term “haloalkoxyalkyl” refers to an alkoxy substitution on an alkylwhich may be partially substituted with halogen atoms

The term “hydroxyalkyl” refers to an alkyl which is substituted with ahydroxyl group.

The term “haloalkoxy” refers to a —OR—X substituent, wherein X is Cl, F,Br, or I, or any combination thereof.

The term “haloalkyl” refers to an alkyl, which is substituted with Cl,F, I, or Br or any combination thereof.

The term “haloalkenyl” refers to an alkenyl, which is substituted withCl, F, I, or Br or any combination thereof.

The term “haloalkynyl” refers to an alkynyl which is substituted withCl, F, I, or Br or any combination thereof.

The term “halogen” or “halo” refers to one or more halogen atoms,defined as F, Cl, Br, and I.

The term “hydroxycarbonyl” refers to a —C(O)—OH substituent.

The term “nitro” refers to a —NO₂ substituent.

The term “thienyl” refers to a 5-member aromatic ring with one sulfuratom.

Throughout the disclosure, reference to the compounds of Formula I isread as also including optical isomers and salts of Formula I, andhydrates thereof. Specifically, when Formula I contains a branched chainalkyl group, it is understood that such compounds include opticalisomers and racemates thereof. Exemplary salts include: hydrochloride,hydrobromide, hydroiodide, and the like.

It is also understood by those skilled in the art that additionalsubstitution is allowable, unless otherwise noted, as long as the rulesof chemical bonding and strain energy are satisfied and the productstill exhibits fungicidal activity.

Another embodiment of the present disclosure is a use of a compound ofFormula I, for protection of a plant against attack by a phytopathogenicorganism or the treatment of a plant infested by a phytopathogenicorganism, comprising the application of a compound of Formula I, or acomposition comprising the compound to soil, a plant, a part of a plant,foliage, and/or seeds.

Additionally, another embodiment of the present disclosure is acomposition useful for protecting a plant against attack by aphytopathogenic organism and/or treatment of a plant infested by aphytopathogenic organism comprising a compound of Formula I and aphytologically acceptable carrier material.

DETAILED DESCRIPTION OF THE PRESENT DISCLOSURE

The compounds of the present disclosure may be applied by any of avariety of known techniques, either as the compounds or as formulationscomprising the compounds. For example, the compounds may be applied tothe roots, seeds or foliage of plants for the control of various fungi,without damaging the commercial value of the plants. The materials maybe applied in the form of any of the generally used formulation types,for example, as solutions, dusts, wettable powders, flowableconcentrates, or emulsifiable concentrates.

Preferably, the compounds of the present disclosure are applied in theform of a formulation, comprising one or more of the compounds ofFormula I with a phytologically acceptable carrier. Concentratedformulations may be dispersed in water, or other liquids, forapplication, or formulations may be dust-like or granular, which maythen be applied without further treatment. The formulations can beprepared according to procedures that are conventional in theagricultural chemical art.

The present disclosure contemplates all vehicles by which one or more ofthe compounds may be formulated for delivery and use as a fungicide.Typically, formulations are applied as aqueous suspensions or emulsions.Such suspensions or emulsions may be produced from water-soluble, watersuspendable, or emulsifiable formulations which are solids, usuallyknown as wettable powders; or liquids, usually known as emulsifiableconcentrates, aqueous suspensions, or suspension concentrates. As willbe readily appreciated, any material to which these compounds may beadded may be used, provided it yields the desired utility withoutsignificant interference with the activity of these compounds asantifungal agents.

Wettable powders, which may be compacted to form water dispersiblegranules, comprise an intimate mixture of one or more of the compoundsof Formula I, an inert carrier and surfactants. The concentration of thecompound in the wettable powder may be from about 10 percent to about 90percent by weight based on the total weight of the wettable powder, morepreferably about 25 weight percent to about 75 weight percent. In thepreparation of wettable powder formulations, the compounds may becompounded with any finely divided solid, such as prophyllite, talc,chalk, gypsum, Fuller's earth, bentonite, attapulgite, starch, casein,gluten, montmorillonite clays, diatomaceous earths, purified silicatesor the like. In such operations, the finely divided carrier andsurfactants are typically blended with the compound(s) and milled.

Emulsifiable concentrates of the compounds of Formula I may comprise aconvenient concentration, such as from about 10 weight percent to about50 weight percent of the compound, in a suitable liquid, based on thetotal weight of the concentrate. The compounds may be dissolved in aninert carrier, which is either a water miscible solvent or a mixture ofwater-immiscible organic solvents, and emulsifiers. The concentrates maybe diluted with water and oil to form spray mixtures in the form ofoil-in-water emulsions. Useful organic solvents include aromatics,especially the high-boiling naphthalenic and olefinic portions ofpetroleum such as heavy aromatic naphtha. Other organic solvents mayalso be used, for example, terpenic solvents, including rosinderivatives, aliphatic ketones, such as cyclohexanone, and complexalcohols, such as 2-ethoxyethanol.

Emulsifiers which may be advantageously employed herein may be readilydetermined by those skilled in the art and include various nonionic,anionic, cationic and amphoteric emulsifiers, or a blend of two or moreemulsifiers. Examples of nonionic emulsifiers useful in preparing theemulsifiable concentrates include the polyalkylene glycol ethers andcondensation products of alkyl and aryl phenols, aliphatic alcohols,aliphatic amines or fatty acids with ethylene oxide, propylene oxidessuch as the ethoxylated alkyl phenols and carboxylic esters solubilizedwith the polyol or polyoxyalkylene. Cationic emulsifiers includequaternary ammonium compounds and fatty amine salts. Anionic emulsifiersinclude the oil-soluble salts (e.g., calcium) of alkylaryl sulphonicacids, oil soluble salts or sulfated polyglycol ethers and appropriatesalts of phosphated polyglycol ether.

Representative organic liquids which may be employed in preparing theemulsifiable concentrates of the compounds of the present invention arethe aromatic liquids such as xylene, propyl benzene fractions; or mixednaphthalene fractions, mineral oils, substituted aromatic organicliquids such as dioctyl phthalate; kerosene; dialkyl amides of variousfatty acids, particularly the dimethyl amides of fatty glycols andglycol derivatives such as the n-butyl ether, ethyl ether or methylether of diethylene glycol, and the methyl ether of triethylene glycoland the like. Mixtures of two or more organic liquids may also beemployed in the preparation of the emulsifiable concentrate. Organicliquids include xylene, and propyl benzene fractions, with xylene beingmost preferred in some cases. Surface-active dispersing agents aretypically employed in liquid formulations and in an amount of from 0.1to 20 percent by weight based on the combined weight of the dispersingagent with one or more of the compounds. The formulations can alsocontain other compatible additives, for example, plant growth regulatorsand other biologically active compounds used in agriculture.

Aqueous suspensions comprise suspensions of one or more water-insolublecompounds of Formula I, dispersed in an aqueous vehicle at aconcentration in the range from about 5 to about 50 weight percent,based on the total weight of the aqueous suspension. Suspensions areprepared by finely grinding one or more of the compounds, and vigorouslymixing the ground material into a vehicle comprised of water andsurfactants chosen from the same types discussed above. Othercomponents, such as inorganic salts and synthetic or natural gums, mayalso be added to increase the density and viscosity of the aqueousvehicle.

The compounds of Formula I can also be applied as granular formulations,which are particularly useful for applications to the soil. Granularformulations generally contain from about 0.5 to about 10 weightpercent, based on the total weight of the granular formulation of thecompound(s), dispersed in an inert carrier which consists entirely or inlarge part of coarsely divided inert material such as attapulgite,bentonite, diatomite, clay or a similar inexpensive substance. Suchformulations are usually prepared by dissolving the compounds in asuitable solvent and applying it to a granular carrier which has beenpreformed to the appropriate particle size, in the range of from about0.5 to about 3 mm. A suitable solvent is a solvent in which the compoundis substantially or completely soluble. Such formulations may also beprepared by making a dough or paste of the carrier and the compound andsolvent, and crushing and drying to obtain the desired granularparticle.

Dusts containing the compounds of Formula I may be prepared byintimately mixing one or more of the compounds in powdered form with asuitable dusty agricultural carrier, such as, for example, kaolin clay,ground volcanic rock, and the like. Dusts can suitably contain fromabout 1 to about 10 weight percent of the compounds, based on the totalweight of the dust.

The formulations may additionally contain adjuvant surfactants toenhance deposition, wetting and penetration of the compounds onto thetarget crop and organism. These adjuvant surfactants may optionally beemployed as a component of the formulation or as a tank mix. The amountof adjuvant surfactant will typically vary from 0.01 to 1.0 percent byvolume, based on a spray-volume of water, preferably 0.05 to 0.5 volumepercent. Suitable adjuvant surfactants include, but are not limited toethoxylated nonyl phenols, ethoxylated synthetic or natural alcohols,salts of the esters or sulphosuccinic acids, ethoxylatedorganosilicones, ethoxylated fatty amines and blends of surfactants withmineral or vegetable oils. The formlulations may also includeoil-in-water emulsions such as those disclosed in U.S. patentapplication Ser. No. 11/495,228, the disclosure of which is expresslyincorporated by reference herein.

The formulations may optionally include combinations that contain otherpesticidal compounds. Such additional pesticidal compounds may befungicides, insecticides, herbicides, nematocides, miticides,arthropodicides, bactericides or combinations thereof that arecompatible with the compounds of the present invention in the mediumselected for application, and not antagonistic to the activity of thepresent compounds. Accordingly, in such embodiments, the otherpesticidal compound is employed as a supplemental toxicant for the sameor for a different pesticidal use. The compounds of Formula I, and thepesticidal compound in the combination can generally be present in aweight ratio of from 1:100 to 100:1.

The compounds of the present disclosure may also be combined with otherfungicides to form fungicidal mixtures and synergistic mixtures thereof.The fungicidal compounds of the present disclosure are often applied inconjunction with one or more other fungicides to control a wider varietyof undesirable diseases. When used in conjunction with otherfungicide(s), the presently claimed compounds may be formulated with theother fungicide(s), tank mixed with the other fungicide(s) or appliedsequentially with the other fungicide(s). Such other fungicides mayinclude 2-(thiocyanatomethylthio)-benzothiazole, 2-phenylphenol,8-hydroxyquinoline sulfate, antimycin, Ampelomyces, quisqualis,azaconazole, azoxystrobin, Bacillus subtilis, benalaxyl, benomyl,benthiavalicarb-isopropyl, benzylaminobenzene-sulfonate (BABS) salt,bicarbonates, biphenyl, bismerthiazol, bitertanol, blasticidin-S, borax,Bordeaux mixture, boscalid, bromuconazole, bupirimate, calciumpolysulfide, captafol, captan, carbendazim, carboxin, carpropamid,carvone, chloroneb, chlorothalonil, chlozolinate, Coniothyrium minitans,copper hydroxide, copper octanoate, copper oxychloride, copper sulfate,copper sulfate (tribasic), cuprous oxide, cyazofamid, cyflufenamid,cymoxanil, cyproconazole, cyprodinil, dazomet, debacarb, diammoniumethylenebis-(dithiocarbamate), dichlofluanid, dichlorophen, diclocymet,diclomezine, dichloran, diethofencarb, difenoconazole, difenzoquation,diflumetorim, dimethomorph, dimoxystrobin, diniconazole, diniconazole-M,dinobuton, dinocap, diphenylamine, dithianon, dodemorph, dodemorphacetate, dodine, dodine free base, edifenphos, enestrobin,epoxiconazole, ethaboxam, ethoxyquin, etridiazole, famoxadone,fenamidone, fenarimol, fenbuconazole, fenfuram, fenhexamid, fenoxanil,fenpiclonil, fenpropidin, fenpropimorph, fentin, fentin acetate, fentinhydroxide, ferbam, ferimzone, fluazinam, fludioxonil, flumorph,fluopicolide, fluoroimide, fluoxastrobin, fluquinconazole, flusilazole,flusulfamide, flutolanil, flutriafol, folpet, formaldehyde, fosetyl,fosetyl-aluminium, fuberidazole, furalaxyl, furametpyr, guazatine,guazatine acetates, GY-81, hexachlorobenzene, hexaconazole, hymexazol,imazalil, imazalil sulfate, imibenconazole, iminoctadine, iminoctadinetriacetate, iminoctadine tris(albesilate), ipconazole, iprobenfos,iprodione, iprovalicarb, isoprothiolane, kasugamycin, kasugamycinhydrochloride hydrate, kresoxim-methyl, mancopper, mancozeb,mandipropamid, maneb, mepanipyrim, mepronil, mercuric chloride, mercuricoxide, mercurous chloride, metalaxyl, mefenoxam, metalaxyl-M, metam,metam-ammonium, metam-potassium, metam-sodium, metconazole,methasulfocarb, methyl iodide, methyl isothiocyanate, metiram,metominostrobin, metrafenone, mildiomycin, myclobutanil, nabam,nitrothal-isopropyl, nuarimol, octhilinone, ofurace, oleic acid (fattyacids), orysastrobin, oxadixyl, oxine-copper, oxpoconazole fumarate,oxycarboxin, pefurazoate, penconazole, pencycuron, pentachlorophenol,pentachlorophenyl laurate, penthiopyrad, phenylmercury acetate,phosphonic acid, phthalide, picoxystrobin, polyoxin B, polyoxins,polyoxorim, potassium bicarbonate, potassium hydroxyquinoline sulfate,probenazole, prochloraz, procymidone, propamocarb, propamocarbhydrochloride, propiconazole, propineb, proquinazid, prothioconazole,pyraclostrobin, pyrazophos, pyributicarb, pyrifenox, pyrimethanil,pyroquilon, quinoclamine, quinoxyfen, quintozene, Reynoutriasachalinensis extract, silthiofam, simeconazole, sodium2-phenylphenoxide, sodium bicarbonate, sodium pentachlorophenoxide,spiroxamine, sulfur, SYP-Z071, SYP-048, tar oils, tebuconazole,tecnazene, tetraconazole, thiabendazole, thifluzamide,thiophanate-methyl, thiram, tiadinil, tolclofos-methyl, tolylfluanid,triadimefon, triadimenol, triazoxide, tricyclazole, tridemorph,trifloxystrobin, triflumizole, triforine, triticonazole, validamycin,vinclozolin, zineb, ziram, zoxamide, Candida oleophila, Fusariumoxysporum, Gliocladium spp., Phlebiopsis gigantean, Streptomycesgriseoviridis, Trichoderma spp.,(RS)—N-(3,5-dichlorophenyl)-2-(methoxymethyl)-succinimide,1,2-dichloropropane, 1,3-dichloro-1,1,3,3-tetrafluoroacetone hydrate,1-chloro-2,4-dinitronaphthalene, 1-chloro-2-nitropropane,2-(2-heptadecyl-2-imidazolin-1-yl)ethanol,2,3-dihydro-5-phenyl-1,4-dithi-ine 1,1,4,4-tetraoxide,2-methoxyethylmercury acetate, 2-methoxyethylmercury chloride,2-methoxyethylmercury silicate, 3-(4-chlorophenyl)-5-methylrhodanine,4-(2-nitroprop-1-enyl)phenyl thiocyanateme: ampropylfos, anilazine,azithiram, barium polysulfide, Bayer 32394, benodanil, benquinox,bentaluron, benzamacril; benzamacril-isobutyl, benzamorf, binapacryl,bis(methylmercury) sulfate, bis(tributyltin) oxide, buthiobate, cadmiumcalcium copper zinc chromate sulfate, carbamorph, CECA, chlobenthiazone,chloraniformethan, chlorfenazole, chlorquinox, climbazole, copperbis(3-phenylsalicylate), copper zinc chromate, cufraneb, cuprichydrazinium sulfate, cuprobam, cyclafuramid, cypendazole, cyprofuram,decafentin, dichlone, dichlozoline, diclobutrazol, dimethirimol,dinocton, dinosulfon, dinoterbon, dipyrithione, ditalimfos, dodicin,drazoxolon, EBP, ESBP, etaconazole, etem, ethirim, fenaminosulf,fenapanil, fenitropan, fluotrimazole, furcarbanil, furconazole,furconazole-cis, furmecyclox, furophanate, glyodine, griseofulvin,halacrinate, Hercules 3944, hexylthiofos, ICIA0858, isopamphos,isovaledione, mebenil, mecarbinzid, metazoxolon, methfuroxam,methylmercury dicyandiamide, metsulfovax, milneb, mucochloric anhydride,myclozolin, N-3,5-dichlorophenyl-succinimide,N-3-nitrophenylitaconimide, natamycin,N-ethylmercurio-4-toluenesulfonanilide, nickelbis(dimethyldithiocarbamate), OCH, phenylmercurydimethyldithio-carbamate, phenylmercury nitrate, phosdiphen,prothiocarb; prothiocarb hydrochloride, pyracarbolid, pyridinitril,pyroxychlor, pyroxyfur, quinacetol; quinacetol sulfate, quinazamid,quinconazole, rabenzazole, salicylanilide, SSF-109, sultropen, tecoram,thiadifluor, thicyofen, thiochlorfenphim, thiophanate, thioquinox,tioxymid, triamiphos, triarimol, triazbutil, trichlamide, urbacid,XRD-563, and zarilamid, IK-1140, NC-224, and any combinations thereof.

Additionally, the compounds of the present invention may be combinedwith other pesticides, including insecticides, nematocides, miticides,arthropodicides, bactericides or combinations thereof that arecompatible with the compounds of the present invention in the mediumselected for application, and not antagonistic to the activity of thepresent compounds to form pesticidal mixtures and synergistic mixturesthereof. The fungicidal compounds of the present disclosure may beapplied in conjunction with one or more other pesticides to control awider variety of undesirable pests. When used in conjunction with otherpesticides, the presently claimed compounds may be formulated with theother pesticide(s), tank mixed with the other pesticide(s) or appliedsequentially with the other pesticide(s). Typical insecticides include,but are not limited to: antibiotic insecticides such as allosamidin andthuringiensin; macrocyclic lactone insecticides such as spinosad;avermectin insecticides such as abamectin, doramectin, emamectin,eprinomectin, ivermectin and selamectin; milbemycin insecticides such aslepimectin, milbemectin, milbemycin oxime and moxidectin; arsenicalinsecticides such as calcium arsenate, copper acetoarsenite, copperarsenate, lead arsenate, potassium arsenite and sodium arsenite;botanical insecticides such as anabasine, azadirachtin, d-limonene,nicotine, pyrethrins, cinerins, cinerin I, cinerin II, jasmolin I,jasmolin II, pyrethrin I, pyrethrin II, quassia, rotenone, ryania andsabadilla; carbamate insecticides such as bendiocarb and carbaryl;benzofuranyl methylcarbamate insecticides such as benfuracarb,carbofuran, carbosulfan, decarbofuran and furathiocarb;dimethylcarbamate insecticides dimitan, dimetilan, hyquincarb andpirimicarb; oxime carbamate insecticides such as alanycarb, aldicarb,aldoxycarb, butocarboxim, butoxycarboxim, methomyl, nitrilacarb, oxamyl,tazimcarb, thiocarboxime, thiodicarb and thiofanox; phenylmethylcarbamate insecticides such as allyxycarb, aminocarb, bufencarb,butacarb, carbanolate, cloethocarb, dicresyl, dioxacarb, EMPC,ethiofencarb, fenethacarb, fenobucarb, isoprocarb, methiocarb,metolcarb, mexacarbate, promacyl, promecarb, propoxur, trimethacarb, XMCand xylylcarb; dinitrophenol insecticides such as dinex, dinoprop,dinosam and DNOC; fluorine insecticides such as bariumhexafluorosilicate, cryolite, sodium fluoride, sodium hexafluorosilicateand sulfluramid; formamidine insecticides such as amitraz,chlordimeform, formetanate and formparanate; fumigant insecticides suchas acrylonitrile, carbon disulfide, carbon tetrachloride, chloroform,chloropicrin, para-dichlorobenzene, 1,2-dichloropropane, ethyl formate,ethylene dibromide, ethylene dichloride, ethylene oxide, hydrogencyanide, iodomethane, methyl bromide, methylchloroform, methylenechloride, naphthalene, phosphine, sulfuryl fluoride andtetrachloroethane; inorganic insecticides such as borax, calciumpolysulfide, copper oleate, mercurous chloride, potassium thiocyanateand sodium thiocyanate; chitin synthesis inhibitors such asbistrifluoron, buprofezin, chlorfluazuron, cyromazine, diflubenzuron,flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron,noviflumuron, penfluoron, teflubenzuron and triflumuron; juvenilehormone mimics such as epofenonane, fenoxycarb, hydroprene, kinoprene,methoprene, pyriproxyfen and triprene; juvenile hormones such asjuvenile hormone I, juvenile hormone II and juvenile hormone III;moulting hormone agonists such as chromafenozide, halofenozide,methoxyfenozide and tebufenozide; moulting hormones such as α-ecdysoneand ecdysterone; moulting inhibitors such as diofenolan; precocenes suchas precocene I, precocene II and precocene III; unclassified insectgrowth regulators such as dicyclanil; nereistoxin analogue insecticidessuch as bensultap, cartap, thiocyclam and thiosultap; nicotinoidinsecticides such as flonicamid; nitroguanidine insecticides such asclothianidin, dinotefuran, imidacloprid and thiamethoxam; nitromethyleneinsecticides such as nitenpyram and nithiazine; pyridylmethyl-amineinsecticides such as acetamiprid, imidacloprid, nitenpyram andthiacloprid; organochlorine insecticides such as bromo-DDT, camphechlor,DDT, pp′-DDT, ethyl-DDD, HCH, gamma-HCH, lindane, methoxychlor,pentachlorophenol and TDE; cyclodiene insecticides such as aldrin,bromocyclen, chlorbicyclen, chlordane, chlordecone, dieldrin, dilor,endosulfan, endrin, HEOD, heptachlor, HHDN, isobenzan, isodrin, kelevanand mirex; organophosphate insecticides such as bromfenvinfos,chlorfenvinphos, crotoxyphos, dichlorvos, dicrotophos, dimethylvinphos,fospirate, heptenophos, methocrotophos, mevinphos, monocrotophos, naled,naftalofos, phosphamidon, propaphos, TEPP and tetrachlorvinphos;organothiophosphate insecticides such as dioxabenzofos, fosmethilan andphenthoate; aliphatic organothiophosphate insecticides such as acethion,amiton, cadusafos, chlorethoxyfos, chlormephos, demephion, demephion-O,demephion-S, demeton, demeton-O, demeton-S, demeton-methyl,demeton-O-methyl, demeton-S-methyl, demeton-S-methylsulphon, disulfoton,ethion, ethoprophos, IPSP, isothioate, malathion, methacrifos,oxydemeton-methyl, oxydeprofos, oxydisulfoton, phorate, sulfotep,terbufos and thiometon; aliphatic amide organothiophosphate insecticidessuch as amidithion, cyanthoate, dimethoate, ethoate-methyl, formothion,mecarbam, omethoate, prothoate, sophamide and vamidothion; oximeorganothiophosphate insecticides such as chlorphoxim, phoxim andphoxim-methyl; heterocyclic organothiophosphate insecticides such asazamethiphos, coumaphos, coumithoate, dioxathion, endothion, menazon,morphothion, phosalone, pyraclofos, pyridaphenthion and quinothion;benzothiopyran organothiophosphate insecticides such as dithicrofos andthicrofos; benzotriazine organothiophosphate insecticides such asazinphos-ethyl and azinphos-methyl; isoindole organothiophosphateinsecticides such as dialifos and phosmet; isoxazole organothiophosphateinsecticides such as isoxathion and zolaprofos; pyrazolopyrimidineorganothiophosphate insecticides such as chlorprazophos and pyrazophos;pyridine organothiophosphate insecticides such as chlorpyrifos andchlorpyrifos-methyl; pyrimidine organothiophosphate insecticides such asbutathiofos, diazinon, etrimfos, lirimfos, pirimiphos-ethyl,pirimiphos-methyl, primidophos, pyrimitate and tebupirimfos; quinoxalineorganothiophosphate insecticides such as quinalphos andquinalphos-methyl; thiadiazole organothiophosphate insecticides such asathidathion, lythidathion, methidathion and prothidathion; triazoleorganothiophosphate insecticides such as isazofos and triazophos; phenylorganothiophosphate insecticides such as azothoate, bromophos,bromophos-ethyl, carbophenothion, chlorthiophos, cyanophos, cythioate,dicapthon, dichlofenthion, etaphos, famphur, fenchlorphos, fenitrothionfensulfothion, fenthion, fenthion-ethyl, heterophos, jodfenphos,mesulfenfos, parathion, parathion-methyl, phenkapton, phosnichlor,profenofos, prothiofos, sulprofos, temephos, trichlormetaphos-3 andtrifenofos; phosphonate insecticides such as butonate and trichlorfon;phosphonothioate insecticides such as mecarphon; phenylethylphosphonothioate insecticides such as fonofos and trichloronat;phenyl phenylphosphonothioate insecticides such as cyanofenphos, EPN andleptophos; phosphoramidate insecticides such as crufomate, fenamiphos,fosthietan, mephosfolan, phosfolan and pirimetaphos;phosphoramidothioate insecticides such as acephate, isocarbophos,isofenphos, methamidophos and propetamphos; phosphorodiamideinsecticides such as dimefox, mazidox, mipafox and schradan; oxadiazineinsecticides such as indoxacarb; phthalimide insecticides such asdialifos, phosmet and tetramethrin; pyrazole insecticides such asacetoprole, ethiprole, fipronil, pyrafluprole, pyriprole, tebufenpyrad,tolfenpyrad and vaniliprole; pyrethroid ester insecticides such asacrinathrin, allethrin, bioallethrin, barthrin, bifenthrin,bioethanomethrin, cyclethrin, cycloprothrin, cyfluthrin,beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin,cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin,zeta-cypermethrin, cyphenothrin, deltamethrin, dimefluthrin, dimethrin,empenthrin, fenfluthrin, fenpirithrin, fenpropathrin, fenvalerate,esfenvalerate, flucythrinate, fluvalinate, tau-fluvalinate, furethrin,imiprothrin, metofluthrin, permethrin, biopermethrin, transpermethrin,phenothrin, prallethrin, profluthrin, pyresmethrin, resmethrin,bioresmethrin, cismethrin, tefluthrin, terallethrin, tetramethrin,tralomethrin and transfluthrin; pyrethroid ether insecticides such asetofenprox, flufenprox, halfenprox, protrifenbute and silafluofen;pyrimidinamine insecticides such as flufenerim and pyrimidifen; pyrroleinsecticides such as chlorfenapyr; tetronic acid insecticides such asspiromesifen; thiourea insecticides such as diafenthiuron; ureainsecticides such as flucofuron and sulcofuron; and unclassifiedinsecticides such as closantel, crotamiton, EXD, fenazaflor, fenoxacrim,flubendiamide, hydramethylnon, isoprothiolane, malonoben, metaflumizone,metoxadiazone, nifluridide, pyridaben, pyridalyl, rafoxanide,triarathene and triazamate, and any combinations thereof.

Additionally, the compounds of the present invention may be combinedwith herbicides that are compatible with the compounds of the presentinvention in the medium selected for application, and not antagonisticto the activity of the present compounds to form pesticidal mixtures andsynergistic mixtures thereof. The fungicidal compounds of the presentdisclosure may be applied in conjunction with one or more herbicides tocontrol a wide variety of undesirable plants. When used in conjunctionwith herbicides, the presently claimed compounds may be formulated withthe herbicide(s), tank mixed with the herbicide(s) or appliedsequentially with the herbicide(s). Typical herbicides include, but arenot limited to: amide herbicides such as allidochlor, beflubutamid,benzadox, benzipram, bromobutide, cafenstrole, CDEA, chlorthiamid,cyprazole, dimethenamid, dimethenamid-P, diphenamid, epronaz,etnipromid, fentrazamide, flupoxam, fomesafen, halosafen, isocarbamid,isoxaben, napropamide, naptalam, pethoxamid, propyzamide, quinonamid andtebutam; anilide herbicides such as chloranocryl, cisanilide, clomeprop,cypromid, diflufenican, etobenzanid, fenasulam, flufenacet, flufenican,mefenacet, mefluidide, metamifop, monalide, naproanilide, pentanochlor,picolinafen and propanil; arylalanine herbicides such as benzoylprop,flampropand flamprop-M; chloroacetanilide herbicides such as acetochlor,alachlor, butachlor, butenachlor, delachlor, diethatyl, dimethachlor,metazachlor, metolachlor, S-metolachlor, pretilachlor, propachlor,propisochlor, prynachlor, terbuchlor, thenylchlor and xylachlor;sulfonanilide herbicides such as benzofluor, perfluidone, pyrimisulfanand profluazol; sulfonamide herbicides such as asulam, carbasulam,fenasulam and oryzalin; antibiotic herbicides such as bilanafos; benzoicacid herbicides such as chloramben, dicamba, 2,3,6-TBA and tricamba;pyrimidinyloxybenzoic acid herbicides such as bispyribac andpyriminobac; pyrimidinylthiobenzoic acid herbicides such as pyrithiobac;phthalic acid herbicides such as chlorthal; picolinic acid herbicidessuch as aminopyralid, clopyralid and picloram; quinolinecarboxylic acidherbicides such as quinclorac and quinmerac; arsenical herbicides suchas cacodylic acid, CMA, DSMA, hexaflurate, MAA, MAMA, MSMA, potassiumarsenite and sodium arsenite; benzoylcyclohexanedione herbicides such asmesotrione, sulcotrione, tefuryltrione and tembotrione; benzofuranylalkylsulfonate herbicides such as benfuresate and ethofumesate;carbamate herbicides such as asulam, carboxazole chlorprocarb,dichlormate, fenasulam, karbutilate and terbucarb; carbanilateherbicides such as barban, BCPC, carbasulam, carbetamide, CEPC,chlorbufam, chlorpropham, CPPC, desmedipham, phenisopham, phenmedipham,phenmedipham-ethyl, propham and swep; cyclohexene oxime herbicides suchas alloxydim, butroxydim, clethodim, cloproxydim, cycloxydim,profoxydim, sethoxydim, tepraloxydim and tralkoxydim;cyclopropylisoxazole herbicides such as isoxachlortole and isoxaflutole;dicarboximide herbicides such as benzfendizone, cinidon-ethyl, flumezin,flumiclorac, flumioxazin and flumipropyn; dinitroaniline herbicides suchas benfluralin, butralin, dinitramine, ethalfluralin, fluchloralin,isopropalin, methalpropalin, nitralin, oryzalin, pendimethalin,prodiamine, profluralin and trifluralin; dinitrophenol herbicides suchas dinofenate, dinoprop, dinosam, dinoseb, dinoterb, DNOC, etinofen andmedinoterb; diphenyl ether herbicides such as ethoxyfen; nitrophenylether herbicides such as acifluorfen, aclonifen, bifenox,chlomethoxyfen, chlornitrofen, etnipromid, fluorodifen, fluoroglycofen,fluoronitrofen, fomesafen, furyloxyfen, halosafen, lactofen, nitrofen,nitrofluorfen and oxyfluorfen; dithiocarbamate herbicides such asdazomet and metam; halogenated aliphatic herbicides such as alorac,chloropon, dalapon, flupropanate, hexachloroacetone, iodomethane, methylbromide, monochloroacetic acid, SMA and TCA; imidazolinone herbicidessuch as imazamethabenz, imazamox, imazapic, imazapyr, imazaquin andimazethapyr; inorganic herbicides such as ammonium sulfamate, borax,calcium chlorate, copper sulfate, ferrous sulfate, potassium azide,potassium cyanate, sodium azide, sodium chlorate and sulfuric acid;nitrile herbicides such as bromobonil, bromoxynil, chloroxynil,dichlobenil, iodobonil, ioxynil and pyraclonil; organophosphorusherbicides such as amiprofos-methyl, anilofos, bensulide, bilanafos,butamifos, 2,4-DEP, DMPA, EBEP, fosamine, glufosinate, glyphosate andpiperophos; phenoxy herbicides such as bromofenoxim, clomeprop, 2,4-DEB,2,4-DEP, difenopenten, disul, erbon, etnipromid, fenteracol andtrifopsime; phenoxyacetic herbicides such as 4-CPA, 2,4-D, 3,4-DA, MCPA,MCPA-thioethyl and 2,4,5-T; phenoxybutyric herbicides such as 4-CPB,2,4-DB, 3,4-DB, MCPB and 2,4,5-TB; phenoxypropionic herbicides such ascloprop, 4-CPP, dichlorprop, dichlorprop-P, 3,4-DP, fenoprop,mecopropand mecoprop-P; aryloxyphenoxypropionic herbicides such aschlorazifop, clodinafop, clofop, cyhalofop, diclofop, fenoxaprop,fenoxaprop-P, fenthiaprop, fluazifop, fluazifop-P, haloxyfop,haloxyfop-P, isoxapyrifop, metamifop, propaquizafop, quizalofop,quizalofop-P and trifop; phenylenediamine herbicides such as dinitramineand prodiamine; pyrazolyl herbicides such as benzofenap, pyrazolynate,pyrasulfotole, pyrazoxyfen, pyroxasulfone and topramezone;pyrazolylphenyl herbicides such as fluazolate and pyraflufen; pyridazineherbicides such as credazine, pyridafol and pyridate; pyridazinoneherbicides such as brompyrazon, chloridazon, dimidazon, flufenpyr,metflurazon, norflurazon, oxapyrazon and pydanon; pyridine herbicidessuch as aminopyralid, cliodinate, clopyralid, dithiopyr, fluoroxypyr,haloxydine, picloram, picolinafen, pyriclor, thiazopyr and triclopyr;pyrimidinediamine herbicides such as iprymidam and tioclorim; quaternaryammonium herbicides such as cyperquat, diethamquat, difenzoquat, diquat,morfamquat and paraquat; thiocarbamate herbicides such as butylate,cycloate, di-allate, EPTC, esprocarb, ethiolate, isopolinate,methiobencarb, molinate, orbencarb, pebulate, prosulfocarb,pyributicarb, sulfallate, thiobencarb, tiocarbazil, tri-allate andvernolate; thiocarbonate herbicides such as dimexano, EXD and proxan;thiourea herbicides such as methiuron; triazine herbicides such asdipropetryn, triaziflam and trihydroxytriazine; chlorotriazineherbicides such as atrazine, chlorazine, cyanazine, cyprazine,eglinazine, ipazine, mesoprazine, procyazine, proglinazine, propazine,sebuthylazine, simazine, terbuthylazine and trietazine; methoxytriazineherbicides such as atraton, methometon, prometon, secbumeton, simetonand terbumeton; methylthiotriazine herbicides such as ametryn,aziprotryne, cyanatryn, desmetryn, dimethametryn, methoprotryne,prometryn, simetryn and terbutryn; triazinone herbicides such asametridione, amibuzin, hexazinone, isomethiozin, metamitron andmetribuzin; triazole herbicides such as amitrole, cafenstrole, epronazand flupoxam; triazolone herbicides such as amicarbazone, bencarbazone,carfentrazone, flucarbazone, propoxycarbazone, sulfentrazone andthiencarbazone-methyl; triazolopyrimidine herbicides such ascloransulam, diclosulam, florasulam, flumetsulam, metosulam, penoxsulamand pyroxsulam; uracil herbicides such as butafenacil, bromacil,flupropacil, isocil, lenacil and terbacil; 3-phenyluracils; ureaherbicides such as benzthiazuron, cumyluron, cycluron, dichloralurea,diflufenzopyr, isonoruron, isouron, methabenzthiazuron, monisouron andnoruron; phenylurea herbicides such as anisuron, buturon, chlorbromuron,chloreturon, chlorotoluron, chloroxuron, daimuron, difenoxuron,dimefuron, diuron, fenuron, fluometuron, fluothiuron, isoproturon,linuron, methiuron, methyldymron, metobenzuron, metobromuron, metoxuron,monolinuron, monuron, neburon, parafluoron, phenobenzuron, siduron,tetrafluoron and thidiazuron; pyrimidinylsulfonylurea herbicides such asamidosulfuron, azimsulfuron, bensulfuron, chlorimuron, cyclosulfamuron,ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron,foramsulfuron, halosulfuron, imazosulfuron, mesosulfuron, nicosulfuron,orthosulfamuron, oxasulfuron, primisulfuron, pyrazosulfuron,rimsulfuron, sulfometuron, sulfosulfuron and trifloxysulfuron;triazinylsulfonylurea herbicides such as chlorsulfuron, cinosulfuron,ethametsulfuron, iodosulfuron, metsulfuron, prosulfuron, thifensulfuron,triasulfuron, tribenuron, triflusulfuron and tritosulfuron;thiadiazolylurea herbicides such as buthiuron, ethidimuron, tebuthiuron,thiazafluoron and thidiazuron; and unclassified herbicides such asacrolein, allyl alcohol, azafenidin, benazolin, bentazone,benzobicyclon, buthidazole, calcium cyanamide, cambendichlor,chlorfenac, chlorfenprop, chlorflurazole, chlorflurenol, cinmethylin,clomazone, CPMF, cresol, ortho-dichlorobenzene, dimepiperate, endothal,fluoromidine, fluridone, fluorochloridone, flurtamone, fluthiacet,indanofan, methazole, methyl isothiocyanate, nipyraclofen, OCH,oxadiargyl, oxadiazon, oxaziclomefone, pentachlorophenol, pentoxazone,phenylmercury acetate, pinoxaden, prosulfalin, pyribenzoxim, pyriftalid,quinoclamine, rhodethanil, sulglycapin, thidiazimin, tridiphane,trimeturon, tripropindan and tritac.

Another embodiment of the present disclosure is a method for the controlor prevention of fungal attack. This method comprises applying to thesoil, plant, roots, foliage, seed or locus of the fungus, or to a locusin which the infestation is to be prevented (for example applying tocereal or grape plants), a fungicidal effective amount of one or more ofthe compounds of Formula I. The compounds are suitable for treatment ofvarious plants at fungicidal levels, while exhibiting low phytotoxicity.The compounds may be useful both in a protectant and/or an eradicantfashion.

The compounds have been found to have significant fungicidal effectparticularly for agricultural use. Many of the compounds areparticularly effective for use with agricultural crops and horticulturalplants.

It will be understood by those in the art that the efficacy of thecompound for the foregoing fungi establishes the general utility of thecompounds as fungicides.

The compounds have broad ranges of activity against fungicidalpathogens. Exemplary pathogens may include, but are not limited to,wheat leaf blotch (Septoria tritici, also known as Mycosphaerellagraminicola), apple scab (Venturia inaequalis), and Cercospora leafspots of sugar beets (Cercospora beticola), peanuts (Cercosporaarachidicola and Cercosporidium personatum) and other crops, and blacksigatoka of bananas (Mycosphaerella fujiensis). The exact amount of theactive material to be applied is dependent not only on the specificactive material being applied, but also on the particular actiondesired, the fungal species to be controlled, and the stage of growththereof, as well as the part of the plant or other product to becontacted with the compound. Thus, all the compounds, and formulationscontaining the same, may not be equally effective at similarconcentrations or against the same fungal species.

The compounds are effective in use with plants in a disease-inhibitingand phytologically acceptable amount. The term “disease inhibiting andphytologically acceptable amount” refers to an amount of a compound thatkills or inhibits the plant disease for which control is desired, but isnot significantly toxic to the plant. This amount will generally be fromabout 0.1 to about 1000 ppm (parts per million), with 1 to 500 ppm beingpreferred. The exact concentration of compound required varies with thefungal disease to be controlled, the type of formulation employed, themethod of application, the particular plant species, climate conditions,and the like. A suitable application rate is typically in the range fromabout 0.10 to about 4 pounds/acre (about 0.01 to 0.45 grams per squaremeter, g/m²).

Any range or desired value given herein may be extended or alteredwithout losing the effects sought, as is apparent to the skilled personfor an understanding of the teachings herein.

The compounds of Formula I may be made using well-known chemicalprocedures. Intermediates not specifically mentioned in this disclosureare either commercially available, may be made by routes disclosed inthe chemical literature, or may be readily synthesized from commercialstarting materials utilizing standard procedures.

The following examples are presented to illustrate the various aspectsof the compounds of the present disclosure and should not be construedas limitations to the claims.

EXAMPLES Preparation of 5-Fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-amine(1)

To a solution of 4-fluorobenzyl alcohol (2.56 g, 20.3 mmol) in1,4-dioxane (20 mL) was added 60% NaH (0.813 g, 20.3 mmol) in severalportions over a period of 10 min. To the magnetically stirred solutionwas added 2-Chloro-5-fluoropyrimidin-4-amine* (2.00 g, 13.6 mmol) andthe mixture was stirred at room temperature until gas evolutionsubsided. The reaction mixture was then heated in a CEM Discovermicrowave reactor at 120° C. for 90 min. The cooled reaction mixture waspartitioned between ethyl acetate and water, the organic phase wasconcentrated, and the product was purified by column chromatography(hexane/ethyl acetate gradient) to yield5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-amine (1.66 g, 52% yield) as awhite solid: mp 129-131° C.; ¹H NMR (300 MHz, CDCl₃) δ 7.91 (d, J=2.6Hz, 1H), 7.42 (m, 2H), 7.03 (m, 2H), 5.27 (s, 2H), 5.05 (br s, 2H); MS(ESI) m/z 238 (M+H)⁺.

-   *4-Amino-2-chloro-5-fluoropyrimidine can be purchased commercially    or can be prepared through known literature methods.-   1. Hayashi, T.; Kawakami, T. JP Patent 2005126389-   2. Durr, G. J. J. Med. Chem. 1965, 8(2), 253.

2-(3-Bromobenzyloxy)-5-fluoropyrimidin-4-ylamine (2)

To a magnetically stirred mixture of KO^(t)Bu (1.0 M in ^(t)BuOH, 1.36ml, 1.36 mmol) was added (3-bromophenyl)methanol (0.25 g, 1.36 mmol). Tothe resulting solution was added 2-chloro-5-fluoropyrimidine-4-ylamine(0.10 g, 0.68 mmol) and the mixture was capped and stirred at 90° C. for4 h. The reaction mixture was cooled to room temperature, diluted withwater, and the resulting precipitate was collected by filtration. Thesolid was washed with water, washed with cyclohexane, and dried in thevacuum oven. A CH₂Cl₂ solution of the compound was loaded onto BiotageSCX column and eluted with CH₂Cl₂ followed by 2.0 M NH₃ in MeOH. Thesolvent was evaporated under reduced pressure to give the title compound(0.100 g, 49%) as an off-white solid: mp 143-145° C.; ¹H NMR (400 MHz,DMSO-d₆) δ 7.90 (d, J=2.5 Hz, 1H), 7.61 (s, 1H), 7.43 (d, J=8.0 Hz, 1H),7.36 (d, J=7.7 Hz, 1H), 7.22 (t, J=7.7 Hz, 1H), 5.28 (s, 2H), 5.20 (brs, 2H); GCMS (EI) m/z 297, 299 (M)⁺.

Preparation of 5-Fluoro-2-[1-(4-fluorophenyl)ethoxy]pyrimidin-4-ylamine(3)

To a magnetically stirred mixture of 4-amino-2-chloro-5-fluoropyrimidine(11.10 g, 75.2 mmol) in 1-(4-Fluorophenyl)ethanol (11.70 g, 82.8 mmol)was added a 1.0 M solution of KO^(t)Bu in ^(t)BuOH (82.8 mL, 82.8 mmol)in one portion, and the resulting tan mixture was heated to reflux andstirred for 24 h. The solvent was removed in vacuo and the resultingred-orange oil was purified by flash chromatography (SiO₂, 0→10%MeOH/CH₂Cl₂) to give 5.5 g of red-orange oil. The oil was suspended inhexanes (100 mL) and stirred for 16 h. Water (100 mL) was added to theunchanged mixture, and the biphasic system was stirred vigorously for 1h. The resulting cream colored solid was collected by vacuum filtration,washed with warm water (55° C., 2×100 mL), and dried under vacuum at 55°C. for 16 h to give5-fluoro-2-[1-(4-fluorophenyl)ethoxy]pyrimidin-4-ylamine (3.30 g, 17.2%yield) as a white solid: mp 96-98° C.; ¹H NMR (300 MHz, CDCl₃) δ 7.84(d, J=2.6 Hz, 1H), 7.42-7.38 (m, 2H), 7.03-6.97 (m, 2H), 5.99 (q, J=6.6Hz, 1H), 5.09 (br s, 2H), 1.61 (d, J=6.6 Hz, 3H); MS (ESI) m/z 252(M+H)⁺, m/z 250 (M−H)⁻.

Preparation of 1-Phenyl-ethanone-O-(4-amino-5-fluoropyrimidin-2-yl)oxime(4)

To a magnetically stirred mixture of 4-amino-2-chloro-5-fluoropyrimidine(0.10 g, 0.68 mmol) and acetophenone oxime (0.092 g, 0.68 mmol) in dryDMF (3 mL) in a 5 mL Biotage Iniator microwave vessel was added NaH(0.027 g of a 60 wt. % suspension, 0.68 mmol) under a N₂ atmosphere.After gas evolution ceased, the resulting mixture was sealed with aBiotage Initiator microwave septa cap and heated to 100° C. in a BiotageInitiator microwave for 60 min. The contents were poured into a vialwith water (5 mL) and CH₂Cl₂ (5 mL), and neutralized with a few drops of2NHCl. The phases were separated and the organic extract was dried overMgSO₄, filtered, and evaporated under a stream of nitrogen. The crudecontents were purified on silica (EtOAc/hexanes gradient) andevaporation of the product fractions gave 0.057 g (34%) of1-Phenyl-ethanone-O-(4-amino-5-fluoro-pyrimidin-2-yl)oxime as anoff-white solid: mp 163-165° C.; ¹H NMR (300 MHz, CDCl₃) δ 8.04 (d,J=2.6 Hz, 1H), 7.75 (m, 2H), 7.42 (m, 3H), 5.25 (bs, 2H), 2.51 (s, 3H);HPLC-MS (ESI) m/z 247 (M+H)⁺.

Preparation of 5-Fluoro-2-(thiophen-2-ylmethoxy)-pyrimidin-4-ylamine (5)

To a mixture of 2-chloro-5-fluoropyrimidin-4-ylamine (2.00 g, 13.5 mmol)and thiophen-2-ylmethanol (1.92 g, 16.9 mmol) with a magnetic stir barin a 20 mL Biotage Initiator microwave reaction vessel was addedKO^(t)Bu (17.0 mL of 1M in ^(t)BuOH, 17.0 mmol). The resulting mixturewas sealed with a Biotage Initiator microwave septa cap and heated in aBiotage Initiator microwave to 100° C. for 30 min. The heating cycle wasrepeated (2×) for a total reaction time of 90 min. The contents werepoured into ice-water and the pH was adjusted to neutral with 2N HCl.The resulting solid was filtered and washed with water (2×) and then 20%ether/hexanes (100 mL). The remaining solid was dried overnight at 50°C. under vacuum to give 4.17 g (68%) of5-fluoro-2-(thiophen-2-ylmethoxy)pyrimidin-4-ylamine as a pale yellowpowder: mp 92-94° C.; ¹H NMR (300 MHz, CDCl₃) δ 7.92 (d, J=2.7 Hz, 1H),7.29 (m, 1H), 7.13 (d, J=3.6 Hz, 1H), 6.97 (m, 1H), 5.46 (s, 2H), 5.17(br s, 2H); MS (ESI) m/z 226 (M+H)⁺.

Preparation ofN-[5-Fluoro-2-(thiophen-2-ylmethoxy)pyrimidin-4-yl]acetamide (6)

In a 2 dram screw cap vial, a solution of5-fluoro-2-(thiophen-2-ylmethoxy)-pyrimidin-4-ylamine (0.10 g, 0.4 mmol)in CH₂Cl₂ was treated with acetyl chloride (0.032 g, 0.4 mmol,) andPS-NMM (0.42 g, 0.8 mmol), a resin-bound equivalent of N-methylmorpholine (NMM). The mixture was shaken at RT for 12 h. The reactionmixture was filtered and the solvent evaporated to yield 0.084 g (75%)of the title compound as white solid: mp 134-136° C.; ¹H NMR (300 MHz,CDCl₃) δ 8.24 (d, J=2.6 Hz, 1H), 7.86 (bs, 1H), 7.31 (m, 1H), 7.23 (m,1H), 7.00 (m, 1H), 5.54 (s, 2H), 2.58 (s, 3H); MS (ESI) m/z 268 (M+H)⁺.

Preparation of[5-Fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]-(4-methylpiperazin-1-ylmethyl)amine(7)

To a magnetically stirred mixture of paraformaldehyde (0.24 g, 8 mmol)in CH₂Cl₂ (20 mL) was added N-methylpiperazine (0.80 g, 8.0 mmol). Thesuspension was stirred overnight at ambient temperature on an orbitalshaker, and then 5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamine (0.47g, 2.0 mmol) was added. The resulting mixture was stirred over theweekend at RT. The solvent was evaporated and the crude residue waswashed twice with 50% ether/petroleum ether and dried under a stream ofN₂ to give 0.21 g (30%) of[5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl](4-methylpiperazin-1-ylmethyl)amineas a beige solid: mp 125-126° C.; ¹H NMR (300 MHz, CDCl₃) δ 7.83 (d,J=2.3 Hz, 1H), 7.43 (m, 2H), 7.03 (t, J=8.5 Hz, 2H), 5.40 (bs, 1H), 5.27(s, 2H), 4.41 (d, J=6.8 Hz, 2H), 2.63 (bs, 4H), 2.47 (bs, 4H), 2.30 (s,3H); HPLC-MS (ESI) m/z 350 (M+H)⁺.

Preparation of[5-Fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]triethylsilanylamine (8)

To a magnetically stirred mixture of5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamine (0.25 g, 1.05 mmol) indry THF (5 mL) at 0° C. was added NaH (0.042 g of 60 wt. % suspension inmineral oil, 1.05 mmol). When bubbling ceased, triethylsilyl chloride(0.158 g, 1.05 mmol) was added dropwise (neat) via syringe. Afterstirring overnight at ambient temperature, the reaction mixture waspoured into ether and washed with a mixture of aqueous saturated sodiumbicarbonate and brine solution. The organic layer was separated, driedover Na₂SO₄, filtered, and evaporated to give a white solid. This crudematerial was purified on silica by column chromatography (EtOAc/hexanesgradient) to give 0.121 g (33%) of[5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]-triethylsilanylamine as aclear yellow oil: ¹H NMR (300 MHz, CDCl₃) δ 7.89 (d, J=2.5 Hz, 1H), 7.39(m, 2H), 7.03 (t, J=8.6 Hz, 2H), 5.27 (s, 2H), 4.53 (s, 1H), 0.99 (m,9H), 0.83 (m, 6H); HPLC-MS (ESI) m/z 352 (M+H)⁺.

Preparation of[5-Fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]bis-carbamic Acid4-fluorophenyl Ester (9)

To a magnetically stirred ice-cold mixture of5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamine (0.25 g, 1.05 mmol) indry THF (5 mL) was added NaH (0.042 g of a 60 wt. % suspension inmineral oil, 1.05 mmol). After bubbling ceased, 4-fluorophenylchloroformate (0.184 g, 1.05 mmol) was added dropwise as a solution indry THF. After stirring one hour, the reaction was partitioned betweenEtOAc and brine solution. The organic extract was dried over Na₂SO₄,filtered, and evaporated. The crude material was purified on silicausing a gradient of EtOAc/Hex and then MeOH/EtOAc to give 0.054 g (14%)of [5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]bis-carbamic acid4-fluoro-phenyl ester as a white solid: mp 103-105° C.; ¹H NMR (300 MHz,CDCl₃) δ 8.58 (d, J=2.2 Hz, 1H), 7.43 (m, 2H), 7.08 (m, 10H), 5.40 (s,2H); HPLC-MS (ESI) m/z 514 (M+H)⁺.

Preparation of [5-Fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]carbamicAcid Phenyl Ester (10)

To a stirred mixture of5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamine (0.20 g, 0.84 mmol) indry THF (3 mL) at ice-bath temperatures was added NaH (0.034 g of 60 wt.% suspension in mineral oil, 0.84 mmol). When bubbling ceased, theresulting mixture was transferred (dropwise) via cannula to an ice-cold,stirred mixture of diphenyl carbonate (1.8 g, 8.4 mmol) in dry THF (5mL). The mixture was stirred overnight, poured into EtOAc, and washedwith saturated aq. NH₄Cl solution followed by brine solution. The EtOAclayer was separated, dried over Na₂SO₄, filtered, and evaporated. Thecrude material was purified on silica gel using a gradient of EtOAc andhexanes to give 0.063 g (21%) of[5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]carbamic acid phenyl esteras a white solid: mp 129-131° C.; ¹H NMR (300 MHz, CDCl₃) δ 8.28 (d,J=2.3 Hz, 1H), 7.43 (m, 5H), 7.30-7.20 (m, 2H), 7.02 (t, J=8.6 Hz, 2H),5.38 (s, 2H); HPLC-MS (ESI) m/z 358 (M+H)⁺.

Preparation of N-[5-Fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]oxalamicAcid Ethyl Ester (11)

To a mixture of 5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamine (0.235g, 0.99 mmol), N-methyl morpholine on polystyrene (0.538 g, 1.24 mmol),and CH₂Cl₂ (5 mL) was added chloro-oxo-acetic acid ethyl ester (0.135 g,0.99 mmol) and the resulting mixture was agitated on an orbital shakerfor 16 h. The reaction contents were filtered onto an acidic SPEcartridge and eluted with CH₂Cl₂. The CH₂Cl₂ filtrate was evaporated togive 0.165 g (50%) ofN-[5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]oxalamic acid ethylester as a clear oil: ¹H NMR (300 MHz, CDCl₃) δ 9.21 (bs, 1H), 8.38 (d,J=2.3 Hz, 1H), 7.48 (m, 2H), 7.03 (t, J=8.5 Hz, 2H), 5.40 (s, 2H), 4.48(q, J=7.1 Hz, 2H), 1.45 (t, J=7.1 Hz, 3H); HPLC-MS (ESI) m/z 338 (M+H)⁺.

Preparation of 3,4-Dichloroisothiazole-5-carboxylic Acid[5-fluoro-2-(4-fluorobenzyl-oxy)pyrimidin-4-yl]amide (12)

To a suspension of 3,4-dichloroisothiazole-5-carboxylic acid (0.15 g,0.76 mmol) in oxalyl chloride (2 mL) was added a catalytic amount ofdimethylformamide (2 drops) and the mixture was heated to 80° C. andstirred for 2 h. The excess oxalyl chloride was removed on the rotaryevaporator. Meanwhile,5-fluoro-2-(4-fluorobenzyloxy)-pyrimidin-4-ylamine (0.17 g, 0.68 mmol)was dissolved in THF (1 mL), treated with LiHMDS (1M in THF, 0.76 mL,0.76 mmol) and stirred for 10 min. The freshly prepared3,4-dichlorothiazole-5-carbonyl chloride*, dissolved in THF (1 mL), wasadded and the reaction was capped and stirred for 12 h. The reaction wasdiluted with water and the target compound was extracted with CH₂Cl₂(3×5 mL). The combined extracts were dried over MgSO₄ and thenevaporated under reduced pressure. The mixture was eluted with CH₂Cl₂through an anionic-exchange solid phase extraction column and thenfurther purified by reverse-phase chromatography to give3,4-dichloroisothiazole-5-carboxylic acid[5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]amide (0.035 g, 12%) as atan solid: mp 87-90° C.; ¹H NMR (400 MHz, DMSO-d₆) δ 11.78 (s, 1H), 8.67(s, 1H), 7.51-7.48 (m, 2H), 7.24-7.19 (m, 2H), 5.25 (s, 2H); MS (ESI)m/z 417 (M+H)⁺, 415 (M−H)⁻.

-   *Nagata, T.; Kogure, A.; Yonekura, N.; Hanai, R.; Kaneko, I.;    Nakano, Y. JP 2007211002 A

Preparation of[5-Fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]phosphoramidic AcidDiethyl Ester (13)

To a magnetically stirred solution of5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamine (0.10 g, 0.42 mmol) indry THF (5 mL) under a nitrogen atmosphere was added NaH (0.017 g of a60 wt. % suspension, 0.42 mmol) and the mixture was stirred untilbubbling ceased. Diethyl chlorophosphate (0.073 g, 0.42 mmol) was addeddropwise, and the mixture was stirred at ambient temperature for 1 h.The reaction mixture was evaporated to dryness and the residue dissolvedin EtOAc and washed saturated aqueous NH₄Cl solution. The organic layerwas separated, dried over Na₂SO₄, filtered, and evaporated. The crudematerial was purified on silica (acetone/CH₂Cl₂ gradient) to give 0.017g (11%) of [5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]phosphoramidicacid diethyl ester as a white solid: mp 109-111° C.; ¹H NMR (300 MHz,CDCl₃) δ8.10 (t, J=1.8 Hz, 1H), 7.43 (m, 2H), 7.03 (t, J=8.5 Hz, 2H),6.18 (br s, 1H), 5.35 (s, 2H), 4.25 (m, 4H), 1.38 (t, J=7.1 Hz, 6H);HPLC-MS (ESI) m/z 374 (M+H)⁺.

Preparation of [5-Fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl](1-methoxypropyl)amine (14)

To a solution of 5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamine (0.10g, 0.42 mmol) in propionaldehyde (2 mL) was added a catalytic amount ofcamphorsulfonic acid. The mixture was agitated on an orbital shaker atroom temperature for 4 h and then evaporated to dryness. Methanol (2 mL)was added, and the resulting solution was warmed to 60° C. for 1 h.After evaporation, the crude product was purified by reverse phasechromatography to yield the title compound (0.030 g, 24% yield) as aclear, colorless oil: ¹H NMR (300 MHz, CDCl₃) δ 7.91 (d, J=2.5 Hz, 1H),7.47-7.41 (m, 2H), 7.09-7.01 (m, 2H), 5.41 (dt, J=9.9 and 6.0 Hz, 1H),5.30 (s, 2H), 5.2 (bd, J˜10 Hz, 1H), 3.12 (s, 3H), 1.88-1.60 (m, 2H),0.98 (t, J=7.1 Hz, 3H). HPLC-MS 308 (ES⁻), 310 (ES⁺).

Preparation of[5-Fluoro-2-(4-methylbenzyloxy)pyrimidin-4-ylamino]methanol (16)

To a solution of 5-fluoro-2-(4-methylbenzyloxy)pyrimidin-4-ylamine (0.10g, 0.43 mmol) in dioxane (2 mL) was added paraformaldehyde (0.060 g, 2mmol) and the mixture was agitated on an orbital shaker at 90° C. for 16h, cooled, and evaporated to dryness. Purification by reverse phasechromatography afforded 0.070 g (63%) of the title compound as a whitesolid: mp 97-98° C.; ¹H NMR (CDCl₃) δ 7.94 (d, J=2.5 Hz, 1H), 7.36 (d,J=7.9 Hz, 2H), 7.19 (d, J=7.9 Hz, 2H), 5.97 (bs, 1H), 5.33 (s, 2H),5.04-4.99 (m, 2H), 3.39 (t, J=8.0 Hz, 1H), 2.37 (s, 3H); MS (ESI) m/z264 (M+H)⁺.

Preparation ofBenzyloxymethyl[5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]amine (18)

To a mixture of[5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamino]methanol (0.10 g, 3.7mmol) in benzyl alcohol (1 mL) was added a catalytic amount of p-toluenesulfonic acid. After 30 min, the reaction was cooled to room temperatureand partitioned between ethyl acetate and saturated sodium bicarbonate.The phases were separated and the organic portion was dried overanhydrous Na₂SO₄, filtered and evaporated to obtain the crude product.Purification by reverse phase chromatography afforded 0.094 g (70%) ofthe title compound as a white solid: mp 64-66° C.; ¹H NMR (CDCl₃) δ 7.93(d, J=2.7 Hz, 1H), 7.47-7.40 (m, 2H), 7.37-7.29 (m, 5H), 7.08-7.00 (m,2H), 5.81-5.70 (bm, 1H), 5.29 (s, 2H), 5.12 (d, J=6.9 Hz, 2H), 4.63 (s,2H); MS (ESI) m/z 358 (M+H)⁺.

Preparation of 2,2-Dimethylpropionicacid[5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamino]methyl Ester (19)

To a mixture of[5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamino]methanol (0.10 g,0.37 mmol) in pyridine (2 mL) was added trimethylacetyl chloride (0.048g, 0.40 mmol), and the mixture was agitated on an orbital shaker at 60°C. for 4 h. The reaction mixture was cooled, evaporated to dryness, andpartitioned between EtOAc and water. The organic layer was dried overNa₂SO₄, filtered, and evaporated to yield the title compound (0.078 g,60% yield) as a white solid: mp 134-135° C.; ¹H NMR (300 MHz, CDCl₃) δ7.97 (d, J=2.5 Hz, 1H), 7.49-7.44 (m, 2H), 7.11-7.03 (m, 2H), 6.17 (bt,J≈7 Hz, 1H), 6.17 (d, J=7.4 Hz, 2H), 5.33 (s, 2H), 1.20 (s, 9H); HPLC-MSm/z 352 (M+H)⁺.

Preparation of N′-[5-Fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]-N,Ndimethyl-formamidine (20)

To a magnetically stirred solution of5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamine (1.00 g, 4.2 mmol) inN,N-dimethylformamide (DMF, 20 mL) was added N,N-dimethylformamidedimethyl acetal (0.55 g, 4.6 mmol) and stirring was continued 16 h atRT. The solution was poured into 100 mL of ice water, whereupon a whiteprecipitate was produced. The mixture was cooled at 0° C. for 1 h andthen filtered to produce the title compound (1.10 g, 89%) as a whitesolid: mp 113-115° C.; ¹H NMR (CDCl₃) δ 8.65 (s, 1H), 8.04 (d, J=2.6 Hz,1H), 7.46-7.40 (m, 2H), 7.07-6.98 (m, 2H), 5.30 (s, 2H), 3.17 (s, 3H),3.16 (s, 3H); MS (ESI) m/z 292 (M+H)⁺. Anal. Calcd for C₁₄H₁₄F₂N₄O: C,57.53; H, 4.83; N, 19.17. Found: C, 57.67; H, 4.84; N, 19.09.

Preparation of[5-Fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]-[1-pyrrolidin-1-yl-methylidene]amine(21)

To a solution ofN′-[5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]-N,N-dimethylformamidine(0.10 g, 0.36 mmol) in toluene (2 mL) was added pyrrolidine (0.051 g,0.72 mmol) and a catalytic amount of camphorsulfonic acid. The ventedvial was placed on an orbital shaker, agitated at 90° C. for 16 h,cooled, and evaporated to dryness. Purification by reverse phasechromatography afforded the title compound (0.060 g, 53% yield) as awhite solid: mp 102-103° C.; ¹H NMR (300 MHz, CDCl₃) δ 8.87 (s, 1H),8.06 (d, J=2.7 Hz, 1H), 7.49-7.42 (m, 2H), 7.09-7.01 (m, 2H), 5.32 (s,2H), 3.73-3.62 (m, 4H), 2.07-1.96 (m, 4H); HPLC-MS (ESI) m/z 319 (M+H)⁺.

Preparation ofN-[5-Fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]-N′-hydroxy-formamidine(22)

To a solution ofN′-[5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]-N,N-dimethyl-formamidine(0.10 g, 0.34 mmol) in EtOH (2 mL) was added hydroxylamine hydrochloride(0.047 g, 0.68 mmol) and the mixture was agitated on an orbital shakerfor 1.5 h at 50° C. The reaction mixture was cooled and evaporated todryness. Water was added to produce a slurry which was filtered toisolate the title compound (0.090 g, 94% yield) as a white solid: mp169-171° C.; ¹H NMR (300 MHz, CDCl₃) δ 8.15 (d, J=2.2 Hz, 1H), 8.02 (bs,2H), 7.49-7.43 (m, 2H), 7.11-7.02 (m, 3H), 5.35 (s, 2H); HPLC-MS (ESI)m/z 281 (M+H)⁺, 279 (M−H)⁻.

Preparation ofN-[5-Fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]-N′-cyanoformamidine(23)

Cyanamide (8.00 g, 190.0 mmol) was stirred at reflux intriethylorthoformate (60 mL) for 2 h. The reaction was cooled to roomtemperature and distilled to provide ethyl-N-cyanoimidate (12.5 g,bp=110-112° C./45 mm Hg).* To this imidate (1 mL) was added5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamine (0.05 g, 0.2 mmol) andthe mixture was heated at 90° C. for 4 h, cooled, diluted withchloroform, filtered, and evaporated. The crude product was purified byreverse phase chromatography to furnish 0.053 g (17%) of the titlecompound as an off white solid: mp 148-149° C.; ¹H NMR (300 MHz, CDCl₃)δ 9.45 and 9.33 (bd, bs, J≈10 Hz, 1H), 8.33 and 8.25 (2d, J≈2 Hz, 1H),7.46-7.38 (m, 2H), 7.11-7.01 (m, 2H), 5.35 and 5.33 (2s, 2H); HPLC-MS(ESI) m/z 290 (M+H)⁺, 288 (M−H)⁻.

-   * Bridsen, Peter K., and Wang, Xiaodong, Synthesis, 1995, 855-8.

Preparation ofN′-[5-Fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]-N,N-dimethyl-propionamidine(24)

To a solution of N,N-Dimethylpropionamide (0.202 g, 2.0 mmol) in CHCl₃(2 mL) was added phosphorous oxychloride (POCl₃, 0.066 g, 0.43 mmol) andthe mixture was agitated on an orbital shaker at room temperature for 1h. Triethylamine (0.22 g, 2.2 mmol) and5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamine (0.10 g, 0.40 mmol)were added, and the mixture was agitated at 50° C. for 3 h, cooled toroom temperature, partitioned between chloroform and water, the phasesseparated, and the organics evaporated under reduced pressure.Purification by reverse phase chromatography afforded the title compound(0.042 g, 31% yield) as a yellow oil: ¹H NMR (300 MHz, CDCl₃) δ 8.87 (s,1H), 8.04 (d, J=2.5 Hz, 1H), 7.46-7.40 (m, 2H), 7.07-6.99 (m, 2H), 5.30(s, 2H), 3.13 (s, 6H), 2.55 (q, J=7.7 Hz, 2H), 1.15 (t, J=7.7 Hz, 3H);HPLC-MS (ESI) m/z 321 (M+H)⁺.

Preparation ofN′-(5-Fluoro-2-hydroxy-pyrimidin-4-yl)-N,N-dimethyl-formamidine (25)

To a magnetically stirred solution of 4-amino-5-fluoro-pyrimidin-2-ol*(4.00 g, 31.0 mmol) in DMF (100 mL) was added N,N-dimethylformamidedimethyl acetal (4.00 g, 34.0 mmol). The mixture was stirred at roomtemperature for 72 h, diluted with diethyl ether (200 mL), and filtered.The solid product was washed with heptane to give the title compound(5.23 g, 92% yield) as a white solid: mp 240-243° C.; ¹H NMR (300 MHz,DMSO-d₆) δ 10.7 (bs, 1H), 8.59 (s, 1H), 7.7 (d, J=5.6 Hz, 1H), 3.18 (s,3H), 3.06 (s, 3H); HPLC-MS (ESI) m/z 185 (M+H)⁺, 183 (M−H)⁻.

-   *4-amino-5-fluoro-pyrimidin-2-ol can be purchased commercially.

Preparation of Carbonic Acid4-(dimethylamino-methyleneamino)-5-fluoropyrimidin-2-yl Ester EthylEster (26)

To a solution ofN′-(5-fluoro-2-hydroxy-pyrimidin-4-yl)-N,N-dimethylformamidine (0.10,0.54 mmol) in CH₂Cl₂ (2 mL) were added triethylamine (0.20 g, 2.0 mmol)and ethyl chloroformate (0.065 g, 0.60 mmol), and the mixture wasagitated on an orbital shaker at room temperature overnight. Thereaction was diluted with CH₂Cl₂ and the solution was washed with water,dried over MgSO₄, filtered and evaporated. The crude product waspurified by silica gel column chromatography (EtOAc/petroleum ethergradient) to yield 0.031 g (22%) of the title compound as a white solid:mp 124-126° C.; ¹H NMR (300 MHz, CDCl₃) δ 8.67 (s, 1H), 8.19 (d, J=2.2Hz, 1H), 4.35 (q, J=7.14 Hz, 2H), 3.21 (s, 6H), 1.40 (t, J=7.14 Hz, 3H);HPLC-MS (ESI) m/z 258 (M+H)⁺.

Preparation of Benzoic Acid4-(dimethylamino-methyleneamino)-5-fluoropyrimidin-2-yl Ester (27)

To a suspension ofN′-(5-fluoro-2-hydroxypyrimidin-4-yl)-N,N-dimethylformamidine (0.10 g,0.54 mmol) in pyridine (2 mL) was added benzoyl chloride (0.084 g, 0.60mmol), and the mixture was agitated on an orbital shaker for 16 h at RT.The reaction mixture was partitioned between EtOAc and saturated aqNaHCO₃, and the organic phase was dried over solid MgSO₄, filtered, andevaporated to give the title compound (0.147 g 94%) as a white solid: mp136-138° C.; ¹H NMR (300 MHz, CDCl₃) δ 8.69 (s, 1H), 8.27 (d, J=2.4 Hz,2H), 8.25-8.20 (m, 2H), 7.69-7.63 (m, 1H), 7.56-7.49 (m, 2H), 3.23 (s,3H), 3.20 (s, 3H); HPLC-MS (ESI) m/z 289 (M+H)⁺.

Preparation of Benzenesulfonic Acid4-(dimethylamino-methyleneamino)-5-fluoro-pyrimidin-2-yl Ester (28)

To a suspension ofN′-(5-fluoro-2-hydroxypyrimidin-4-yl)-N,N-dimethylformamidine (0.10 g,0.54 mmol) in pyridine (2 mL) was added benzene sulfonyl chloride (0.106g, 0.60 mmol) and the mixture was agitated on an orbital shaker for 16 hat room temperature. The reaction mixture was partitioned between EtOAcand saturated aq NaHCO₃, and the organic phase was dried over solidMgSO₄, filtered, and concentrated under reduced pressure. Purificationby reverse phase chromatography (H₂O/MeCN gradient) afforded the titlecompound (0.089 g, 46% yield) as a white solid: mp 124-125° C.; ¹H NMR(300 MHz, CDCl₃) δ 8.54 (s, 1H), 8.12-8.07 (m, 3H), 7.73-7.66 (m, 1H),7.62-7.56 (m, 2H), 3.21 (s, 6H); HPLC-MS (ESI) m/z 325 (M+H)⁺.

Preparation of Benzenesulfonic Acid 4-amino-5-fluoropyrimidin-2-yl Ester(29)

To a solution of HCl in doxane (3 mL of 10%) was added benzenesulfonicacid 4-(dimethylamino-methyleneamino)-5-fluoropyrimidin-2-yl ester(0.090, 0.3 mmol) and the mixture was agitated on an orbital shaker atroom temperature for 1.5 h. The solvent was removed by evaporation andthe residue was dissolved in a 1:1 solution of dioxane and water (2.5mL) and treated with saturated aq NaHCO₃ (0.5 mL). After 16 h, thereaction mixture was partitioned between EtOAc and water and the organicphase was dried over Na₂SO₄, filtered, and the solvent evaporated toyield the title compound (0.059 g, 79% yield) as a white solid: mp139-141° C.; ¹H NMR (300 MHz, DMSO-d₆) δ 8.05-8.00 (m, 3H), 7.90-7.75(m, 3H), 7.70-7.63 (m, 2H); HPLC-MS (ESI) m/z 268 (M−H)⁻, 270 (M+H)⁺.

Preparation of Benzenesulfonic Acid 4-amino-5-fluoropyrimidin-2-yl Ester(29)

To a suspension of 5-fluorocytosine (0.177 g, 1.4 mmol) in pyridine (5mL) was added and benzene sulfonyl chloride (0.284 g, 1.6 mmol) and themixture was stirred at room temperature for 2 h. The reaction mixturewas evaporated to dryness and the crude material purified by reversephase chromatography to yield the title compound (0.106 g, 29% yield) asa white solid: mp 145-146° C.; ¹H NMR (300 MHz, DMSO-d₆) δ 8.05-8.00 (m,3H), 7.9-7.75 (m, 3H), 7.70-7.63 (m, 2H); HPLC-MS (ESI) m/z 270 (M+H)⁺,268 (M−H)⁻.

Preparation of(2-Fluorobenzyl)-[5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl]amine(30)

A) A magnetically stirred solution of 2,4-dichloro-5-fluoropyrimidine*(0.105 g, 0.63 mmol) in 5 mL of dry THF was treated with2-fluorobenzylamine (0.085 g, 0.68 mmol) and excess triethylamine, andthe resulting mixture was heated at 80° C. for 5 h. The reaction mixturewas partitioned between CH₂Cl₂ and dilute HCl, and the organic phase waswashed with brine, dried over Na₂SO₄, and filtered. The solvent wasremoved under reduced pressure to yield 0.157 g (97%) of the titlecompound as a yellow solid: mp 117-118° C.; ¹H NMR (300 MHz, CDCl₃) δ7.90 (d, J=2.6, 1H), 7.47-7.27 (m, 2H), 7.21-7.01 (m, 2H), 5.54 (s, 1H),4.76 (d, J=5.9, 2H); MS (ESI) m/z 256 (M+H)⁺.

-   *2,4-Dichloro-5-fluoropyrimidine can be purchased commercially.

B) A solution of(2-chloro-5-fluoropyrimidin-4-yl)-(2-fluorobenzyl)amine* (0.103 g, 0.40mmol) in 5 mL of dry THF was treated with 4-fluorobenzylalcohol (0.062g, 0.49 mmol) and a 1.0 M solution of KO^(t)Bu in ^(t)BuOH (0.4 mL, 0.4mmol). The mixture was heated at 80° C. in a sealed vial for 18 h,partitioned between CH₂Cl₂ and water, and the organic phase was washedwith brine, dried over Na₂SO₄, and filtered. The solvent was removedunder reduced pressure and the residue purified by flash columnchromatography (SiO₂, 10→20% EtOAc/petroleum ether) to yield the titlecompound (0.157 g, 42%) as a white solid: mp 83-84° C.; ¹H NMR (300 MHz,CDCl₃) δ 7.83 (d, J=2.8, 1H), 7.45-7.27 (m, 5H), 7.15-6.96 (m, 5H), 5.37(br s, 1H), 5.29 (s, 3H), 4.74 (d, J=5.9, 3H); MS (ESI) m/z 346 (M+H)⁺.

-   *Singh, R.; Argade, A.; Payan, D. G.; Clough, J.; Keim, H.; Sylvain,    C.; Li, H.; Bhamidipati, S., WO 2004014382 A1 20040219

Preparation of5-fluoro-2-(3-methoxybenzyloxy)-4-(1-(4-methoxyphenyl)-hydrazinyl)pyrimidine(31)

A) A 1.0 M solution of KO^(t)Bu in KO^(t)Bu (66 mL, 66 mmol) was addedto a mixture of 2,4-dichloro-5-fluoropyrimidine (5.04 g, 30.1 mmol) and3-methoxybenzyl alcohol (7.8 mL, 62.8 mmol) in a 250 mL round bottomflask. A significant exotherm was observed and the resulting mixture wasstirred at room temperature for 2 h. The reaction was diluted with EtOAc(100 mL) and washed with brine (50 mL×2). The organic layer was driedover MgSO₄, filtered, and concentrated under reduced pressure.Crystallization from hot EtOH provided a material which was collected ona fritted funnel and rinsed with ice-cold EtOH to provide the titlecompound (7.94 g, 71%) as a white solid: mp 81-83° C.; ¹H NMR (300 MHz,CDCl₃) δ 8.10 (d, J=2.3 Hz, 1H), 7.29 (m, 2H), 7.02 (m, 4H), 6.87 (dt,J=2.2, 7.8 Hz, 2H), 5.44 (s, 2H), 5.35 (s, 2H), 3.82 (s, 3H), 3.82 (s,3H); MS (ESI) m/z 371 (M+H)⁺.

B) A solution of 2.0 N KOH in water (85 mL, 170 mmol) was added to amixture of 5-fluoro-2,4-bis(3-methoxybenzyloxy)pyrimidine (7.9 g, 21.3mmol) and EtOH (21 mL) in a 500 mL round bottom flask. A refluxcondenser was attached, and the reaction was heated at 95° C. for 16 h.After cooling to room temperature, the reaction mixture was washed withEt₂O (2×50 mL), and then acidified with 1 N HCl to pH 3. The resultingsolid material was collected on a fritted funnel. Subsequent extractionwith excess EtOAC, and concentration under reduced pressure provided thetitle compound (3.63 g, 68%) as a white solid: mp 136-139; ¹H NMR (300MHz, DMSO-d₆) δ 12.97 (br s, 1H), 7.87 (d, J=3.7 Hz, 1H), 7.30 (t, J=7.9Hz, 1H), 7.00 (m, 2H), 6.91 (dd, J=1.8, 8.0 Hz, 1H), 5.29 (s, 2H), 3.74(s, 3H); MS (ESI) m/z 251 (M+H)⁺.

C) An oven-dried 100 mL Schlenk flask was charged with5-fluoro-2-(3-methoxybenzyloxy)pyrimidin-4-ol (3.63 g, 14.5 mmol) andN,N-dimethylaniline (3.7 mL, 29.2 mL). Phosphorous oxychloride (POCl₃,40 mL, 429 mmol) was added, and resulting solution was heated to 95° C.under nitrogen. After 2 h, the reaction was cooled to room temperatureand concentrated to constant volume under reduced pressure at 50° C. Theremaining residue was diluted with Et₂O (50 mL) and washed with 1 N HCl(2×50 mL). Concentration at reduced pressure provided a solid, which waswashed with water and collected by vacuum filtration. The title compound(4.09 g, 105%) was isolated as a white solid: mp 96-100° C.; ¹H NMR (300MHz, DMSO-d₆) δ 8.81 (d, J=0.8 Hz, 1H), 7.30 (t, J=8.1 Hz, 1H), 7.02 (m,2H), 6.91 (dd, J=2.3, 8.3 Hz, 1H), 5.34 (s, 2H), 3.75 (s, 3H); MS (ESI)m/z 269 (M+H)⁺.

D) To a mixture of 4-chloro-2-(3-methoxybenzyl)-5-fluoropyrimidine(0.153 g, 0.568 mmol) and 4-methoxyphenyl-hydrazine hydrochloride (0.324g, 1.85 mmol) in ethanol (5 mL) was added triethylamine (0.272, 2.69mmol) and the mixture was heated to 50° C. for 16 h. The reaction wascooled to room temperature and diluted with Et₂O (50 mL). The Et₂Osolution was washed with water (2×50 mL), dried over MgSO₄, filtered,and concentrated. The residue was triturated with Et₂O to obtain5-fluoro-2-(3-methoxy-benzyloxy)-4-(1-(4-methoxyphenyl)hydrazinyl)pyrimidine(0.113 g, 54% yield) as a white solid: mp 121-123.5° C.; ¹H NMR (300MHz, DMSO-d₆) δ 8.02 (d, J=5.4 Hz, 1H), 7.28 (t, J=8.1 Hz, 1H), 7.22 (d,J=8.5 Hz, 2H), 6.99-6.93 (m, 2H), 6.93-6.85 (m, 3H), 5.25 (s, 2H), 3.75(s, 3H), 3.74 (s, 3H); MS (ESI) m/z 371 (M+H)⁺, 354 (M-NH₂)⁻.

Preparation ofO-allyl-N-(5-fluoro-2-(3-methoxybenzyloxy)pyrimidin-4-yl)hydroxyl-amine(32)

To a mixture of 4-chloro-2-(3-methoxybenzyl)-5-fluoropyrimidine (0.151g, 0.558 mmol) and O-allyl hydroxylamine hydrochloride (0.201 g, 1.83mmol) in 5:1 MeOH:CH₃CN (5 mL) was added triethylamine (0.273 g, 2.70mmol) and the mixture was heated at 50° C. for 18 h. The reaction wascooled to room temperature and diluted with Et₂O (50 mL). The organicsolution was washed with water (2×50 mL), dried over MgSO₄, filtered,and concentrated. Purification by flash chromatography (SiO₂, 17%->50%EtOAc/hexane) affordedO-allyl-N-(5-fluoro-2-(3-methoxybenzyloxy)-pyrimidin-4-yl)hydroxylamine(0.113 g, 66% yield) as a colorless oil: ¹H NMR (300 MHz, DMSO-d₆) δ10.94 (broad singlet, 1H), 7.94 (broad singlet, 1H), 7.28 (t, J=8.0 Hz,1H), 6.95-7.03 (m, 2H), 6.88 (dd, J=2.5, 7.9 Hz, 1H), 5.97 (tdd, J=5.8,10.6, 17.0 Hz, 1H), 5.32 (dd, J=1.5, 17.4 Hz, 1H), 5.24 (s, 2H), 5.22(dd, J=1.2, 10.6 Hz, 1H), 4.39 (d, J=6.0 Hz, 2H), 3.74 (s, 3H); MS (ESI)m/z 306 (M+H)⁺, 304 (M−H)⁻.

Preparation of1-[2-(3-Cyanobenzyloxy)-5-fluoropyrimidin-4-yl]-3-(2-fluorobenzyl)urea(34)

To a magnetically stirred mixture of3-(4-amino-5-fluoropyrimidin-2-yloxymethyl)-benzonitrile (0.075 g, 0.31mmol) and 2-fluorobenzylisocyanate (0.59 mL, 0.46 mmol) in dry DMF (1.5mL) was added LiHMDS (1.0 M in THF, 0.31 ml, 0.30 mmol). The vial wascapped and the mixture stirred at room temperature for 8 h. Saturatedaq. NH₄Cl (3 ml) was added and the mixture was stirred for 4 h. Theheterogeneous mixture was filtered, and the solid was washed with hotwater, washed with E₂O, and then dried under vacuum to give the titlecompound (0.075 g, 62%) as a white solid: mp 177-178° C.; ¹H NMR (400MHz, DMSO-d₆) δ 10.04 (s, 1H), 8.90 (t, J=5.7 Hz, 1H), 8.37 (d, J=2.8Hz, 1H), 7.85 (br s, 1H), 7.80 (d, J=7.5 Hz, 1H), 7.74 (d, J=8.0 Hz,1H), 7.60 (t, J=7.8 Hz, 1H), 7.42-7.38 (m, 1H), 7.35-7.29 (m, 1H),7.20-7.14 (m, 2H), 5.33 (s, 2H), 4.49 (d, J=5.8 Hz, 2H); HPLC-MS (ESI)m/z 396.3 (M+H)⁺, 394.3 (M−H)⁻.

Preparation of 1-[5-Fluoro-2-(3-methoxybenzyloxy)pyrimidin-4-yl](3′-propyl carbamoyl)-3-propyl-urea (36)

To a magnetically stirred mixture of5-fluoro-2-(3-methoxybenzyloxy)pyrimidin-4-ylamine (0.075 g, 0.30 mmol)and propylisocyanate (0.057 mL, 0.60 mmol) in dry DMF (1.5 mL) was addedLiHMDS (1.0 M in THF, 0.60 ml, 0.60 mmol). The vial was capped and thereaction was stirred at room temperature for 8 h. The solvent wasevaporated under reduced pressure and the crude material was purified byreverse-phase chromatography to give the title compound (0.043 g, 10%)as a tan solid: mp 75-78° C.; ¹H NMR (400 MHz, DMSO-d₆) δ 12.34 (s, 1H),8.49 (s, 1H), 7.89 (s, 1H), 7.29 (t, J=7.8 Hz, 1H), 7.05-7.01 (m, 2H),6.90 (dd, J=6.9 Hz, J=2.5 Hz, 1H), 5.30 (s, 2H), 3.75 (s, 3H), 3.74-3.68(m, 2H), 3.15-3.10 (m, 2H), 1.58-1.44 (m, 4H), 0.89-0.85 (m, 6H);HPLC-MS (ESI) m/z 420.4 (M+H)⁺, 418.4 (M−H)⁻.

Preparation of1-[2-(3-Cyanobenzyloxy)-5-fluoropyrimidin-4-yl]-3-propylthiourea (37)

To a magnetically stirred mixture of3-(4-amino-5-fluoropyrimidin-2-yloxymethyl)-benzonitrile (0.075 g, 0.31mmol) and propylisothiocyanate (0.047 mL, 0.46 mmol) in dry DMF (1.5 mL)was added LiHMDS (1.0 M in THF, 0.31 ml, 0.31 mmol). The vial was cappedand reaction was stirred for 8 h. Saturated aq NH₄Cl (3 ml) was added tothe vial and the mixture was stirred for 4 h. The heterogeneous mixturewas filtered and the solid was washed with hot water, washed withhexanes, and dried under vacuum to give the title compound (0.055 g,52%) as a pale-yellow solid: mp 163-165° C.; ¹H NMR (400 MHz, DMSO-d₆) δ10.77 (s, 1H), 10.38 (s, 1H), 8.47 (d, J=2.7 Hz, 1H), 7.90 (s, 1H), 7.82(d, J=7.5 Hz, 1H), 7.78 (d, J=8.1 Hz, 1H), 7.62 (t, J=7.7 Hz, 1H), 5.42(s, 2H), 3.55 (dd, J=12.4, 6.8 Hz, 2H), 1.65-1.59 (m, 2H), 0.95 (t,J=7.5 Hz, 3H): HPLC-MS (ESI) m/z 346.3 (M+H)⁺, 344.2 (M−H)⁻.

Preparation ofN-[5-Fluoro-2-(4-methylbenzyloxy)pyrimidin-4-yl]methanesulfonamide (38)

To a solution of 5-fluoro-2-(4-methylbenzyloxy)pyrimidin-4-ylamine(0.100 g, 0.43 mmol) in anhydrous THF (4 mL) was added LiHMDS (1.07 mLof 1.0M, 1.07 mmol) dropwise at room temperature, and the resultingorange solution was stirred for 20 min. Methanesulfonyl chloride (0.108g, 0.94 mmol) was added in one portion and the turbid, light orangesolution was stirred for 60 min. The reaction was quenched with brine (5mL) and the THF phase was separated. The aq. phase was extracted w/EtOAc (5 mL), and the organics were combined, dried over Na₂SO₄,filtered, and concentrated to an orange gummy residue. The residue waspurified by flash chromatography (SiO₂, 0→100% EtOac/hexanes) to give0.034 g (26%) of the title compound as a white solid: mp 145-148° C.; ¹HNMR (400 MHz, CDCl₃) δ 8.19 (s, 1H), 7.33 (d, J=7.9 Hz, 2H), 7.17 (d,J=7.9 Hz, 2H), 5.35 (s, 2H), 3.37 (s, 3H), 2.35 (s, 3H); HPLC-MS (ESI)m/z 312 (M+H)⁺, 310 (M−H)⁻.

Preparation ofN-[5-Fluoro-2-(4-fluorobenzyloxy)-pyrimidin-4-yl]-S-(2-nitrophenyl)-thiohydroxylamine(39)

To a solution of 5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylamine (0.05g, 0.2 mmol) and a 1.0 M solution of KO^(t)Bu in ^(t)BuOH (1.0 mL, 1.0mmol) was added nitrobenzene-sulfenyl chloride (0.044 g, 0.23 mmol) inone portion, and the resulting brown solution was stirred for 60 min.The reaction was diluted with water (2 mL) and neutralized to pH 7 with1N HCl. The aq. phase was extracted with EtOAc (5 mL), and the organicswere combined, dried over Na₂SO₄, filtered, and concentrated. The crudematerial was purified by reverse phase chromatography to yield the titlecompound (0.020 g, 26%) as a yellow solid: mp 184° C.; ¹H NMR (300 MHz,CDCl₃) δ 8.36 (d, J=7.25 Hz, 1H), 8.09 (d, J=2.3 Hz, 1H), 7.59 (m, 1H),7.36 (m, 2H), 7.29 (m, 2H), 6.88 (m, 2H), 6.23 (bs, 1H), 5.19 (s, 2H);HPLC-MS (ESI) m/z 391 (M+H)⁺, 389 (M−H)⁻.

Preparation of Benzenesulfonic Acid4-acetylamino-5-fluoro-pyrimidin-2-yl Ester (40)

N-(5-fluoro-2-hydroxypyrimidin-4-yl)-acetamide (200 mg, 1.17 mmol) wassuspended in pyridine (5 mL) and stirred at ambient temperature. To thestirred suspension was added benzenesulfonyl chloride (226 mg, 1.29mmol) and agitation was continued for 16 hours. The solvent wasevaporated under a stream of nitrogen and the residue was suspended indichloromethane (2-3 mL), placed directly onto a silica gel column, andeluted with ethyl acetate in petroleum ether (0-50% gradient) to isolate180 mg, 0.58 mmol (49%) of the title compound as a white solid: mp142-143° C.; ¹H NMR (DMSO-d₆) δ 10.96 (s, 1H), 8.67 (d, J=2.6 Hz, 1H),8.12-8.06 (m, 2H), 7.86-7.79 (m, 1H), 7.73-7.65 (m, 2H), 2.98 (s, 3H);HPLC-MS (ESI) m/z 312 (M+H)⁺, 310 (M−H)⁻.

-   *N-(5-fluoro-2-hydroxypyrimidin-4-yl)-acetamide can be prepared    through known literature methods.-   1. Duschinsky, R., Fells, E., Hoffer, M. U.S. Pat. No. 3,309,359

Preparation of 2,2-dimethylpropionic Acid4-(dimethylamino-methyleneamino)-5-fluoro-pyrimidin-2-yloxymethyl Ester(41)

N′-(5-fluoro-2-hydroxypyrimidin-4-yl)-N,N-dimethylformamidine (100 mg,0.54 mmol), cesium carbonate (196 mg, 0.60 mmol), and chloromethylpivalate (90 mg, 0.6 mmol) were shaken together in DMF (3 mL) at ambienttemperature for 16 hours. The reaction mixture was partitioned betweenethyl acetate and water, dried over magnesium sulfate, filtered andevaporated to yield a colorless oil which was treated with diethyl ether(3-4 mL) to produce a solid. The solid was removed and the ethersolution was placed onto a silica gel column and eluted with ethylacetate in petroleum ether (0-50% gradient) to isolate 14 mg, 0.05 mmol(9%) of the title compound as a white solid: mp 86-88° C.; ¹H NMR(CDCl₃) δ 8.73 (s, 1H), 8.06 (d, J=2.6 Hz, 1H), 6.04 (s, 2H), 3.20 (s,3H), 3.18 (s, 3H), 1.16 (s, 9H); HPLC-MS (ESI) m/z 299 (M+H)⁺.

Preparation ofN′-(5-fluoro-2-methoxymethoxypyrimidin-4-yl)-N,N-dimethyl-formamidine(42)

N′-(5-fluoro-2-hydroxypyrimidin-4-yl)-N,N-dimethylformamidine (100 mg,0.54 mmol), cesium carbonate (196 mg, 0.60 mmol), and bromomethyl methylether (75 mg, 0.6 mmol) were shaken together in DMF (3 mL) at ambienttemperature for 4 hours. The reaction mixture was partitioned betweenethyl acetate and water, dried over magnesium sulfate, filtered andevaporated to yield a colorless oil which was placed directly onto asilica gel column and eluted with ethyl acetate in petroleum ether(0-80% gradient) to isolate 23 mg, 0.1 mmol (19%) of the title compoundas a colorless oil: ¹H NMR (CDCl₃) δ 8.66 (s, 1H), 8.05 (d, J=2.6 Hz,1H), 5.46 (s, 2H), 3.53 (s, 3H), 3.17 (s, 3H), 3.16 (s, 3H); HPLC-MS(ESI) m/z 229 (M+H)⁺.

Preparation of [5-Fluoro-2-(3-methoxybenzyloxy)pyrimidin-4-yl]sulfamide(43)

To a magnetically stirred solution of4-chloro-5-fluoro-2-(3-methoxybenzyloxy)pyrimidine* (1.3 g, 4.84 mmol)in dry DMF (5 mL) was added a pre-mixed suspension of 60% NaH (0.45 g,10.65 mmol) and sulfamide (0.93 g, 9.68 mmol) in dry DMF (5 mL). Theresulting off-white suspension was stirred at room temperature for 72hrs. The orange suspension was then heated to 50° C. for 48 hours andcooled to room temperature. The reaction mixture was partitioned betweenethyl acetate and brine solution. The organic extract was dried overNa₂SO₄, filtered, and evaporated. The crude material was purified bycolumn chromatography on normal phase silica using a gradient ofEtOAc/Hex and reverse phase using a gradient of H₂O/ACN to yield[5-Fluoro-2-(3-methoxybenzyloxy)pyrimidin-4-yl]sulfamide (115 mg, 7.2%yield) as a white solid: mp 126-130° C.; ¹H NMR (300 MHz, CD₃OD) δ 8.01(d, J=3.63 Hz, 1H), 7.25 (m, 1H), 7.01 (m, 2H), 6.88 (m, 1H), 5.37 (s,2H), 3.78 (s, 3H); MS (ESI) m/z 326.9 (M−H)⁻.

-   * The 4-chloro-5-fluoro-2-(3-methoxybenzyloxy)pyrimidine    intermediate was prepared as described in the synthesis of 31.

Preparation of 5-fluoro-4-hydrazinyl-2-(3-methoxybenzyloxy)pyrimidine(44)

A 125 mL Erlenmeyer flask was charged with4-chloro-5-fluoro-2-(3-methoxybenzyl-oxy)pyrimidine (1.50 g, 5.58 mmol)and EtOH (50 mL). Hydrazine monohydrate (900 μL, 18.5 mmol) was added,and the resulting mixture was allowed to stir at room temperature. After22 h, the reaction was transferred to a 500 mL Erlenmeyer flask anddiluted with water (200 mL), whereupon a white solid began toprecipitate from solution. After stirring for 7 h, solid product wascollected in a fritted funnel and rinsed with excess water. After dryingon the frit, the title compound was obtained (1.23 g, 83%) as a whitesolid: mp 103-106° C.; ¹H NMR (300 MHz, DMSO-d₆) δ 8.92 (bs, 1H), 7.86(d, J=3.6 Hz, 1H), 7.27 (t, J=8.1 Hz, 1H), 6.94-7.01 (m, 2H), 6.87 (dd,J=2.4, 7.9 Hz, 1H), 5.24 (s, 2H), 4.46 (bs, 2H), 3.74 (s, 3H); MS (ESI)m/z 265.2 (M+H)⁺, 263.2 (M−H)⁻.

Preparation of(E)-5-Fluoro-2-(3-methoxybenzyloxy)-4-(2-(thiophen-2-ylmethylene)-hydrazinyl)pyrimidine(45)

A 20 mL vial was charged with5-fluoro-4-hydrazinyl-2-(3-methoxybenzyloxy)-pyrimidine (74.7 mg, 0.283mmol), EtOH (2 mL), thiophene-2-carbaldehyde (26 μL, 0.284 mmol) and 1 MHCl in Et₂O (14 μL, 0.014 mmol) and heated at 50° C. on shaker. After 90minutes, the reaction was cooled to room temperature concentrated onhigh vacuum to provide the title compound (77.8 mg, 77%) as a yellowsolid: mp 136-139° C.; ¹H NMR (300 MHz, DMSO-d₆) δ 11.46 (bs, 1H), 8.50(bs, 1H), 8.16 (d, J=3.6 Hz, 1H), 7.64 (d, J=5.0 Hz, 1H), 7.41 (d, J=3.4Hz, 1H), 7.28 (t, J=8.0 Hz, 1H), 7.12 (dd, J=3.8, 4.8 Hz, 1H), 7.04 (m,2H), 6.88 (dd, J=2.4, 8.3 Hz, 1H), 5.27 (s, 2H), 3.73 (s, 3H); MS (ESI)m/z 359.2 (M+H)⁺, 357.2 (M−H)⁻.

Preparation of2-(benzyloxy)-4-[(dimethyl-λ⁴-sulfanylidene)amino]-5-fluoropyrimidine(47)

A 10 mL oven-dried Schlenk flask was charged with2-(benzyloxy)-5-fluoropyrimidin-4-amine (101 mg, 0.462 mmol), CH₂Cl₂ (2mL), and dimethylsulfide (75.0 μL, 1.02 mmol) and was cooled to 0° C. inan ice bath. N-Chlorosuccinimide (122 mg, 0.914 mmol) was added and theresulting mixture was allowed to stir at 0° C. for 45 minutes, and thenat room temperature for 30 minutes. A solution of NaOMe in MeOH (25%,360 μL, 1.35 mmol) was added. After 20 minutes, the reaction wasquenched with water (3 mL) and allowed to stir for 1 hour. The crudereaction mixture was then diluted with CH₂Cl₂ and washed with water (50mL×2), dried over anhydrous Na₂SO₄, filtered, and concentrated by rotaryevaporation and then on high vacuum to give the title compound (120 mg,93%) as an off white solid: mp 125-129° C.; ¹H NMR (300 MHz, DMSO-d₆): δ7.70 (d, J=3.9 Hz, 1H), 7.25-7.44 (m, 5H), 5.21 (s, 2H), 2.75 (s, 6H);MS (ESI) m/z 281.1 (M+H)⁺.

-   *Yamamoto, Y.; Yamamoto, H. J. Am. Chem. Soc. 2004, 126, 4128-4129.

Preparation of1-[5-fluoro-2-(4-methylbenzyloxy)-pyrimidin-4-yl]-2,3-dipropyl-isothiourea(49)

To a magnetically stirred solution of1-[5-Fluoro-2-(4-methyl-benzyloxy)-pyrimidin-4-yl]-3-propyl-thiourea(0.50 g, 1.40 mmol) in CH₃CN (4 mL), was added potassium carbonate (0.20g, 1.40 mmol) at room temperature and the mixture was stirred for 20min. N-Propylbromide (0.19 g, 1.40 mmol) was added at room temperatureand the resulting mixture stirred for 15 h. The reaction mixture wasdiluted with H₂O and extracted with CH₂Cl₂ (3×20 mL). The combinedorganic layers were dried over Na₂SO₄, filtered, and the solventevaporated. The crude mixture was purified on silica (EtOAc/hexanesgradient) and evaporation of the product fractions gave 0.335 g (63%) of1-[5-Fluoro-2-(4-methyl-benzyloxy)-pyrimidin-4-yl]-2,3-dipropyl-isothioureaas a pale yellow viscous liquid: ¹H NMR (300 MHz, CDCl₃) δ 10.56 (bs,1H), 8.09 (d, J=2.6 Hz, 1H), 7.31 (m, 2H), 7.24 (m, 2H), 5.28 (s, 2H),3.28 (dd, J=13.6, 6.5 Hz, 4H), 2.36 (s, 3H), 1.62 (m, 4H), 1.0 (t, J=7.4Hz, 4H); HPLC-MS (ESI) m/z 377 (M+H)⁺.

Preparation of O-(4-amino-5-fluoropyrimidin-2-yl)-t-butylN-methyl-N-hydroxycarbamate (50)

In a 2 dram screw cap vial, a solution of4-amino-2-chloro-5-fluoropyrimidine (0.1 g, 0.68 mmol) and t-butylN-methyl-N-hydroxycarbamate * (0.11 g, 0.75 mmol) was treated with a 1.0M solution of KO^(t)Bu in ^(t)BuOH (1.0 mL, 1.0 mmol) in one portion,and the resulting yellow solution was heated at 100° C. and shaken for24 h. The reaction mixture was cooled, extracted with EtOAC (3×5 mL),and the solvent evaporated. The crude mixture was purified via reversephase chromatography to yield 0.10 g (56.9%) of the title compound asyellow solid: mp 123-125° C.; ¹H NMR (300 MHz, CDCl₃) δ 7.96 (d, J=2.3Hz, 1H), 5.26 (bs, 2H), 3.32 (s, 3H), 1.43 (s, 9H); MS (ESI) m/z 259(M+H)⁺.

-   *t-butyl N-methyl-N-hydroxycarbamate can be prepared through known    literature methods:-   1. Carrasco, M. R.; Brown, R. T.; Serafimova, I. M.; Silva O. J.    Org. Chem., 2003, 68 (1), 195.

Preparation of O-ethyl5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylcarbamothioate (51)

5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-amine (300 mg, 1.26 mmol) wasstirred in chloroform (25 mL) and water (12 mL). Sodium bicarbonate (870mg, 10.12 mmol) was added followed by dropwise addition of thiophosgene(218 mg, 1.9 mmol). The reaction mixture was stirred at room temperaturefor 16 hours, then diluted with chloroform (20 mL) and the phases wereseparated. The organic extract was dried over sodium sulfate, filtered,and concentrated by rotary evaporation to ⅓ volume. To this chloroformsolution of crude isothiocyanate was added abs. ethanol (10 mL) and themixture was heated in a sealed tube for 1 h. The reaction mixture wascooled to room temperature, concentrated and purified by flashchromatography on silica, to give 45 mg (11%) of O-ethyl5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-ylcarbamothioate as a paleyellow solid: mp 109-119° C.; ¹H NMR (CDCl₃) δ 8.30 (bs, 2H), 7.44 (m,2H), 7.06 (m, 2H), 5.36 (s, 2H), 4.66 (q, J=6 Hz, 2H), 1.45 (t, J=6 Hz,3H); HPLC-MS (ESI): m/z 326 (ES⁺).

Preparation ofN-(5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl)ethanethioamide (53)

N-(5-fluoro-2-(4-fluorobenzyloxy)pyrimidin-4-yl)acetamide (50 mg, 0.42mmol) was stirred in a Biotage Initiator® microwave vessel with1,2-dichloroethane (3 mL) and Lawesson's reagent (170 mg, 0.42 mmol).The vessel was heated in a Biotage Initiator® microwave to 100° C. for 5minutes then cooled room temperature, filtered, and diluted with CH₂Cl₂.The reaction mixture was then washed brine, and the layers wereseparated. The organic extract was dried onto silica and purified byflash chromatography. The product-containing fractions were thenevaporated to dryness and purified again by reverse-phase HPLC to give 4mg of N-(5-fluoro-2-(4-fluorobenzyl-oxy)pyrimidin-4-yl)ethanethioamide(4%) as a yellow glass: ¹H NMR (CDCl₃) δ 9.34 (b, 1H), 8.29 (d, J=3 Hz,1H), 7.41 (m, 2H), 7.06 (m, 2H), 5.33 (s, 2H), 3.13 (s, 3H); HPLC-MS(ESI): m/z 294 (ES⁻).

Biological Testing Protocols:

1. Evaluation of Fungicidal Activity: Leaf Blotch of Wheat(Mycosphaerella graminicola; Anamorph: Septoria tritici; Bayer CodeSEPTTR):

Wheat plants (variety Yuma) were grown from seed in a greenhouse in 50%mineral soil/50% soil-less Metro mix until the first leaf was fullyemerged, with 7-10 seedlings per pot. These plants were inoculated withan aqueous spore suspension of Septoria tritici either prior to or afterfungicide treatments. After inoculation the plants were kept in 100%relative humidity (one day in a dark dew chamber followed by two tothree days in a lighted dew chamber) to permit spores to germinate andinfect the leaf. The plants were then transferred to a greenhouse fordisease to develop.

2. Evaluation of Fungicidal Activity: Leaf Spot of Sugar Beets(Cercospora beticola; Bayer Code CERCBE):

Sugar beets (variety HH-88) were grown in soil-less Metro mix in agreenhouse. The spores were harvested from moisturized infected leafsurface by washing whole leaves in water, and then filtered through twolayers of cheesecloth. The young seedlings were inoculated with thespore suspension. The plants were kept in a dark dew room for 48 hrs,and then placed under a plastic hood in a greenhouse with a temperatureof 26° C.

3. Evaluation of Fungicidal Activity: Leaf Spot of Peanut(Mycosphaerella arachidis; Bayer Code MYCOAR; Anamorph: Cercosporaarachidicola):

Peanuts seedlings (variety Star) were grown in soil-less Metro mix. Thespores were harvested from moisturized infected leaf surface by washingwhole leaves in water, and then filtered through two layers ofcheesecloth. The young seedlings were inoculated with the sporesuspension. The plants were kept in a dark dew room for 48 hrs, and thenplaced under a plastic hood in a greenhouse with a temperature of 26° C.

4. Evaluation of Fungicidal Activity: Apple Scab (Venturia inaequalis;Bayer Code VENTIN):

Apple seedlings (McIntosh or Golden Delicious) were grown in Metro mixin a greenhouse. Fungal spores were collected from infected leaf tissue.Plants were inoculated with the spore suspension. Plants were placed ina dew room for 24 hours with 100% relative humidity and then transferredto a greenhouse with a temperature of 18° C. for disease to develop.

5. Evaluation of Fungicidal Activity: Black Sigatoka Disease of Banana(Mycosphaerella fijiensis; BAYER Code MYCOFI):

Efficacy against Mycosphaerella fijiensis was tested using newly emergedleaves of field grown banana plants. 20 ml of a diluted formulation ofcompound 1 of the required concentration were sprayed onto each testleaf over a delineated area of 20×20 cm. The leaves were subsequentlyallowed to become infected by natural inoculum, and were visuallyassessed for percent disease control ˜40-45 days later.

The following table presents the activity of typical compounds of thepresent disclosure when evaluated in these experiments. Theeffectiveness of the test compounds in controlling disease wasdetermined by assessing the severity of disease on treated plants, thenconverting the severity to percent control based on the level of diseaseon untreated, inoculated plants.

In each case of Tables I-III the rating scale is as follows:

% Disease Control Rating  76-100 A 51-75 B 26-50 C  0-25 D Not Tested E

TABLE I 3 DC and 1 DP Activity of Compounds on SEPTTR at 25 and 100 ppmSEPTTR SEPTTR SETTTR SEPTTR Mass Mass 3DC 3DC 1DP 1DP Spec. Spec. CmpdStructure 25 ppm 100 ppm 25 ppm 100 ppm Phys. App. MP (ES+) (ES−) GCMS 1

A A A A white solid 130- 132 238 236 2

A A A A off-white powder 143- 145 297, 298 3

A A A A oil product 250 4

A A A A off-white solid 163- 165 247 5

A A A A White Solid  90-92 226 6

A A A A white solid 134- 136 268 266 7

A A A A beige solid 125- 126 350 348 8

A A A A clear yellow oil 352 350 9

A A A A white solid 103- 105 514 10

A A A A white solid 129- 131 358 356 11

A A A A clear oil 338 336 12

A A A A tan solid  87-90 417 415 13

D D C B white solid 109- 111 374 372 14

A A A A clear colorless oil 310 308 15

A A A A White Solid 135- 137 234 232 16

A A A A white solid  97-98 264 262 17

A A A A white solid 108- 110 268 266 18

B B B A white solid  64-66 358 356 19

B A A A white solid 134- 135 352 20

A A A A white powder 115- 116 293 21

A A A A off white solid 102- 103 319 22

A A A A white solid 169- 171 281 279 23

A A A A off white solid 148- 149 290 288 24

A A A A clear yellow oil 321 25

A A A A tan solid 240- 243 183 26

A A A A white solid 124- 126 258 27

A A A A white crystalline solid 136- 138 289 28

A A A A white solid 124- 125 325 29

B A A A white solid 139- 140 270 268 30

B A B A white solid  88-90 346 344 31

D D D D off white solid 121- 123.5 371 354 32

D A C A colorless oil 306 304 33

A A A A fluffy white solid 184- 186 243 245 34

D D D D white solid 177- 178 396 394 35

A A A A yellow solid 104- 106 250 248 36

B A C A tan solid  75-78 420 418 37

A A A A white needles 150- 151 339 337 38

D C C C White Solid 145- 148 312 310 39

D D A A yellow solid 184 391 389 40

E E E E white solid 142- 143 312 310 41

E E E E white solid  86-88 299 42

E E E E colorless oil 229 43

B B C B yellow glassy solid 126- 130 327 44

B A D A off white solid 102- 105 265 263 45

C C B A yellow solid 136- 139 359 357 46

A A A A orange-white solid 220 218 47

E E E E off white solid 125- 129 281 48

A A A A off-white solid 149- 150 335 333 49

E E E E Pale yellow viscous liquid 377 50

C A C A pale yellow solid 123- 125 259 51

E E E E Pale yellow solid 326 52

B B A A white solid 160- 162 280 278 53

A A A A yellow glass 294 54

D D B A white solid 118- 121 417 415 55

A A A A white solid 124 224 56

E E E E Pale yellow solid 388 57

A A A A white solid 122- 124 282 58

A A A A white solid 170 (dec) 307 59

D C D D white solid 190- 191 371 369 60

A A A A white solid 143 306 304 61

D D A A white solid 111- 113 326 62

E E E E Off white solid 234 63

E E E E yellow oil 325 64

D C D D white solid 170- 172 375 373 65

C B C B brown/orange solid  60-64 383 381 66

A A A A yellow solid  76-79 264 262 67

E E E E Pale yellow solid 459 68

D B D B WHITE SOLID 128- 130 269 69

B A A A beige wax 300 298 70

C A C A white solid  94-97 312 71

A A A A 292 290 72

A A A A beige solid 155- 156 265 263 73

E E E E Gummy liquid 310 74

D D B A white solid 245 243 75

A A C A off-white solid 164- 166 435 433 76

C C C C black semi- solid 277 77

C A D A colorless oil 348 346 78

A A A A white solid 125- 127 234 79

A A A A white solid 134- 135 319 80

D B D D white solid  63-69* 272 81

D D D D off-white solid 187- 189 361 359 82

D C C C orange oil 325 83

A A A A clear oil 278 84

E E E E Gummy liquid 262 85

A A C A yellow solid 151- 156 403 401 86

D D C B white solid 368 366 87

D A B A yellow solid 154- 155 379 377 88

C A C A clear colorless oil 282 280 89

A A A A tan solid 129- 130 331 90

C B A A yellow solid 180- 187 441 439 91

E E E E Gummy liquid 276 [M + Na] 92

E E E E Off white solid 381 93

A A A A white solid 122 274 272 94

A A A A off white solid  63-65 291 95

A A A A yellow solid 118- 120 292 — 96

D D D D brown oil 334 97

D D D B white solid 104- 107 348 345 98

D D D D white solid 168- 169 389 387 99

D B D A WHITE SOLID  74-77 244 100

D D D D white solid 163- 164 254 252 101

D D B B white solid 127- 129 338 102

D C D D dark brown solid 118- 122 325 103

B A A A yellow solid  90-92 312 104

A A A A yellow solid 179- 181 277 275 105

D D D D brown solid 143- 148 288 285 106

D C D D yellow clear oil 240 238 107

A A A A white solid 280 278 108

A A A A white solid 123- 124 321 109

E E E E white solid 188- 192 276 274 110

E E E E Pale yellow solid 338 111

D D D D pale yellow oil 347 112

A A A A white solid 128- 131 340.8 (Na+) 113

D C B A PALE YELLOW GUMMY SOLID 266 114

D D D D white solid 133- 135 389 307 115

A A A A yellow-white wax 271 116

D D D D white solid 162- 164 377 375 117

C C C B yellow solid 173- 178 391 389 118

E E E E Off white solid 338 119

B A C A white powder 122- 123 351 349 120

A A A A off-white solid 173- 174 270 268 121

B A B A clear pale yellow oil 372 370 122

C A D B white solid 107- 108 325 323 123

C A D C clear yellow oil 356 354 124

E E E E Pale yellow liquid 294 125

D D C C yellow solid 175- 180 509 507 126

A A A A brown oil 405 403 127

A A A A white solid 126 284 282 128

E E E E Off white solid 363 129

A A C A white solid 119- 120 302 300 130

A A A A white solid 139- 141 269 131

C A C B white crystals 133- 134 263 132

A A A A beige solid 171- 173 316 (M + Na) 133

B A B A white solid 120- 123 248 134

B A D B 350 348 135

B A A A off-white solid 144- 146 391 389 136

A A A A off white solid 103- 105 286 284 137

C A C A white solid  55-57 214 212 138

A A A A off white solid 111- 116 254 252 139

D C C B white solid 106 356 354 140

A A A A white solid 120- 125 317 141

B C D A beige solid 175- 176 290 142

D D D D off-white solid 204- 205 382 380 143

E E E E Off white solid 296 144

A A A A white solid 101 306 304 145

A A A A clear oil 260 146

A A A A white solid 295 147

C C D B off white solid 146.8- 149.4 297 294 148

D D B B yellow solid 125- 129 374 372 149

D B C A yellow oil 356 354 150

C A D A 322 320 151

C C D D yellow oil 417 415 152

C A C A white solid 157- 161 341 339 153

A A A A white solid 144- 145 275 273 154

A A A A white solid 158 335 155

A A B A white solid  94-96 330 156

A A A A white solid 128- 130 318 316 157

C C C A yellow solid 170- 175 379 377 158

A A A A white solid  91-93 342 340 159

C D D D OFF WHITE SOLID 327 160

A A A A clear yellow oil 333 161

C A A A white solid 121.5- 125 267 264 162

D D C A white solid  71-73 354 352 163

D D D D off-white solid 161- 162 330 328 164

D B C B clear oil 360 165

E E E E Off white solid 397 166

A A A A brown semi- solid 291 167

D D D C white tacky solid 365 363 168

D C D C 334 169

D D B A off-white solid 154- 155 393 391 170

D D D D off-white solid 169- 171 353 351 171

A A A A off-white solid  85-87 248 246 172

D D D D white solid  77-78 188 186 173

D B B A white solid 141- 147 322 174

A A A A 322 320 175

D D A A yellow solid 177- 179 388 176

A A B A 362 177

A A A A white solid 119- 120 342 178

A A A A white solid 153 264 262 179

A A A A white solid 155- 156 276 274 180

D D D B white solid 163- 165 417 415 181

A A A A white solid 203- 205 259 257 182

A A A A white solid 160- 161 307 305 183

D D D D white solid 175- 177 378 376 184

B A A A white solid 147- 148 289 185

A A A A pale yellow glass 268 186

D D B B fluffy white solid 172- 173 323 321 187

D B D D LIGHT GREEN SOLID  90-92 291 188

A A A A white solid  92-94 234 232 189

B A B A white solid 163- 164 279 190

D D D D white solid  74-75 312 310 191

A A A A viscous yellow oil 354 352 192

B A A A white solid foam 193

A A A A yellow solid 120 326 324 194

A A A A white solid 154 274 272 195

C A B A light yellow solid  51-53 387 385 196

A A A A white solid  93-95 256 254 197

B A B A white solid  65-66 262 260 198

E E E E Pale yellow solid 441 199

B A D A 368 366 200

D D D C yellow solid 181- 186 421 419 201

D D D D white solid 161- 162 401 399 202

E E E E Pale yellow solid 380 203

D B D D white solid 159- 161 — 303 204

E E E E Pale yellow solid 368 205

D B D D pale yellow oil 321 318 206

E E E E Off white solid 352 207

D D D C tan solid 142- 147 298 296 208

D C D D white solid 196- 198 371 369 209

A A A A white solid  84-85 275 210

A A A A white solid 121- 123 256 254 211

A A A A off-white solid 173- 174 326 324 212

A A A A off-white solid 122- 124 346 344 213

A A A A White Solid  90-92 226 214

D D D D WHITE SOLID 110- 113 291 215

E E E E Off white solid 248 216

B A A A white solid 108- 112 298 296 217

E E E E Pale yellow liquid 376 218

E E E E Pale yellow solid 473 219

D B B A off-white solid 141- 143 262 260 220

A A A A 372 370 221

E E E E white solid 113- 115 215 222

E E E E Pale yellow viscous liquid 423 223

A A A A white solid 132- 134 236 234 224

D C C A white solid 184 347 345 225

E E E E 306 226

A A A A white glassy solid  68-77 370 227

A A A A white solid  56-57 324 322 228

B A C A light yellow solid 362 360 229

E E E E Off white solid 322 230

D D A A yellow solid 159- 163 403 401 231

D D D D white solid 193- 194 375 373 232

A A A A white solid 105- 107 252 250 233

A A B A white solid 114- 115 234

A A A A pale yellow solid 357 235

B A A A viscous yellow oil 345 342 236

A A A A white solid 111- 113 238 237

D D D D white solid  62-65 240 238 238

D C D B clear colorless oil 515 513 239

B A A A white solid 165- 166 403 401 240

D D D C white solid  86-87 268 266 241

A B A A white solid 164- 165 365 242

E E E E Pale yellow solid 320 243

E E E E Pale yellow solid 429 244

D A D A pale yellow solid 138- 142 332 329 245

B A B A white solid 145- 148 254 252 246

E E D D white solid 157- 158 254 252 247

A A A A off white solid  94-95 295 248

A A D A OFF WHITE SOLID 102- 104 304 249

C B C A off white solid  92-93 358 356 250

E E E E white solid 117- 118 254 252 251

A A A A beige solid 120- 122 300 252

D D C C white solid 132- 135 253

B A C A yellow oil 263 261 254

E E E E Gummy liquid 268 255

E E E E Off white solid 200 256

D C D D white solid  83-84 184 182 257

B A B A white solid  90-91 296 294 258

C B B A off white solid  80-82 236 233 259

A A B A white solid 103- 105 310 260

A A A A off white slid  95 (dec) 357 261

B A B A pale amber oil 340 262

A A B A white solid 101- 105 263

E E E E Off white solid 270 M + Na 264

A A B A white solid 131- 133 356 265

E E E E Yellow solid 344 266

D A A A white solid 137- 138 391 389 267

D D D D white solid 104- 105 172 170 268

C B D C white solid 126- 127 247 269

D D D D pale green solid  91-94 265 237 270

D D D D white solid 111- 112 239 271

B A A A white solid 119 306 304 272

A A A A clear yellow oil 349 273

A A B A 340 338 274

A A A A off white solid  84-86 319 275

A A A A beige solid 136 227 276

A A A A 322 320 277

E E E E 290 278

E E E E Off white solid 411 279

A A B A YELLOW GUMMY SOLID 316 280

A A A A 340 338 281

E E E E Pale yellow solid 427 282

C B D C dark brown solid 158- 163 312 309 283

D C B A yellow solid 166- 176 441 439 284

D D D D white solid 196- 198 236 234 285

C C B A pale brown solid 118- 120 331 329 286

B A A A off-white solid 121- 123 248 246 287

A A A A white solid 115- 116 363 361 288

D D D D white solid 188- 190 401 399 289

A A A A white solid 128 254 290

E E E E Pale yellow solid 425 291

D C D D off-white solid 198- 200 357 355 292

A A A A colorless oil 369 293

D D D D white solid 200- 202 340 337 294

D A D A yellow oil 347 295

A A A A 366 296

D C D D white solid 235 233 297

E E E E Pale yellow liquid 368 298

A A A A 354 352 299

E E E E off white solid  83-88 562 300

A A A A white solid 106- 107 250 248 301

B A C C tan solid 136- 139 386 384 302

A A A A grey solid 105- 107 286 303

B A C A thick oil 290 304

E E E E Yellow liquid 276 [M + Na] 305

E E E E white solid 292 290 306

C C D A brown solid 108- 112 341 339 307

A A A A white solid 161- 163 261 258 308

A A A A yellow solid 182- 183 256 309

A A A A white solid 292 290 310

E E E E colorless oil 400 398 311

A A A A white solid 160- 161 286 312

A A A A white solid 196- 200 309 307 313

A A A A white solid  99- 102 246 314

A A A A 317 315 315

A A B A white solid  64-65 202 200 316

A A A A yellow solid 138- 140 303 317

C A B A pale amber oil 345 318

E E E E 314 319

E E E E Pale yellow viscous liquid 393 320

C C D D yellow solid 209 377 321

A A A A LIGHT YELLOW SOLID 112- 114 244 322

D D D D yellow solid 235- 237 267 265 323

A A A A white solid 153 248 246 324

D C A A yellow solid 185- 189 409 407 325

A A A A off white solid 138- 141 250 248 326

B A A A pale amber oil 333 327

B A B A pale amber oil 345 328

A A A A off-white solid 116- 117 264 262 329

D D D D white solid 187- 188 387 385 330

D C D A white solid  75-77 340 338 331

A A A A clear colorless oil 308 306 332

B C A A yellow-white solid 121- 123 356 354 333

E E E E Gummy liquid 388 334

A A A A white solid  79-80 301 335

A A A A orange oil 282 336

E E E E Gummy liquid 262 337

C C C A white solid 191- 192 208 206 338

A A A A white solid 102- 103 349 339

C B D C white solid  63-65 264 262 340

C A D A yellow oil 294 291 341

A A A A white solid 129 268 266 342

A A A A off-white crystals 147- 149 305 303 343

A A C A white solid  55-57 284 282 344

D C C C off white solid 117- 121 363 361 345

A A A A white solid 154- 156 276 346

A A A A clear oil 352 350 347

A A A A white solid 134- 135 317 348

A A A A white solid 128- 130 349

E E E E Pale yellow liquid 278 350

A A A A white solid 117 314 312 351

A A A A white solid 151 280 278 352

D D D D colorless liquid 310 307 353

D D D D white solid  68-72 335 333 354

C A B A clear pale yellow oil 370 368 355

A A A A white solid 150- 152 330 356

C B C B orange oil 301 357

D B C C off white solid 173- 177 313 311 358

C A D B brown solid 120- 123 293 291 359

A C A A white solid 172- 174 360 360

A A A A white solid 105- 106 390 388 361

A A B A white solid 150- 153 339 362

B A B A white solid 115- 116 282 280 363

E E E E Pale yellow viscous liquid 441 364

A A A A white solid 114- 115 342 340 365

A A A A tacky yellow glass 252 366

B A A A yellow solid 186- 192 377 375 367

D D D D off white solid  94- 97.5 341 368

A A A A tan solid  95-96 286 284 369

A A A A white solid 138- 139 323 370

D D D D white solid  93-94 212 210 371

D D D D white solid 168- 169 371 369 372

E E C A white solid 138- 139 263 261 373

C B D D brown solid  44-50 313 310 374

A A B A clear pale yellow oil 282 280 375

C A D D yellow oil 322 320 376

D C D D lavender powder 214- 216 363 361 377

B A A A pale amber oil 329 378

A A B A white solid 177- 179 290 288 379

B A A A white solid  84-85 310 308 380

D A A A off white solid  73-76 343 381

A A A A light yellow solid 173- 175 276 274 382

D A A A white solid 149- 152 336 383

C D D D yellow solid 118- 120 — 299 384

C A B A dark oil 241 239 385

A A A A ivory solid 104- 105 292 290 386

A A A A white solid 124 264 262 387

A A A A orange oil 274 388

E E E E Pale yellow solid 384 389

A A A A light yellow solid 88.5- 89.5 308.8 (Na+) 390

A A A A off white solid  96- 100 236 234 391

C A B A off-white solid 132- 135 346 344 392

A A A A off-white solid 210 393

C A C A clear oil 277 394

A A A A white solid 177- 179 356 354 395

C B D D yellow oil 249 247 396

A A A A off-white solid 181- 183 274 272 397

D D D D colorless oil 282 279 398

D C D D white solid 176- 178 385 383 399

A A B A white solid 174 249 247 400

A A A A off-white solid 154- 156 264 262 401

A A A A off-white solid 271 402

A A A A white solid 121- 122 331 403

C A A A white solid  93-94 292 404

A A A A white solid 289 287 405

A A A A clear pale yellow oil 305 406

A A A A white solid 134- 138 312 407

D D D D yellow oil 318 408

D A D A yellow solid 144- 145 377 375 409

A A A A tan solid 210 410

B A B A white solid 114- 115 336 411

C C A A white solid 138- 142 400 398 412

D B D A colorless oil 344 342 413

A A A A white solid 245- 247 234 232 414

E E E E white solid 125 (dec) 319 415

A A B A 384 382 416

D C D D 358 417

A A A A white solid 105- 115 (dec) 253 418

A A A A brown oil 300 419

A A A A 336 334 420

A A A A white solid  93-94 255 421

A A A A pale amber oil 315 422

A A A A white solid 111- 112 317 423

D D D D white solid 236 234 424

B A B A pale amber solid  93- 100 347 425

A A A A white solid  95-99 372 426

E E E E Colourless liquid 324 427

A A A A yellow white solid 125- 126 302 428

C A B B light yellow solid 309 307 429

A A A A beige solid 168- 169 261 259 430

A A A A dark brown soid 128- 130 235 233 431

A A A A clear yellow oil 238 432

E E E E Pale yellow solid 411 433

D D D D yellow solid 214 212 434

A A A A clear oil 338 435

B A A A white solid 115- 117 324 322 436

A A A A white solid 115 241 437

D B D B brown solid 182- 183 246 244 438

D D B A white solid 162- 164 387 385 439

E E E E Yellow solid 298 [M + Na] 440

C D D D yellow solid 172- 179 401 399 441

A A A A light yellow solid  61-62 278 276 442

A A A A fluffy off- white solid 195- 196 297 293 443

C C A A yellow solid 173- 177 387 385 444

A A A A white solid 121- 123 336 445

A A B A brown oil 408 406 446

E E E E white solid 152- 153 347 345 447

E E E E Pale yellow liquid 214 448

E E E E Pale yellow solid 364 449

E E E E Off white solid 489 450

A B A A white solid 155 294 292 451

D D D D white solid 158- 160 263 261 452

A A A A white solid 108- 109 326 324 453

B A A A light yellow glass 344 342 454

C D D A off white solid 153.5- 157.9 337 334 455

C A B A white solid 101- 103 268 266 456

D A B A yellow oil 377 457

B A B A LIGHT YELLOW SOLID  53-55 257 458

D D D B white tacky solid 358 356 459

A A B A 352 350 460

A A A A white solid 304 302 461

E E E E Gummy liquid 290 462

B C B A white solid 143- 144 278 276 463

C B D B colorless oil 308 306 464

D C D D off-white solid 171- 174 419 417 465

A A A A tan solid 155- 157 271 269 466

D D D D light yellow glass 386 384 467

A A A A white solid 120- 121 292.8 (Na+) 468

A A A A white powder 143- 145 254 469

A A A A white solid  98-99 288 470

C C D D pale pink solid 154.4- 157.2 342 340 471

E E E E Gummy liquid 282 472

A A A A yellow solid  58-61 266 264 473

C A C A fluffy white solid 123- 124 253 251 474

A A A A clear oil 324 475

B A B A white solid 170- 171 349 351 476

A A A A white solid 123- 125 318 316 477

D B D D white solid 189- 191 389 387 478

A A B A 372 370 479

B B A A yellow solid 143- 150 488 480

D D D D pale yellow solid 150- 154 324 322 481

A A A A white solid 169- 174 (dec) 482

D C D D off white solid 111- 115 312 309 483

A A A A clear yellow oil 307 484

A A A A yellow oil 323 485

D D D D white solid 206- 207 357 355 486

C C D D ivory solid 188- 189 302 300 487

D A D A white solid 153.8- 157.1 268 266 488

D D D D white solid 191- 192 238 236 489

A A D B white solid 122- 123 182 180 490

A A A A 306 304 491

E E E E Pale yellow solid 411 492

D C D C pale brown solid 139- 143 335 333 493

D D D C pale yellow solid  95-98 318 315 494

A A A A off white solid  77-78 293 495

E E E E Yellow solid 350 496

E E E E Pale yellow solid 463 497

D C B A white solid 123- 124 352 350 498

A A A A white solid  56-58 296 294 499

E E E E 292 500

A A A A white solid 147- 150 306 304 501

A A A A viscous semisolid 316 314 502

D D D D white solid 130- 134 336 503

A A A A clear oil 341 339 504

D D D B off-white solid 165- 166 412 410 505

E E E E Brown liquid 294 506

D D C A white solid  95-97 346 344 507

D A B A YELLOW GUMMY SOLID 382 508

A A A A tan solid 226 509

C D D D tan solid  72-77 220 218 510

B A B A white solid 150 262 260 511

C C B B yellow oil 271 512

D D D B off white solid  63-67 318 513

A A A A sticky solid 264 514

A A A A yellow oil 288 515

D D D A brown solid 123- 129 363 361 516

A A A A clear pale yellow oil 303 301 517

A A A A white solid 125- 127 243 518

A A A A tan oil 335 519

D D D D white solid 208- 211 405 403 520

E E E E Pale yellow solid 308 521

E E E E Pale yellow solid 278 522

D D D C rust solid 188- 189 246 244 523

A A A A white solid 127- 130 356.8 (Na+) 524

D B D B white solid 100- 101 264 262 525

A A A A yellow solid 154- 160 427 425 526

D D D B yellow solid 216- 218 404 527

D D B A yellow solid 178- 182 459 457 528

D B A A tan solid 121- 124 327 325 529

D D D D OFF WHITE SOLID 188- 190 530

B A A A pale amber oil 321 531

A A A A 384 382 532

D C C B off white solid 157- 162 343 341 533

D C B B white solid 120- 123 331 329 534

D C D C white solid 147- 148 335 333 535

D D D D white solid 182- 183 387 385 536

C C D D white solid 171- 172 319 317 537

A A A A off-white solid 112- 113 292 290 538

B A C B pale biege solid 103- 107 250 247 539

D D A A white solid 142- 144 373 371 540

A A A A white solid 185 289 287 541

A A A A white solid  99- 100 347 542

E E E E Off white solid 266 543

A A A A colorless oil 276 544

D D D C white solid 134- 140 322 545

D B D C white solid 134- 135 199 546

B D B B white solid 235- 238 360 547

A A A A white solid 130- 132 273 271 548

D D D D white solid 196- 198 330 328 549

D D C D white solid 187- 188 241 239 550

A A A A white solid 105- 106 292 290 551

E E D C white solid 155- 156 240 238 552

D A D A off-white solid 148- 149 369 367 553

A A A A clear oil 334 332 554

C A C A white solid 123- 124 260 258 555

D D D D white solid 203- 205 (dec) 364 362 556

D A C A WHITE SOLID 100- 103 323 557

D D C D white solid 208- 210 343 341 558

C C A A yellow solid 167- 171 373 371 559

A A B A PALE YELLOW SOLID 212 560

D A D C yellow solid 261 259 561

A A A A clear oil 349 562

D C D D yellow oil 333 331 563

E E E E Colourless liquid 290 564

C A B A white solid 109 248 246 565

E E E E White solid 445 566

D D D D white solid 158- 159 323 321 567

C A C B clear yellow oil 388 386 568

A A B A off-white solid 125- 126 339 337 569

B A A A white solid  90 320 318 570

A A A A off white solid 101- 102 281 571

A A A A white solid 132- 133 280 278 572

C B C A off-white solid 178- 179 405 403 573

D D C B white solid 201- 202 236 234 574

A A A A white solid 131 289 287 575

E E E E yellow oil 321 576

C A C A white solid 117- 122 277 577

A A A A off-white solid  86-88 240 578

A A A A pale yellow solid 140- 142 277 579

E E E E Pale yellow soild 262 580

D B B A white solid 185- 187 256 581

A A A A white solid 120 268 266 582

A A A A off-white solid 162 290 288 583

A A D A white solid 108- 109 249 247 584

D A D A off white solid 153- 154 224 222 585

A A A A white solid 125 (dec) 323 586

D D D D colorless oil 320 587

C A D D white solid 200- 201 363 361 588

D D D D white solid 86.3- 89.8 335 589

D D D D white solid >200 294 292 590

A A A A white solid 154 268 266 591

E E E E Off white solid 282 592

A A A A yellow oil 260 593

E E D B white solid 134- 135 240 238 594

D C D B white solid 104.4- 107 356 354 595

D D C A off-white solid 160- 161 391 389 596

A A A A off-white solid 105- 107 305 302 597

A A A A clear oil 280 598

A A B A white solid 156- 160 356 599

A A B A clear oil 359 357 600

A A A A clear oil 365 601

A A A A white solid  53-54 308 306 602

D D D B white solid 144 247 603

D D C A off white solid 173- 176 374 372 604

A A A A off-white solid 106- 108 #### #### 605

D A B A WHITE SOLID  64-67 350 606

E E E E 316 607

D C D D white solid 112- 113 334 608

B A B A dark red oil 279 262 609

A A A A white solid 112 280 278 610

C B A A white solid 157- 159 319 611

A A A A white solid 143- 145 612

A A A A yellow solid 165- 172 398 396 613

A A A A 368 366 614

A A A A white solid  75-76 310 308 615

A A C A YELLOW SOLID  58-60 237 616

A A A A white solid 149- 151 287 617

A A A A clear oil 288 618

E E E E Off white solid 429 619

E E E E Gummy liquid 306 620

E E E E Pale yellow solid 350 621

E E E E Off white solid 266 622

E E E E Pale yellow liquid 296 623

B A A A white solid 112 280 278 624

B A B A LIGHT BROWN SOLID 128- 130 310 625

D C D C white solid 114- 115 202 626

A A A A white solid 130- 131 317 627

E E E E Pale yellow solid 475 628

B A C A beige solid 101- 103 227 629

D B D B light yellow solid 374 372 630

A A A A white solid 167- 169 276 631

D D D D clear yellow oil 184 182 632

A A A A white solid 128- 131 320 318 633

A A A A white solid 308 634

A A A A white solid 130- 133 359 635

D A C A white solid 117- 118 247 636

A A A A white solid 132- 135 319 637

A A A A white solid 158- 160 249 638

D B B A white solid  77-78 370 368 639

B A A A white solid 136- 137 403 401 640

A A A A yellow white solid 218- 220 258 641

E E E E Pale yellow liquid 276 642

E E E E white foam  61-65 410 (M + Na) 643

A A A A pasty off- white solid 644

A A A A white solid 164- 166 255 645

D B C A white solid 117- 118 264 262 646

A A B A white solid 185- 187 298 296 647

A A A A white solid  89-90 290.8 (Na+) 648

A A A A white solid 132 344 342 649

D A D C LIGHT YELLOW SOLID 130- 132 278 650

A A A A yellow solid 108 322 320 651

D B D D white solid 381 379 652

D A D B yellow oil 350 348 653

C A D D white solid  58-59 184 654

A A A A white solid 118- 121 324 655

B C B A yellow solid 144- 146 461 459 656

A A A A clear oil 334 657

E E E E Off white solid 459 658

D B D B YELLOW GUMMY SOLID 659

E E E E Pale yellow solid 477 660

C D A A white solid 160- 161 661

E E E E Off white solid 280 662

C C D A yellow solid 176 409 407 663

A A A A yellow solid 123- 124 323 664

D D D C OFF WHITE SOLID 125- 127 356 665

E E E E Colourless liquid 242 666

E E E E Yellow solid 248 667

D A D A brown solid 108- 111 357 355 668

A A C A 347 345 669

A A A A white solid 135- 136 305 670

B A B A off-white solid 188- 190 401 399 671

A A A A white solid 153- 154 672

A A A A off-white solid 127- 129 314 673

A A A A off-white solid  94-95 266 264 674

A A A A clear oil 366 364 675

A A A A light tan waxy solid 292 290 676

D D C A yellow oil 354 352 677

A A A A white solid 113- 114 250 248 678

C A D A off-white crystals 128- 129 321 319 679

A A A A off white solid  98-99 363 680

C C D D yellow solid 175- 182 433 431 681

A A A A white solid  86-88 285 682

A A A A off-white solid 153- 155 290 683

E E E E Colourless liquid 236 [M + Na] 684

A A A A white solid  94-95 335 685

D D D A yellow solid 175- 183 433 431 686

E E E E white solid 160- 161 262 260 687

D D C A yellow solid 122 338 336 688

A A A A white solid  93-95 289 689

A A A A white solid 126- 128 254 252 690

A A B A 379 377 691

B A B A yellow solid 162 262 260 692

A A A A clear yellow oil 305 693

A A A A white solid 127- 130 292 290 694

D C D C white solid 181- 183 451 449 695

D C D A WHITE SOLID 100- 102 256 696

B A A A off-white solid  98- 102 276 274 697

C C D D LIGHT YELLOW SOLID 393 698

A A A A white solid 117 314 312 699

B A A A tannish solid 222 700

C A D B tan solid 185- 187 375 373 701

D A D A pale yellow solid 138- 142 332 329 702

A A A A clear oil 382 380 703

D D D C white solid 116- 117 435 433 704

A A A A white solid  76-77 347 705

B A A A white solid 117- 119 288 286 706

D B D A light yellow solid 163- 165 346 344 707

A A A A orange solid 156 299 297 708

A A A A white solid  89-90 292 290 709

D B D A clear colorless oil 388 386 710

B A B A colorless oil 262 260 711

C A B A white solid 138- 139 379 377 712

E E E E Off white solid 415 713

B A A A brown solid  95-98 238 714

A A A A yellow oil 294 292 715

D D C B white solid 198- 201 251 249 716

A A A A yellow solid  93 326 324 717

A A B A 338 718

C C C A pale yellow solid 135- 139 356 353 719

E E D B white solid 103- 104 300 298 720

A A A A white solid 115 299 721

E E E E 370 368 722

D C D D light yellow solid  58-59 184 182 723

E E E E Pale yellow solid 400 724

D D D C white solid 170- 171 335 333 725

A A A A yellow solid 146- 147 346 344 726

A A A A white solid 109- 110 305 727

A A A A clear yellow oil 307 305 728

E E E E Brown liquid 228 729

B B B C light yellow solid 178- 180 307 730

A A A A clear yellow oil 279 731

D D D D white solid  84-85 200 198 732

B A A A pale amber oil 362 733

A A A A white solid  96-98 234 232 734

A A A A White Solid 110- 111 250 248 735

A A A A white solid 278 736

D D D D white solid 370 368 737

D D D D YELLOW SOLID 361 738

E E E E Pale yellow solid 334 739

A A A A white solid  87-88 295 293 740

E E D D yellow oil 242 240 741

A A C A clear colorless oil 280 278 742

E E E E Pale yellow solid 284 [M + Na] 743

A A A A yellow solid  93 320 744

A A A A tan oil 335 745

A A A A WHITE SOLID 158- 160 224 746

D A D D orange solid 106- 108 168 166 747

B A D A tan oil — 196 748

E E D D white solid 112- 113 250 248 749

A A A A 324 322 750

C B C A 328 751

C A B A pale amber oil 319 752

A A A A colorless oil 308 306 753

A A A A clear pale yellow oil 278 276 754

D C D D colorless oil 336 333 755

D D C C pale yellow oil 331 756

C D D D white solid 199- 200 348 346 757

A A A A light yellow needles 127- 129 299 297 758

C B C A yellow solid 163- 170 459 457 759

C A B A yellow oil 330 328 760

E E E E Off white solid 356 761

E E E E Brown liquid 306 762

A A A A white solid  61-62 352 350 763

A A A A off-white solid 221 764

D D D D white solid 145- 146 278 276 765

D D D C white solid  44-49 335 333 766

D C D B dark brown solid 132- 140 325 323 767

A A A A white solid 110 (dec) 319 768

D C D C white solid 183- 184 249 247 769

D A B A off-white solid 150- 152 421 419 770

A A A A yellow oil 306 771

A A A A 386 384 772

A A A A yellow solid 180- 181 255 773

D D C A white solid 132- 134 368 366 774

D D D D LIGHT YELLOW SOLID 339 775

D D D D white solid  77-80 310 307 776

D D D D white solid 157- 158 311 309 777

D C D D white solid 404 402 778

A A A A white solid 146- 147 387 385 779

A A A A white solid 118- 120 201 780

A A A A white solid 107- 108 268 266 781

D C D B light yellow solid 160- 162 398 396 782

C A D C 375 373 783

A A A A off-white solid  51-54 278 276 784

D D D D white solid 112- 115 250 785

A A A A white solid 163- 164 340 786

E E E E Pale yellow semi solid 370 787

A A A A white solid 171 286 284 788

A A A A white solid  59-60 285 789

A A A A white solid 134- 141 353 790

A A A A clear oil 304 791

E E E E clear oil 365 792

C B A A white solid 123- 125 338 336 793

D D D D off white solid 158- 166 323 321 794

A A A A white solid 108 266 795

A A A A white solid 124- 125 335 796

A A A A white solid 149 286 284 797

C A B A off-white solid 167- 168 417 415 798

A A A A clear oil 358 799

D D D D white solid 200- 202 363 361 800

A A A A tan solid 238 801

E E E E Off white solid 338 802

D D D D white solid  98-99 230 228

TABLE II 1 DP Activity of Compounds on SEPTTR at 50 and 200 ppm SEPTTRSEPTTR Mass Mass 1DP 1DP Phys. Spec. Spec. Cmpd Structure 50 ppm 200 ppmApp. MP (ES+) (ES−) GCMS 803

D B 320 804

C B 360 805

B A 342 806

E A 384 807

E A 294 808

A A 350 809

B A 346 810

E A 350 811

A A 412 812

E A 290 813

A A 412 814

E A 384 815

A A white solid 115- 118 354 352 816

A A 378 817

C A 318 818

D D 317 819

E A off white solid 328 820

C A 362 821

E A 290 822

C A 332 823

E A 290 824

A A 346 825

B A 364 826

E A 328 827

D C 314 828

D D 304 829

C A 428 830

D D 308 831

B A 322 832

D D white solid 167- 169 238 236 833

C B 318 834

E A 296 835

E A 384 836

B A 304 837

D D 316 838

E A 384 839

E A 360 840

B A 362 841

B A 346 842

A A 388 843

C A 330 844

A A 357 845

A A 296 846

D C white solid 108- 110 226 224 847

A E white solid 155- 157 288 286 848

D D white solid 212 210 849

A A 316 850

D B yellow- white solid 189- 191 144 851

A A 380 852

B A 278 853

D D white solid 112- 114 158 854

B A 368 855

E A 344 856

E A off-white solid 221 857

B A 397 858

D C 335 859

A A 344 860

E A 400 861

D C 316 862

B A 338 863

A A 398 864

D C white solid 115- 117 212 210 865

C A 358 866

D A 266 867

A A 334 868

B A 414 869

E A 346 870

E A 330 871

D C 338 872

C B 316 873

D D 335 874

D D 351 875

D A 316 876

D D 249 877

E A 330 878

A A yellow gummy solid 312 310 879

A A 380 880

D C 359 881

A A 274 882

A A 372 883

A A 398 884

A A orange oil 350 348 885

C B 334 886

A A 360 887

E A 294 888

D B 329 889

A A 397 890

E A 352 891

A A yellowish solid 221 892

B A 358 893

A A 362 894

D D 320 895

A A 294 896

E A 384 897

D B 308 898

D D 250 899

C A 306 900

B A 344 901

B A 363 902

E A 317 903

D A 336 904

D C 368 905

C B 336 906

E A 346 907

B A 398 908

A A 358 909

E A 328 910

E A 334 911

D D 358 912

E A 350 913

A A 329 914

D A 314 915

D D 337 916

A A 340 917

D B yellow- white solid 54- 58 278 276 918

A A 362 919

E A 304 920

A A 359 921

A A 364 922

B C 330 923

E A 352 924

A A 362 925

D D 324 926

A A 338 927

B A 278 928

A A 372 929

B A 374 930

D A 342 931

E A 346 932

A A white solid 49- 51 170 168 933

C B white solid 145- 149 223 934

D C 340 935

C A 345 936

A A white solid 66- 91 234 232 937

A A 330 938

E A 296 939

D A off-white solid 225 940

D D 274 941

D D 282 942

A A 414 943

B A 398 944

D D 280 945

A A 350 946

B A 334 947

A A white solid 144- 146 330 328 948

D D 342 949

B A 330 950

D D 346 951

B A 342 952

E C 261 953

C A 412

TABLE III 1 DP Activity of Compounds on CERCBE, VENTIN, and MYCOFICERCBE CERCBE VENTIN VENTIN MYCOFI MYCOFI 1DP 1DP 1DP 1DP 1DP 1DP Cmpd #25 ppm 75 ppm 25 ppm 75 ppm 50 ppm 200 ppm 1 C C A A C B 3 E E D A E E 4A A A A E E 5 E E A A E E 7 B B A A E E 9 D D A C E E 10 D D B A E E 11D D A A E E 14 D D A A E E 15 E E A A E E 20 E E B A E E 23 D B B A E E24 D D C A E E 35 E E A A E E 36 B B B A E E 46 E E A A E E 61 D D A B EE 68 B B B A E E 69 D C B A E E 79 D C C C E E 121 D D A C E E 122 C C AA E E 125 C C C A E E 135 C C B B E E 137 D D D A E E 141 D D D C E E155 D D C D E E 158 D D B B E E 163 D D D C E E 164 D D C B E E 169 D DB C E E 180 D C C D E E 187 D C B C E E 189 C D B B E E 190 C C C C E E207 D D D C E E 209 E E B A E E 211 D D C B E E 214 B B A A E E 221 C BD C E E 226 D C C A E E 233 D D D B E E 236 E E A A E E 248 D D D B E E251 D B A A E E 260 A B A A E E 270 C C D C E E 271 C C C B E E 288 D CB C E E 311 C C C C E E 313 E E C B E E 316 B A A A E E 335 C A A A E E337 B A B A E E 341 D D C D E E 342 C A A A E E 343 A A A B E E 345 E EB A E E 347 E E A C E E 352 D D D C E E 353 C C C A E E 356 B D B C E E370 C C C C E E 373 D D D C E E 384 D D B D E E 410 C C C B E E 411 C CB B E E 418 D D B B E E 436 B C A A E E 452 D D D C E E 469 E E B A E E481 C A A A E E 483 D D C A E E 488 D D C C E E 510 E E A A E E 524 D DB B E E 538 D D C B E E 554 D B A A E E 560 D C D A E E 569 C A A A E E570 D C C A E E 582 B B A A E E 584 C C C C E E 593 C B A A E E 626 D DC A E E 630 D D B A E E 631 D D D C E E 635 C C C A E E 649 D D C C E E651 C C D D E E 687 D D C B E E 694 C C C B E E 707 B C B B E E 710 D DC C E E 719 D C B B E E 720 D B B A E E 730 C C B B E E 732 C A C A E E734 E E A A E E 739 D D C B E E 741 D D B A E E 764 C D C C E E 800 A AA A E E 804 D D D D E E 845 D D C C E E 849 C C A B E E 858 C C C D E E860 D C C B E E 894 D D D C E E 933 C C D C E E 941 D D B C E E 952 D DD D E E

1. A compound of formula I

wherein R¹ is —N(R³)R⁴; R² is —OR²¹; R³ is: H; C₁-C₆ alkyl optionallysubstituted with 1- to 3 R⁵; C₂-C₆ alkenyl optionally substituted with1-3 R⁵; a 5- or 6-membered heteroaromatic ring selected from the groupconsisting of furanyl, pyridinyl, pyridinyl-N-oxide, pyrimidinyl,pyridazinyl, pyrazinyl, thiazolyl, triazinyl, thiadiazolyl, oxazolyl,isoxazolyl, triazolyl, each heteroaromatic ring being optionallysubstituted with 1-3 R³⁰; imidazole fused with an aromatic orheteroaromatic ring selected from the group consisting of benzene,oxazole, isoxazole, furan, thiazole, pyrimidine, pyridine, pyrrole,pyrazine, thiophene, each aromatic or heteroaromatic ring beingoptionally substituted with 1 to 3 R³⁰; benzo[1,3]dioxolyl;3H-isobenzofuran-1-onyl; cyano; C₃-C₆ alkynyl optionally substitutedwith 1-3 R⁵; —C(═O)R⁶; —C(═O)OCH₂C(═O)R⁸; —C(═S)R⁶; —C(═S)NHR⁸;—C(═O)N(R⁸)R¹⁰; —OR⁷; —P(O)(OR¹⁵)₂; —S(O)₂R⁸; —SR⁸; —Si(R⁸)₃; —N(R⁹)R¹⁰;—N═C(R¹⁵)R¹⁶; —(CHR²²)_(m)R³⁷; —(CHR²⁴)OR²⁹; or —C(═NR¹⁶)SR¹⁶; wherein mis an integer from 1-3; R⁴ is: H; C₁-C₆ alkyl, optionally substitutedwith 1-3 R⁵; —C(═O)R⁶; or —C(═O)N(R⁸)R¹⁰; alternatively R³ and R⁴ may betaken together to form: a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹; ═C(R¹²)N(R¹³)R¹⁴; ═C(R¹³)(R¹⁴); ═C(R¹⁵)OR¹⁵;═S(R³⁴)₂; or ═NR³⁵; R⁵ is independently halogen, C₁-C₆ alkyl, C₁-C₄haloalkyl, C₁-C₄ alkoxy, C₁-C₄ haloalkoxy, C₁-C₄ alkylthio, C₁-C₄haloalkylthio, amino, C₁-C₃ alkylamino, C₂-C₆ alkoxycarbonyl, C₂-C₆alkylcarbonyl, C₂-C₆ alkylaminocarbonyl, —OH, N-methyl piperazine orC₃-C₆ trialkylsilyl; R⁶ is independently H, C₁-C₆ alkyl, C₁-C₅haloalkyl, C₁-C₅ alkoxy, C₁-C₅ haloalkoxy C₂-C₆ alkoxycarbonyl, C₁-C₄alkoxyalkoxy, C₂-C₆ alkylaminocarbonyl; 1-benzo[1,2,3]thiadiazol-7-yl,thiazolyl, benzyl, phenyl, phenoxy, or benzyloxy wherein the thiazolyl,benzyl, phenyl, phenoxy, or benzyloxy may be optionally substituted with1-3 R²⁰, a 5- or 6-membered saturated or unsaturated ring containing 1-3heteroatoms wherein each ring may be optionally substituted with 1-3R¹¹; R⁷ is H, C₁-C₆ alkyl, C₂-C₆ alkenyl, C₁-C₅ haloalkyl, benzyl whichmay be optionally substituted with 1-5 R²⁰, CHR¹⁸C(O)OR¹⁹, or a 5- or6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹; R⁸ isindependently C₁-C₆ alkyl, C₁-C₆ haloalkyl, amino, C₁-C₆ alkylamino,C₂-C₆ dialkylamino, phenyl optionally substituted with 1-3 R³⁰, or a 5-or 6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹; R⁹ is H,C₁-C₆ alkyl C₁-C₆ haloalkyl, —C(═O)R¹⁷, or phenyl optionally substitutedwith 1-3 R²⁰, R¹⁰ is H or C₁-C₆ alkyl, C₁-C₆ haloalkyl, or phenyloptionally substituted with 1-3 R²⁰; R¹¹ is independently halogen, C₁-C₆alkyl, C₁-C₆ haloalkyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, C₁-C₆ alkylthio,C₁-C₆ haloalkylthio, amino, C₁-C₆ alkylamino, C₂-C₆ dialkylamino, C₂-C₆alkoxycarbonyl, or C₂-C₆ alkylcarbonyl; R¹² is H or C₁-C₄ alkyl; R¹³ andR¹⁴ are independently H, cyano, —OH, C₁-C₄ alkyl, C₁-C₆ alkoxy, C₂-C₆,alkylcarbonyl, phenyl, or benzyl wherein the phenyl or benzyl may beoptionally substituted with 1-3 R²⁰; alternatively R¹³ and R¹⁴ may betaken together to form: a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹, or 3,4-dihydro-1H-isoquinolin-2-yl;alternatively R¹² and R¹³ may be taken together to form: a 5- or6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹; R¹⁵ is Hor C₁-C₆ alkyl; R¹⁶ is H, C₁-C₆ alkyl, or phenyl optionally substitutedwith 1-3 R²⁰; alternatively R¹⁵ and R¹⁶ may be taken together as—(CH₂)₄— or —(CH₂)₅—; R¹⁷ is H, C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆alkoxy, phenyl, phenoxy, or benzyloxy wherein each ring may beoptionally substituted with 1-3 R²⁰; R¹⁸ is H, C₁-C₆ alkyl, or C₁-C₆haloalkyl; R¹⁹ is H, C₁-C₆ alkyl, C₁-C₆ haloalkyl, or benzyl; R²⁰ isindependently halogen, cyano, nitro, amino, C₁-C₆ alkoxyalkoxy, C₁-C₆alkyl, C₁-C₆ haloalkyl, C₁-C₆ hydroxyalkyl, C₂-C₆ alkoxyalkyl, C₂-C₆haloalkoxyalkyl, C₂-C₆ alkenyl, C₂-C₆ haloalkenyl, C₃-C₆ alkynyl, C₃-C₆haloalkynyl, hydroxyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, C₂-C₆ alkenyloxy,C₂-C₆ haloalkenyloxy, C₃-C₆ alkynyloxy, C₃-C₆ haloalkynyloxy, C₁-C₆alkylthio, C₁-C₆ haloalkylthio, C₁-C₆ alkylsulfonyl, C₁-C₆haloalkylsulfonyl, C₂-C₆ alkenylthio, C₂-C₆ haloalkenylthio, C₂-C₆haloalkenylsulfonyl, C₃-C₆ alkynylthio, C₃-C₆ alkynylsulfonyl, C₃-C₆haloalkynylsulfonyl, C₁-C₆ alkylamino, C₂-C₈ dialkylamino, C₃-C₈dialkylaminocarbonyl, C₂-C₆ alkoxycarbonyl, C₂-C₆ alkylcarbonyl, C₃-C₆trialkylsilyl, 2-[(E)-methoxyimino]-N-methyl-acetamidyl, phenyl, benzyl,benzyloxy, phenoxy, or a 5- or 6-membered heteroaromatic ring whereineach phenyl, benzyl, benzyloxy, phenoxy, or 5- or 6-memberedheteroaromatic ring may be optionally substituted with 1-3 substitutentsindependently selected from R³¹; R²¹ is: H; C₁-C₁₄ alkyl; C₁-C₆haloalkyl; C₂-C₄ alkenyl; C₂-C₄ haloalkenyl; C₃-C₄ alkynyl; C₃-C₄haloalkynyl; phenyl, naphthyl, or tetrahydroquinolinyl each optionallysubstituted with 1-3 R²⁰; —(CHR²²)_(m)R²³; —(CHR²⁴)_(m)C(O)OR²⁵;—(CHR²⁴)_(m)C(O)R²⁶; —(CHR²⁴)_(m)C(O)N(R²⁷)R²⁸; —(CHR²⁴)_(m)OR²⁹;—(CHR²⁴)_(m)SR²⁹; —(CHR²⁴)_(m)N(R²⁷)R²⁸; —C(═O)R³²; —N═C(R³²)(R³⁶);—NR²⁵C(═O)OR²⁵; —Si(R⁸)₃; —SO₂R³³; C₂-C₆ alkoxy carbonyl; C₂-C₆alkylaminocarbonyl; C₂-C₆ alkylcarbonyl; sugars selected from the groupconsisting of beta-D-glucose-tetraacetate, rhamnose, fructose, andpentose; or a 5- or 6-membered heteroaromatic ring selected from thegroup consisting of furanyl, pyridinyl, pyridinyl-N-oxide, pyrimidinyl,pyridazinyl, pyrazinyl, pyrazolyl, thiazolyl, triazinyl, thiadiazolyl,oxazolyl, triazolyl or isoxazolyl wherein each 5- or 6-memberheteroaromatic ring may be optionally substituted with 1-5 R²⁰; R²² isindependently: H; halogen; cyano; nitro; C₁-C₆ alkyl; C₁-C₆ haloalkyl;phenyl or benzyl optionally substituted with 1-3 R²⁰; C₁-C₆hydroxyalkyl; C₂-C₆ alkoxylalkyl; C₃-C₆ haloalkynyl; C₂-C₆ alkenyl;C₂-C₆ haloalkenyl; C₃-C₆ alkynyl; C₁-C₆ alkoxy; C₁-C₆ haloalkoxy; C₁-C₆alkylthio; C₁-C₆ alkylamino; C₂-C₈ dialkylamino; C₃-C₆ cycloalkylamino;C₄-C₆ (alkyl)cycloalkylamino; C₂-C₆ alkylcarbonyl; C₂-C₆ alkoxycarbonyl;C₂-C₆ alkylaminocarbonyl; C₃-C₈ dialkylaminocarbonyl; C₃-C₆trialkylsilyl; ring-fused heteroaromatic rings selected from the groupconsisting of benzothiophenyl, quinolinyl, isoquinolinyl,thieno[2,3-b]pyridyl, 1-methyl-1H-thieno[2,3-c]pyrazolyl, andbenzoimidazolyl, wherein each of the rings may be further substitutedwith 1-3 R²⁰; or a 5- or 6-membered heteroaromatic ring selected fromthe group consisting of furanyl, pyridinyl, pyridinyl-N-oxide,pyrimidinyl, pyridazinyl, pyrazinyl, thiazolyl, triazinyl, thiadiazolyl,oxazolyl, isoxazolyl, triazolyl and thienyl; R²³ is: H; halogen; C₁-C₆alkyl; C₁-C₆ haloalkyl; C₂-C₆ dialkylamino; phenyl optionallysubstituted with 1-5 R²⁰; ring-fused heteroaromatic rings selected fromthe group consisting of benzothiophenyl, quinolinyl, isoquinolinyl,thieno[2,3-b]pyridyl, 1-methyl-1H-thieno[2,3-c]pyrazolyl, benzofuranyland benzoimidazolyl, 2,3-dihydro-benzofuran-2-yl,4-methyl-4H-thieno[3,2-b]pyrrol-5-yl, 1-methyl-1H-indol-5-yl,imidazo[1,2-a]pyridin-2-yl, imidazo[2,1-b]thiazol-6-yl,benzothiazol-2-yl, benzo[b]thiophen-7-yl, and 1-methyl-1H-indazol-3-yl,wherein each of the rings may be further substituted with 1-3 R²⁰;naphthyl; benzo[1,3]dioxolyl; pyrrolidinonyl; oxetanyl; C₁-C₆ alkylthiooptionally substituted with 1-5 R²⁰; a 5- or 6-membered saturated orunsaturated ring containing 1-3 heteroatoms wherein each ring may beoptionally substituted with 1-3 R¹¹; or a 5- or 6-memberedheteroaromatic ring selected from the group consisting of furanyl,pyridinyl, pyridinyl-N-oxide, pyrimidinyl, pyridazinyl, pyrazinyl,pyrazolyl, thiazolyl, triazinyl, thiadiazolyl, oxazolyl, isoxazolyl,triazolyl, imidazolyl, thiophene-2-yl and thiophen-3-yl wherein eachheteroaromatic ring may be optionally substituted with 1-3 R²⁰; R²⁴ isH, C₁-C₆ alkyl, C₁-C₆ alkoxy, benzyl, or phenyl wherein each of thebenzyl or phenyl may be optionally substituted with 1-3 R²⁰; R²⁵ is H,C₁-C₆ alkyl, phenyl or benzyl optionally substituted with 1-3 R²⁰; R²⁶is: H; C₁-C₆ alkyl; C₁-C₆ alkoxy; phenyl optionally substituted with 1-3R²⁰; or a 5- or 6 membered heteroaromatic ring selected from the groupconsisting of furanyl, pyridinyl, pyridinyl-N-oxide, pyrimidinyl,pyridazinyl, pyrazinyl, thiazolyl, triazinyl, thiadiazolyl, oxazolyl,triazolyl and isoxazolyl; R²⁷ and R²⁸ are independently: H; C₁-C₆ alkyl;benzyl or phenyl wherein each of the benzyl or phenyl may be optionallysubstituted with 1-3 R²⁰; or a 5- or 6-membered saturated or unsaturatedring containing 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹; R²⁹ is: H; C₁-C₆ alkyl; C₁-C₆ haloalkyl; C₁-C₆alkoxyalkyl; C₂-C₆ alkylcarbonyl; benzyl or phenyl wherein each of thebenzyl or phenyl may be optionally substituted with 1-3 R²⁰; or a 5- or6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹; R³⁰ isindependently halogen, cyano, nitro, C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆hydroxyalkyl, C₂-C₆ alkoxyalkyl, C₂-C₆ haloalkoxyalkyl, C₂-C₆ alkenyl,C₂-C₆ haloalkenyl, C₃-C₆ alkynyl, C₃-C₆ haloalkynyl, hydroxyl, C₁-C₆alkoxy, C₁-C₆ haloalkoxy, C₂-C₆ alkenyloxy, C₂-C₆ haloalkenyloxy, C₃-C₆alkynyloxy, C₃-C₆ haloalkynyloxy, C₁-C₆ alkylthio, C₁-C₆ alkylsulfonyl,C₁-C₆ haloalkylsulfonyl, C₂-C₆ alkenylthio, C₂-C₆ haloalkenylthio, C₂-C₆haloalkenylsulfonyl, C₃-C₆ alkynylthio, C₃-C₆ alkynylsulfonyl, C₃-C₆haloalkynylsulfonyl, C₁-C₆ alkylamino, C₂-C₈ dialkylamino, C₃-C₈dialkylaminocarbonyl, C₃-C₆ trialkylsilyl, thiazolyl, phenyl,pyrimidinyl, or pyridyl, wherein the thiazolyl, phenyl, pyridyl, orpyrimidinyl may be optionally substituted with 1-3 R²⁰; R³¹ isindependently halogen, cyano, nitro, C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆hydroxyalkyl, C₂-C₆ alkoxyalkyl, C₂-C₆ haloalkoxyalkyl, C₂-C₆ alkenyl,C₂-C₆ haloalkenyl, C₃-C₆ alkynyl, C₃-C₆ haloalkynyl, hydroxyl, C₁-C₆alkoxy, C₁-C₆ haloalkoxy, C₂-C₆ alkenyloxy, C₂-C₆ haloalkenyloxy, C₃-C₆alkynyloxy, C₃-C₆ haloalkynyloxy, C₁-C₆ alkylthio, C₁-C₆ alkylsulfonyl,C₁-C₆ haloalkylsulfonyl, C₂-C₆ alkenylthio, C₂-C₆ haloalkenylthio, C₂-C₆haloalkenylsulfonyl, C₃-C₆ alkynylthio, C₃-C₆ alkynylsulfonyl, C₃-C₆haloalkynylsulfonyl, C₁-C₆ alkylamino, C₂-C₈ dialkylamino, C₃-C₈dialkylaminocarbonyl, or C₃-C₆ trialkylsilyl; R³² is independently:C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆ hydroxyalkyl, C₂-C₆ alkoxyalkyl,C₂-C₆ haloalkoxyalkyl, C₂-C₆ alkenyl, C₂-C₆ haloalkenyl, C₃-C₆ alkynyl,C₃-C₆ haloalkynyl, hydroxyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, C₂-C₆alkenyloxy, C₂-C₆ haloalkenyloxy, C₃-C₆ alkynyloxy, C₃-C₆haloalkynyloxy, C₁-C₆ alkylthio, C₁-C₆ alkylsulfonyl, C₁-C₆haloalkylsulfonyl, C₂-C₆ alkenylthio, C₂-C₆ haloalkenylthio, C₂-C₆haloalkenylsulfonyl, C₃-C₆ alkynylthio, C₃-C₆ alkynylsulfonyl, C₃-C₆haloalkynylsulfonyl, C₁-C₆ alkylamino, C₂-C₈ dialkylamino, C₃-C₈dialkylaminocarbonyl, C₃-C₆ trialkylsilyl; phenyl wherein the phenylring may be optionally substituted with 1-3 R²⁰; or a 5- or 6-memberedsaturated or unsaturated ring containing 1-3 heteroatoms wherein eachring may be optionally substituted with 1-3 R¹¹; R³³ is independently:C₁-C₆ alkyl, C₁-C₆ haloalkyl, phenyl or thienyl optionally substitutedwith 1-3 R²⁰; or a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹; R³⁴ is: C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₂-C₆alkoxyalkyl, C₁-C₆ alkylamino; or a 5- or 6-membered saturated orunsaturated ring containing 1-3 heteroatoms wherein each ring may beoptionally substituted with 1-3 R¹¹; R³⁵ is: C₁-C₆ alkyl, C₂-C₆alkylcarbonyl; or a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹; R³⁶ is H, cyano, C₁-C₆ alkyl, C₁-C₆ alkoxy,benzyl, or phenyl wherein each of the benzyl or phenyl may be optionallysubstituted with 1-3 R²⁰; alternatively R³² and R³⁶ may be takentogether to form: a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹; and R³⁷ is independently: H, halogen, orphenyl optionally substituted with 1-5 R²⁰; C₁-C₆ alkyl, C₁-C₆haloalkyl, hydroxyl, C₁-C₆ alkoxy, or C₁-C₆ haloalkoxy; or a 5- or6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹.
 2. Thecompound of claim 1 wherein R³ is C₁-C₆ alkyl, —C(═O)R⁶,—(CHR²²)_(m)R³⁷, —(CHR²⁴)OR²⁹, —OR⁷, —C(═S)NHR⁸, —Si(R⁸)₃,—C(═O)OCH₂C(═O)R⁸, R⁴ is H, R⁶ is C₁-C₆ alkyl, C₁-C₆ alkyl, C₁-C₅haloalkyl, C₁-C₅ alkoxy, C₂-C₆ alkoxycarbonyl, phenyl, benzyl, C₁-C₄alkoxyalkoxy, thiazolyl wherein the thiazole may be optionallysubstituted with 1-3 R²⁰, R⁷ is H, C₁-C₆ alkyl, R⁸ is C₁-C₆ alkyl, C₁-C₆haloalkyl, or phenyl optionally substituted with 1-3 R³⁰, R²⁴ is H,C₁-C₆ alkyl, R²⁹ is H, C₁-C₆ alkyl, C₁-C₆ alkoxyalkyl, R³⁰ is halogen,C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, phenylwherein each phenyl may be optionally substituted with 1-3 R²⁰, R²⁰ ishalogen, C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, R³⁷ is halogen,phenyl optionally substituted with 1-5 R²⁰, C₁-C₆ alkyl, C₁-C₆haloalkyl, hydroxyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, a 5- or 6-memberedsaturated or unsaturated ring containing 1-3 heteroatoms wherein eachring may be optionally substituted with 1-3 R¹¹, R²¹ is (—CHR²²)_(m)R²³,m is 1, R²² is H, R²³ is a 5- or 6-membered saturated or unsaturatedring containing 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹. R¹¹ is halogen, C₁-C₆ alkyl, C₁-C₆ alkoxy,C₁-C₆ haloalkoxy.
 3. The compound of claim 1 wherein R³ is C₁-C₆ alkyl,—C(═O)R⁶, —(CHR²²)_(m)R³⁷, —(CHR²⁴)OR²⁹, —OR⁷, —C(═S)NHR⁸, —Si(R⁸)₃,—C(═O)OCH₂C(═O)R⁸, R⁴ is H, R⁶ is C₁-C₆ alkyl, C₁-C₆ alkyl, C₁-C₅haloalkyl, C₁-C₅ alkoxy, C₂-C₆ alkoxycarbonyl, phenyl, benzyl, C₁-C₄alkoxyalkoxy, thiazolyl wherein the thiazole may be optionallysubstituted with 1-3 R²⁰, R⁷ is H, C₁-C₆ alkyl, R⁸ is C₁-C₆ alkyl, C₁-C₆haloalkyl, or phenyl optionally substituted with 1-3 R³⁰, R²⁴ is H,C₁-C₆ alkyl, R²⁹ is H, C₁-C₆ alkyl, C₁-C₆ alkoxyalkyl, R³⁰ is halogen,C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, phenylwherein each phenyl may be optionally substituted with 1-3 R²⁰, R²⁰ ishalogen, C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, R³⁷ is halogen,phenyl optionally substituted with 1-5 R²⁰, C₁-C₆ alkyl, C₁-C₆haloalkyl, hydroxyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, a 5- or 6-memberedsaturated or unsaturated ring containing 1-3 heteroatoms wherein eachring may be optionally substituted with 1-3 R¹¹, R¹¹ is halogen, C₁-C₆alkyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, R²¹ is (—CHR²²)_(m)R²³, m is 1,R²² is H, C₁-C₄ alkyl, phenyl, R²³ is a ring-fused heteroaromatic ringsselected from the group consisting of benzothiophenyl, quinolinyl,isoquinolinyl, thieno[2,3-b]pyridyl, 1-methyl-1H-thieno[2,3-c]pyrazolyl,benzofuranyl and benzoimidazolyl, 2,3-dihydro-benzofuran-2-yl,4-methyl-4H-thieno[3,2-b]pyrrol-5-yl, 1-methyl-1H-indol-5-yl,imidazo[1,2-a]pyridin-2-yl, imidazo[2,1-b]thiazol-6-yl,benzothiazol-2-yl, benzo[b]thiophen-7-yl, 1-methyl-1H-indazol-3-yl,wherein each of the rings may be further substituted with 1-3 R²⁰. 4.The compound of claim 1 wherein R³ is C₁-C₆ alkyl, —C(═O)R⁶,—(CHR²²)_(m)R³⁷, —(CHR²⁴)OR²⁹, —OR⁷, —C(═S)NHR⁸, —Si(R⁸)₃,—C(═O)OCH₂C(═O)R⁸, R⁴ is H, R⁶ is C₁-C₆ alkyl, C₁-C₆ alkyl, C₁-C₅haloalkyl, C₁-C₅ alkoxy, C₂-C₆ alkoxycarbonyl, phenyl, benzyl, C₁-C₄alkoxyalkoxy, thiazolyl wherein the thiazole may be optionallysubstituted with 1-3 R²⁰, R⁷ is H, C₁-C₆ alkyl, R⁸ is C₁-C₆ alkyl, C₁-C₆haloalkyl, or phenyl optionally substituted with 1-3 R³⁰, R²⁴ is H,C₁-C₆ alkyl, R²⁹ is H, C₁-C₆ alkyl, C₁-C₆ alkoxyalkyl, C₂-C₆alkylcarbonyl, R³⁰ is halogen, C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆alkoxy, C₁-C₆ haloalkoxy, phenyl wherein each phenyl may be optionallysubstituted with 1-3 R²⁰, R³⁷ is halogen, phenyl optionally substitutedwith 1-5 R²⁰, C₁-C₆ alkyl, C₁-C₆ haloalkyl, hydroxyl, C₁-C₆ alkoxy,C₁-C₆ haloalkoxy, a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹, R¹¹ is halogen, C₁-C₆ alkyl, C₁-C₆ alkoxy,C₁-C₆ haloalkoxy, R²¹ is (—CHR²²)_(m)R²³, m is 1, R²² is H, R²³ isnaphthyl, benzo[1,3]dioxolyl, phenyl optionally substituted with 1-5R²⁰, R²⁰ is halogen, cyano, nitro, amino, C₁-C₆ alkoxyalkoxy, C₁-C₆alkyl, C₁-C₆ haloalkyl, C₁-C₆ hydroxyalkyl, C₂-C₆ alkoxyalkyl, C₂-C₆haloalkoxyalkyl, C₂-C₆ alkenyl, hydroxyl, C₁-C₆ alkoxy, C₁-C₆haloalkoxy, C₁-C₆ alkylthio, C₁-C₆ haloalkylthio, C₁-C₆ alkylsulfonyl,C₁-C₆ alkylamino, benzyloxy, phenoxy, wherein each benzyloxy, phenoxy,may be optionally substituted with 1-3 substitutents independentlyselected from R³¹, R³¹ is halogen, C₁-C₆ alkyl, C₁-C₆ alkoxy.
 5. Thecompound of claim 1 wherein R³ is C₁-C₆ alkyl, —C(═O)R⁶,—(CHR²²)_(m)R³⁷, —(CHR²⁴)OR²⁹, —OR⁷, —C(═S)NHR⁸, —Si(R⁸)₃,—C(═O)OCH₂C(═O)R⁸, R⁴ is H, R⁶ is C₁-C₆ alkyl, C₁-C₆ alkyl, C₁-C₅haloalkyl, C₁-C₅ alkoxy, C₂-C₆ alkoxycarbonyl, phenyl, benzyl, C₁-C₄alkoxyalkoxy, thiazolyl wherein the thiazole may be optionallysubstituted with 1-3 R²⁰, R⁷ is H, C₁-C₆ alkyl, R⁸ is C₁-C₆ alkyl, C₁-C₆haloalkyl, or phenyl optionally substituted with 1-3 R³⁰, R²⁴ is H,C₁-C₆ alkyl, R²⁹ is H, C₁-C₆ alkyl, C₁-C₆ alkoxyalkyl, C₂-C₆alkylcarbonyl, R³⁰ is halogen, nitro C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆alkoxy, C₁-C₆ haloalkoxy, phenyl wherein each phenyl may be optionallysubstituted with 1-3 R²⁰, R²⁰ is halogen, C₁-C₆ alkyl, C₁-C₆ alkoxy,C₁-C₆ haloalkoxy, C₁-C₆ alkoxyalkoxy, C₁-C₆ haloalkyl, C₁-C₆hydroxyalkyl, C₂-C₆ alkoxyalkyl, C₂-C₆ haloalkoxyalkyl, hydroxyl, C₁-C₆alkylamino, C₂-C₈ dialkylamino, phenyl wherein each phenyl may beoptionally substituted with 1-5 R³¹, 5- or 6-membered heteroaromaticring wherein each heteroaromatic ring may be optionally substituted with1-3 R³¹, R³¹ is halogen, C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy,R³⁷ is halogen, phenyl optionally substituted with 1-5 R²⁰, C₁-C₆ alkyl,C₁-C₆ haloalkyl, hydroxyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, a 5- or6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹, R¹¹ ishalogen, C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, R²¹ is(—CHR²²)_(m)R²³, m is 1, R²² is —CH₃, —CH₂CH₃, —CH₂CH₂CH₃, benzyl,4-fluoro-phenyl, R²³ is phenyl, 4-fluoro-phenyl, p-tolyl.
 6. Thecompound of claim 1 wherein R³ is C₁-C₆ alkyl, —C(═O)R⁶,—(CHR²²)_(m)R³⁷, —(CHR²⁴)OR²⁹, —OR⁷, —C(═S)NHR⁸, —Si(R⁸)₃,—C(═O)OCH₂C(═O)R⁸, R⁴ is H, R⁶ is C₁-C₆ alkyl, C₁-C₅ haloalkyl, C₁-C₅alkoxy, C₂-C₆ alkoxycarbonyl, phenyl, benzyl, C₁-C₄ alkoxyalkoxy,thiazolyl wherein the thiazole may be optionally substituted with 1-3R²⁰, R⁷ is H, C₁-C₆ alkyl, R⁸ is C₁-C₆ alkyl, C₁-C₆ haloalkyl, or phenyloptionally substituted with 1-3 R³⁰, R²⁴ is H, C₁-C₆ alkyl, R²⁹ is H,C₁-C₆ alkyl, C₁-C₆ alkoxyalkyl, C₂-C₆ alkylcarbonyl, R³⁰ is halogen,nitro C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy,phenyl wherein each phenyl may be optionally substituted with 1-3 R²⁰,R²⁰ is halogen, C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, C₁-C₆alkoxyalkoxy, C₁-C₆ hydroxyalkyl, C₂-C₆ alkoxyalkyl, C₂-C₆haloalkoxyalkyl, hydroxyl, C₁-C₆ haloalkoxy, C₁-C₆ alkylamino, C₂-C₈dialkylamino, phenyl wherein each phenyl may be optionally substitutedwith 1-5 R³¹, 5- or 6-membered heteroaromatic ring wherein eachheteroaromatic ring may be optionally substituted with 1-3 R³¹, R³¹ ishalogen, C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, R³⁷ is halogen,phenyl optionally substituted with 1-5 R²⁰, C₁-C₆ alkyl, C₁-C₆haloalkyl, hydroxyl, C₁-C₆ alkoxy, a 5- or 6-membered saturated orunsaturated ring containing 1-3 heteroatoms wherein each ring may beoptionally substituted with 1-3 R¹¹, R¹¹ is halogen, C₁-C₆ alkyl, C₁-C₆alkoxy, C₁-C₆ haloalkoxy, R²¹ is (—CHR²²)_(m)R²³, m is 1, R²² is H,C₁-C₆ alkyl, R²³ is phenyl, p-tolyl, 4-fluoro-phenyl, 4-methoxy-phenyl,3-methoxy-phenyl, thiophen-2-yl, thiophen-3-yl, 3-fluoro-phenyl,3-bromo-phenyl, benzothiophen-2-yl, 2,4,6-trimethyl-phenyl,1-ethyl-2-methoxy-phenyl, 3-benzonitrile, 3-fluoro-4-methoxy-phenyl. 7.The compound of claim 1 wherein R³ is C₁-C₆ alkyl, —C(═O)R⁶,—(CHR²²)_(m)R³⁷, —(CHR²⁴)OR²⁹, —OR⁷, —C(═S)NHR⁸, R⁴ is H, R²¹ is—C(═O)R³², N═C(R³²)(R³⁶), —SO₂R³³, —NR²⁵C(═O)OR²⁵, C₂-C₆ alkoxycarbonyl; C₂-C₆ alkylaminocarbonyl; C₂-C₆ alkylcarbonyl, R⁶ is C₁-C₆alkyl, C₁-C₅ haloalkyl, C₁-C₅ alkoxy, C₂-C₆ alkoxycarbonyl, phenyl,benzyl, C₁-C₄ alkoxyalkoxy, thiazolyl wherein the thiazole may beoptionally substituted with 1-3 R²⁰, R⁷ is H, C₁-C₆ alkyl, R⁸ is C₁-C₆alkyl, C₁-C₆ haloalkyl, or phenyl optionally substituted with 1-3 R³⁰,R²⁴ is H, C₁-C₆ alkyl, R²⁹ is H, C₁-C₆ alkyl, C₁-C₆ alkoxyalkyl, C₂-C₆alkylcarbonyl, R³⁰ is halogen, nitro, C₁-C₆ alkyl, C₁-C₆ haloalkyl,C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, phenyl wherein each phenyl may beoptionally substituted with 1-3 R²⁰, R²⁵ is H, C₁-C₆ alkyl, R³³ is C₁-C₆alkyl, C₁-C₆ haloalkyl, phenyl or thienyl optionally substituted with1-3 R²⁰, R³² is C₁-C₆ alkyl, C₁-C₆ haloalkyl, alkoxyalkyl, C₂-C₆haloalkoxyalkyl, R³⁶ is H, cyano, C₁-C₆ alkyl, C₁-C₆ alkoxy, benzyl, orphenyl wherein each of the benzyl or phenyl may be optionallysubstituted with 1-3 R²⁰, R²⁰ is halogen, C₁-C₆ alkoxyalkoxy, C₁-C₆alkyl, C₁-C₆ haloalkyl, C₁-C₆ hydroxyalkyl, C₂-C₆ alkoxyalkyl, C₂-C₆haloalkoxyalkyl, hydroxyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, C₁-C₆alkylamino, C₂-C₈ dialkylamino, phenyl wherein each phenyl may beoptionally substituted with 1-5 R³¹, 5- or 6-membered heteroaromaticring wherein each heteroaromatic ring may be optionally substituted with1-3 R³¹, R³¹ is halogen, C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy,R³⁷ is halogen, phenyl optionally substituted with 1-5 R²⁰, C₁-C₆ alkyl,C₁-C₆ haloalkyl, hydroxyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy, a 5- or6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹, R¹¹ ishalogen, C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ haloalkoxy.
 8. The compound ofclaim 1 wherein R³ is C₁-C₆ alkyl, —C(═O)R⁶, —C(═O)N(R⁸)R¹⁰, R⁴ is C₁-C₆alkyl, —C(═O)R⁶, —C(═O)N(R⁸)R¹⁰, R⁶ is C₁-C₆ alkyl, C₁-C₅ haloalkyl,C₁-C₅ alkoxy, C₂-C₆ alkoxycarbonyl, phenyl, benzyl, C₁-C₄ alkoxyalkoxy,thiazolyl wherein the thiazole may be optionally substituted with 1-3R²⁰, R⁸ is C₁-C₆ alkyl, C₁-C₆ haloalkyl, or phenyl optionallysubstituted with 1-3 R³⁰, R¹⁰ is H, C₁-C₆ alkyl, phenyl optionallysubstituted with 1-3 R²⁰, R²¹ is —C(═O)R³², —N═C(R³²)(R³⁶), —SO₂R³³,NR²⁵C(═O)OR²⁵, C₂-C₆ alkoxy carbonyl; C₂-C₆ alkylaminocarbonyl; C₂-C₆alkylcarbonyl, R³⁰ is halogen, nitro C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆alkoxy, C₁-C₆ haloalkoxy, phenyl wherein each phenyl may be optionallysubstituted with 1-3 R²⁰, R²⁵ is H, C₁-C₆ alkyl, R³³ is C₁-C₆ alkyl,C₁-C₆ haloalkyl, phenyl or thienyl optionally substituted with 1-3 R²⁰,R³² is C₁-C₆ alkyl, C₁-C₆ haloalkyl, alkoxyalkyl, C₂-C₆ haloalkoxyalkyl,R³⁶ is H, cyano, C₁-C₆ alkyl, C₁-C₆ alkoxy, benzyl, or phenyl whereineach of the benzyl or phenyl may be optionally substituted with 1-3 R²⁰,R²⁰ is halogen, C₁-C₆ alkoxyalkoxy, C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆hydroxyalkyl, C₂-C₆ alkoxyalkyl, C₂-C₆ haloalkoxyalkyl, hydroxyl, C₁-C₆alkoxy, C₁-C₆ haloalkoxy, C₁-C₆ alkylamino, C₂-C₈ dialkylamino, phenylwherein each phenyl may be optionally substituted with 1-5 R³¹, 5- or6-membered heteroaromatic ring wherein each heteroaromatic ring may beoptionally substituted with 1-3 R³¹, R³¹ is halogen, C₁-C₆ alkyl, C₁-C₆alkoxy, C₁-C₆ haloalkoxy.
 9. The compound of claim 1 wherein R³ is C₁-C₆alkyl, —C(═O)R⁶, —C(═O)N(R⁸)R¹⁰, R⁴ is C₁-C₆ alkyl, —C(═O)R⁶,—C(═O)N(R⁸)R¹⁰, R⁶ is C₁-C₆ alkyl, C₁-C₅ haloalkyl, C₁-C₅ alkoxy, C₂-C₆alkoxycarbonyl, phenyl, benzyl, C₁-C₄ alkoxyalkoxy, thiazolyl whereinthe thiazole may be optionally substituted with 1-3 R²⁰, R⁸ is C₁-C₆alkyl, C₁-C₆ haloalkyl, or phenyl optionally substituted with 1-3 R³⁰,R³⁰ is halogen, nitro, C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆ alkoxy, C₁-C₆haloalkoxy, phenyl wherein each phenyl may be optionally substitutedwith 1-3 R²⁰, R¹⁰ is H, C₁-C₆ alkyl, phenyl optionally substituted with1-3 R²⁰, R²¹ is (—CHR²²)_(m)R²³, m is 1, R²² is H, R²³ is phenyloptionally substituted with 1-5 R²⁰.
 10. The compound of claim 1 whereinR³ is C₁-C₆ alkyl, —C(═O)R⁶, —C(═O)N(R⁸)R¹⁰, R⁴ is C₁-C₆ alkyl,—C(═O)R⁶, —C(═O)N(R⁸)R¹⁰, R⁶ is C₁-C₆ alkyl, C₁-C₅ haloalkyl, C₁-C₅alkoxy, C₂-C₆ alkoxycarbonyl, phenyl, benzyl, C₁-C₄ alkoxyalkoxy,thiazolyl wherein the thiazole may be optionally substituted with 1-3R²⁰, R⁸ is C₁-C₆ alkyl, C₁-C₆ haloalkyl, or phenyl optionallysubstituted with 1-3 R³⁰, R¹⁰ is H, C₁-C₆ alkyl, phenyl optionallysubstituted with 1-3 R²⁰, R²¹ is (—CHR²²)_(m)R²³, m is 1, R²² is —CH₃,—CH₂CH₃, —CH₂CH₂CH₃, benzyl, 4-fluoro-phenyl, R²³ is phenyl,4-fluoro-phenyl, p-tolyl, R²⁰ is halogen, C₁-C₆ alkyl, C₁-C₆ alkoxy. 11.The compound of claim 1 wherein R³ is C₁-C₆ alkyl, —C(═O)R⁶,—C(═O)N(R⁸)R¹⁰, R⁴ is C₁-C₆ alkyl, —C(═O)R⁶, —C(═O)N(R⁸)R¹⁰, R⁶ is C₁-C₆alkyl, C₁-C₅ haloalkyl, C₁-C₅ alkoxy, C₂-C₆ alkoxycarbonyl, phenyl,benzyl, C₁-C₄ alkoxyalkoxy, thiazolyl wherein the thiazole may beoptionally substituted with 1-3 R²⁰, R⁸ is C₁-C₆ alkyl, C₁-C₆ haloalkyl,or phenyl optionally substituted with 1-3 R³⁰, R¹⁰ is H, C₁-C₆ alkyl,phenyl optionally substituted with 1-3 R²⁰, R²¹ is (—CHR²²)_(m)R²³, m is1, R²² is H, R²³ is phenyl, p-tolyl, 4-fluoro-phenyl, 4-methoxy-phenyl,3-methoxy-phenyl, thiophen-2-yl, thiophen-3-yl, 3-fluoro-phenyl,3-bromo-phenyl, benzothiophen-2-yl, 2,4,6-trimethyl-phenyl,1-ethyl-2-methoxy-phenyl, 3-benzonitrile, 3-fluoro-4-methoxy-phenyl. 12.The compound of claim 1 wherein R³ and R⁴ may be taken together to form:a 5- or 6-membered saturated or unsaturated ring containing 1-3heteroatoms wherein each ring may be optionally substituted with 1-3R¹¹, R²¹ is (—CHR²²)_(m)R²³, m is 1, R²² is H, R²³ is phenyl optionallysubstituted with 1-5 R²⁰.
 13. The compound of claim 1 wherein R³ and R⁴may be taken together to form a 5- or 6-membered saturated orunsaturated ring containing 1-3 heteroatoms wherein each ring may beoptionally substituted with 1-3 R¹¹, R¹¹ is halogen, C₁-C₆ alkyl, R²¹ is—C(═O)R³², —N═C(R³²)(R³⁶), —SO₂R³³, NR²⁵C(═O)OR²⁵, C₂-C₆ alkoxycarbonyl; C₂-C₆ alkylaminocarbonyl; C₂-C₆ alkylcarbonyl, R²⁵ is H, C₁-C₆alkyl, R³³ is C₁-C₆ alkyl, C₁-C₆ haloalkyl, phenyl or thienyl optionallysubstituted with 1-3 R²⁰, R³² is C₁-C₆ alkyl, C₁-C₆ haloalkyl,alkoxyalkyl, C₂-C₆ haloalkoxyalkyl, C₂-C₆ alkenyl, R³⁶ is H, cyano,C₁-C₆ alkyl, C₁-C₆ alkoxy, benzyl, or phenyl wherein each of the benzylor phenyl may be optionally substituted with 1-3 R²⁰, R²⁰ is halogen,C₁-C₆ alkyl, C₁-C₆ alkoxy.
 14. The compound of claim 1 wherein R³ and R⁴may be taken together to form: a 5- or 6-membered saturated orunsaturated ring containing 1-3 heteroatoms wherein each ring may beoptionally substituted with 1-3 R¹¹, R¹¹ is halogen, C₁-C₆ alkyl, R²¹ is(—CHR²²)_(m)R²³, m is 1, R²² is —CH₃, —CH₂CH₃, —CH₂CH₂CH₃, benzyl,4-fluoro-phenyl, R²³ is phenyl, 4-fluoro-phenyl, p-tolyl.
 15. Thecompound of claim 1 wherein R³ and R⁴ may be taken together to form a 5-or 6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹, R¹¹ ishalogen, C₁-C₆ alkyl, R²¹ is (—CHR²²)_(m)R²³, m is 1, R²² is H, R²³ isphenyl, p-tolyl, 4-fluoro-phenyl, 4-methoxy-phenyl, 3-methoxy-phenyl,thiophen-2-yl, thiophen-3-yl, 3-fluoro-phenyl, 3-bromo-phenyl,benzothiophen-2-yl, 2,4,6-trimethyl-phenyl, 1-ethyl-2-methoxy-phenyl,3-benzonitrile, 3-fluoro-4-methoxy-phenyl.
 16. The compound of claim 1wherein R³ and R⁴ may be taken together to form, ═C(R¹²)N(R¹³)R¹⁴, R¹²is H, C₁-C₄ alkyl, R¹³ is H, cyano, —OH, C₁-C₄ alkyl, C₁-C₆ alkoxy,phenyl, or benzyl wherein the phenyl or benzyl may be optionallysubstituted with 1-3 R²⁰, R¹⁴ is H, cyano, —OH, C₁-C₄ alkyl, C₁-C₆alkoxy, phenyl, or benzyl wherein the phenyl or benzyl may be optionallysubstituted with 1-3 R²⁰, alternatively R¹³ and R¹⁴ may be takentogether to form a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹, alternatively R¹² and R¹³ may be takentogether to form a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹, R¹¹ is halogen, C₁-C₆ alkyl, R²¹ is —C(═O)R³²,—N═C(R³²)(R³⁶), —SO₂R³³, NR²⁵C(═O)OR²⁵, C₁-C₆ alkyl, C₁-C₆ alkoxy, R²⁵is H, C₁-C₆ alkyl, R³² is C₁-C₆ alkyl, phenyl wherein the phenyl may beoptionally substituted with 1-3 R²⁰. R³³ is C₁-C₆ alkyl, phenyl orthienyl optionally substituted with 1-3 R²⁰, R³⁶ is cyano, C₁-C₆ alkyl,phenyl wherein the phenyl may be optionally substituted with 1-3 R²⁰,and R²⁰ is halogen, C₁-C₆ alkyl, C₁-C₆ alkoxy.
 17. The compound of claim1 wherein R³ and R⁴ may be taken together to form, ═C(R¹²)N(R¹³)R¹⁴, R¹²is H, C₁-C₄ alkyl, R¹³ is H, cyano, —OH, C₁-C₄ alkyl, C₁-C₆ alkoxy,phenyl, or benzyl wherein the phenyl or benzyl may be optionallysubstituted with 1-3 R²⁰, R¹⁴ is H, cyano, —OH, C₁-C₄ alkyl, C₁-C₆alkoxy, phenyl, or benzyl wherein the phenyl or benzyl may be optionallysubstituted with 1-3 R²⁰, alternatively R¹³ and R¹⁴ may be takentogether to form a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹, alternatively R¹² and R¹³ may be takentogether to form a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹, R¹¹ is halogen, C₁-C₆ alkyl, R²¹ is(—CHR²²)_(m)R²³, m is 1, R²² is H, C₁-C₄ alkyl, phenyl, R²³ is aring-fused heteroaromatic rings selected from the group consisting ofbenzothiophenyl, quinolinyl, isoquinolinyl, thieno[2,3-b]pyridyl,1-methyl-1H-thieno[2,3-c]pyrazolyl, benzofuranyl and benzoimidazolyl,2,3-dihydro-benzofuran-2-yl, 4-methyl-4H-thieno[3,2-b]pyrrol-5-yl,1-methyl-1H-indol-5-yl, imidazo[1,2-a]pyridin-2-yl,imidazo[2,1-b]thiazol-6-yl, benzothiazol-2-yl, benzo[b]thiophen-7-yl,1-methyl-1H-indazol-3-yl, wherein each of the rings may be furthersubstituted with 1-3 R²⁰, R²⁰ is halogen, C₁-C₆ alkyl, C₁-C₆ alkoxy. 18.The compound of claim 1 wherein R³ and R⁴ may be taken together to form,═C(R¹²)N(R¹³)R¹⁴, R¹² is H, C₁-C₄ alkyl, R¹³ is H, cyano, —OH, C₁-C₄alkyl, C₁-C₆ alkoxy, phenyl, or benzyl wherein the phenyl or benzyl maybe optionally substituted with 1-3 R²⁰, R¹⁴ is H, cyano, —OH, C₁-C₄alkyl, C₁-C₆ alkoxy, phenyl, or benzyl wherein the phenyl or benzyl maybe optionally substituted with 1-3 R²⁰, alternatively R¹³ and R¹⁴ may betaken together to form a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹, alternatively R¹² and R¹³ may be takentogether to form a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹, R¹¹ is halogen, C₁-C₆ alkyl, R²¹ is(—CHR²²)_(m)R²³, m is 1, R²² is H, R²³ is a 5- or 6-membered saturatedor unsaturated ring containing 1-3 heteroatoms wherein each ring may beoptionally substituted with 1-3 R¹¹, R²⁰ is halogen, C₁-C₆ alkyl, C₁-C₆alkoxy.
 19. The compound of claim 1 wherein R³ and R⁴ may be takentogether to form, ═C(R¹²)N(R¹³)R¹⁴, R¹² is H or C₁-C₄ alkyl, R¹³ is H,cyano, —OH, C₁-C₄ alkyl, C₁-C₆ alkoxy, phenyl, or benzyl wherein thephenyl or benzyl may be optionally substituted with 1-3 R²⁰, R¹⁴ is H,cyano, —OH, C₁-C₄ alkyl, C₁-C₆ alkoxy, phenyl, or benzyl wherein thephenyl or benzyl may be optionally substituted with 1-3 R²⁰,alternatively R¹³ and R¹⁴ may be taken together to form a 5- or6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹,alternatively R¹² and R¹³ may be taken together to form a 5- or6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹, R¹¹ ishalogen, C₁-C₆ alkyl, R²¹ is (—CHR²²)_(m)R²³, m is 1, R²² is H, R²³ is a5- or 6-membered heteroaromatic ring selected from the group consistingof furanyl, pyridinyl, pyridinyl-N-oxide, pyrimidinyl, pyridazinyl,pyrazinyl, pyrazolyl, thiazolyl, triazinyl, thiadiazolyl, oxazolyl,isoxazolyl, triazolyl, imidazolyl, thiophene-2-yl and thiophen-3-yl,1-methyl-1H-pyrazol-3-yl, wherein each heteroaromatic ring may beoptionally substituted with 1-3 R²⁰, R²⁰ is halogen, C₁-C₆ alkyl, C₁-C₆alkoxy.
 20. The compound of claim 1 wherein R³ and R⁴ may be takentogether to form, ═C(R¹²)N(R¹³)R¹⁴, R¹² is H or C₁-C₄ alkyl, R¹³ is H,cyano, —OH, C₁-C₄ alkyl, C₁-C₆ alkoxy, phenyl, or benzyl wherein thephenyl or benzyl may be optionally substituted with 1-3 R²⁰, R¹⁴ is H,cyano, —OH, C₁-C₄ alkyl, C₁-C₆ alkoxy, phenyl, or benzyl wherein thephenyl or benzyl may be optionally substituted with 1-3 R²⁰,alternatively R¹³ and R¹⁴ may be taken together to form a 5- or6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹,alternatively R¹² and R¹³ may be taken together to form a 5- or6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹, R¹¹ ishalogen, C₁-C₆ alkyl, R²¹ is (—CHR²²)_(m)R²³, m is 1, R²² is H, R²³ isphenyl optionally substituted with 1-5 R²⁰, R²⁰ is halogen, C₁-C₆ alkyl,C₁-C₆ alkoxy.
 21. The compound of claim 1 wherein R³ and R⁴ may be takentogether to form, ═C(R¹²)N(R¹³)R¹⁴, R¹² is H or C₁-C₄ alkyl, R¹³ is H,cyano, —OH, C₁-C₄ alkyl, C₁-C₆ alkoxy, phenyl, or benzyl wherein thephenyl or benzyl may be optionally substituted with 1-3 R²⁰, R¹⁴ is H,cyano, —OH, C₁-C₄ alkyl, C₁-C₆ alkoxy, phenyl, or benzyl wherein thephenyl or benzyl may be optionally substituted with 1-3 R²⁰,alternatively R¹³ and R¹⁴ may be taken together to form a 5- or6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹,alternatively R¹² and R¹³ may be taken together to form a 5- or6-membered saturated or unsaturated ring containing 1-3 heteroatomswherein each ring may be optionally substituted with 1-3 R¹¹, R¹¹ ishalogen, C₁-C₆ alkyl, R²⁰ is halogen, C₁-C₆ alkyl, C₁-C₆ alkoxy, R²¹ is(—CHR²²)_(m)R²³, m is 1, R²² is —CH₃, —CH₂CH₃, —CH₂CH₂CH₃, benzyl,4-fluoro-phenyl, R²³ is phenyl, 4-fluoro-phenyl, p-tolyl.
 22. Thecompound of claim 1 wherein R³ and R⁴ may be taken together to form,═C(R¹²)N(R¹³)R¹⁴, R¹² is H or C₁-C₄ alkyl, R¹³ is H, cyano, —OH, C₁-C₄alkyl, C₁-C₆ alkoxy, phenyl, or benzyl wherein the phenyl or benzyl maybe optionally substituted with 1-3 R²⁰, R¹⁴ is H, cyano, —OH, C₁-C₄alkyl, C₁-C₆ alkoxy, phenyl, or benzyl wherein the phenyl or benzyl maybe optionally substituted with 1-3 R²⁰, alternatively R¹³ and R¹⁴ may betaken together to form a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹, alternatively R¹² and R¹³ may be takentogether to form a 5- or 6-membered saturated or unsaturated ringcontaining 1-3 heteroatoms wherein each ring may be optionallysubstituted with 1-3 R¹¹, R¹¹ is halogen, C₁-C₆ alkyl, R²⁰ is halogen,C₁-C₆ alkyl, C₁-C₆ alkoxy, R²¹ is (—CHR²²)_(m)R²³, m is 1, R²² is H, R²³is phenyl, p-tolyl, 4-fluoro-phenyl, 4-methoxy-phenyl, 3-methoxy-phenyl,thiophen-2-yl, thiophen-3-yl, 3-fluoro-phenyl, 3-bromo-phenyl,benzothiophen-2-yl, 2,4,6-trimethyl-phenyl, 1-ethyl-2-methoxy-phenyl,3-benzonitrile, 3-fluoro-4-methoxy-phenyl.
 23. The compound of claim 1wherein R³ is H; R⁴ is H, R²¹ is —C(═O)R³², —N═C(R³²)(R³⁶), —SO₂R³³,NR²⁵C(═O)OR²⁵, C₁-C₆ alkyl, C₁-C₆ alkoxy, R²⁵ is H, C₁-C₆ alkyl, R³² isC₁-C₆ alkyl, phenyl wherein the phenyl may be optionally substitutedwith 1-3 R²⁰. R³³ is C₁-C₆ alkyl, phenyl or thienyl optionallysubstituted with 1-3 R²⁰, R³⁶ is cyano, C₁-C₆ alkyl, phenyl wherein thephenyl may be optionally substituted with 1-3 R²⁰, and R²⁰ is halogen,C₁-C₆ alkyl, C₁-C₆ alkoxy.
 24. The compound of claim 1 wherein R³ is H;R⁴ is H, R²¹ is (—CHR²²)_(m)R²³, m is 1, R²² is H, C₁-C₄ alkyl, phenyl,R²³ is a ring-fused heteroaromatic rings selected from the groupconsisting of benzothiophenyl, quinolinyl, isoquinolinyl,thieno[2,3-b]pyridyl, 1-methyl-1H-thieno[2,3-c]pyrazolyl, benzofuranyland benzoimidazolyl, 2,3-dihydro-benzofuran-2-yl,4-methyl-4H-thieno[3,2-b]pyrrol-5-yl, 1-methyl-1H-indol-5-yl,imidazo[1,2-a]pyridin-2-yl, imidazo[2,1-b]thiazol-6-yl,benzothiazol-2-yl, benzo[b]thiophen-7-yl, 1-methyl-1H-indazol-3-yl,wherein each of the rings may be further substituted with 1-3 R²⁰, R²⁰is halogen, C₁-C₆ alkyl, C₁-C₆ alkoxy.
 25. The compound of claim 1wherein R³ is H; R⁴ is H, R²¹ is (—CHR²²)_(m)R²³, m is 1, R²² is H, R²³is a 5- or 6-membered saturated or unsaturated ring containing 1-3heteroatoms wherein each ring may be optionally substituted with 1-3R¹¹.
 26. The compound of claim 1 wherein R³ is H; R⁴ is H, R²¹ is(—CHR²²)_(m)R²³, m is 1, R²² is H, R²³ is a 5- or 6-memberedheteroaromatic ring selected from the group consisting of furanyl,pyridinyl, pyridinyl-N-oxide, pyrimidinyl, pyridazinyl, pyrazinyl,pyrazolyl, thiazolyl, triazinyl, thiadiazolyl, oxazolyl, isoxazolyl,triazolyl, imidazolyl, thiophene-2-yl and thiophen-3-yl,1-methyl-1H-pyrazol-3-yl, wherein each heteroaromatic ring may beoptionally substituted with 1-3 R²⁰, R²⁰ is halogen, nitro, C₁-C₆ alkyl,C₁-C₆ alkoxy.
 27. The compound of claim 1 wherein R³ is H; R⁴ is H, R²¹is (—CHR²²)_(m)R²³, m is 1, R²² is C₁-C₆ alkyl, phenyl optionallysubstituted with 1-5 R²⁰, R²³ is, naphthyl, phenyl optionallysubstituted with 1-5 R²⁰, R²⁰ is halogen, nitro, C₁-C₆ alkyl, C₁-C₆alkoxy, phenoxy, phenyl wherein each phenoxy, phenyl may be optionallysubstituted with 1-3 substitutents independently selected from R³¹, R³¹is halogen, C₁-C₆ alkyl, C₁-C₆ haloalkyl, benzyl, pyridyl.
 28. Thecompound of claim 1 wherein R³ is H; R⁴ is H, R²¹ is (—CHR²²)_(m)R²³, mis 1, R²² is H, R²³ is naphthyl, benzo[1,3]dioxolyl, phenyl optionallysubstituted with 1-5 R²⁰, R²⁰ is halogen, cyano, nitro, amino, C₁₋₆alkoxyalkoxy, C₁-C₆ alkyl, C₁-C₆ haloalkyl, C₁-C₆ hydroxyalkyl, C₂-C₆alkoxyalkyl, C₂-C₆ haloalkoxyalkyl, C₂-C₆ alkenyl, hydroxyl, C₁-C₆alkoxy, C₁-C₆ haloalkoxy, C₁-C₆ alkylthio, C₁-C₆ haloalkylthio, C₁-C₆alkylsulfonyl, C₁-C₆ alkylamino, benzyloxy, phenoxy, wherein eachbenzyloxy, phenoxy, may be optionally substituted with 1-3 substitutentsindependently selected from R³¹, R³¹ is halogen, C₁-C₆ alkyl, C₁-C₆alkoxy.
 29. The compound of claim 1 wherein R³ is H; R⁴ is H, R²¹ is(—CHR²²)_(m)R²³, m is 1, R²² is —CH₃, —CH₂CH₃, —CH₂CH₂CH₃, benzyl,4-fluoro-phenyl, R²³ is phenyl, 4-fluoro-phenyl, p-tolyl.
 30. Thecompound of claim 1 wherein R³ is H; R⁴ is H, R²¹ is (—CHR²²)_(m)R²³, mis 1, R²² is H, R²³ is phenyl, p-tolyl, 4-fluoro-phenyl,4-methoxy-phenyl, 3-methoxy-phenyl, thiophen-2-yl, thiophen-3-yl,3-fluoro-phenyl, 3-bromo-phenyl, benzothiophen-2-yl,2,4,6-trimethyl-phenyl, 1-ethyl-2-methoxy-phenyl, 3-benzonitrile,3-fluoro-4-methoxy-phenyl.
 31. A composition for the control of a fungalpathogen including the compound of claim 1 and a phytologicallyacceptable carrier material.
 32. The composition of claim 31 wherein thefungal pathogen is one Apple Scab (Venturia inaequalis), Speckled LeafBlotch of Wheat (Septoria tritici), Leaf spot of sugarbeets (Cercosporabeticola), Leaf Spot of peanut (Cercospora arachidicola), and BlackSigatoka (Mycosphaerella fijiensis).
 33. A method for the control andprevention of fungal attack on a plant, the method including the stepsof: applying a fungicidally effective amount of at least one of thecompounds of claim 1 to at least one of the plant, an area adjacent tothe plant, soil adapted to support growth of the plant, a root of theplant, foliage of the plant, and a seed adapted to produce at least oneof the plant and another plant.